Lipase variants and microcapsule compositions comprising such lipase variants
By mutating specific amino acid positions of cotton-like leptophila lipase, a novel lipase variant with improved washing performance and storage stability was developed, solving the odor generation and storage of existing lipases during washing. The problem of insufficient stability.
Patent Information
- Application Number
- CN202411269262.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2018-06-28
- Filing Date
- 2018-09-25
- Publication Date
- 2024-11-08
AI Technical Summary
The existing cotton-like lipase variant of the thermophilus lipase produces odor during the washing process and lacks storage stability, which affects its application performance.
A new lipase variant has been developed that has at least 60% but less than 100% sequence identity and is replaced with the parent lipase at specific amino acid positions, including G23S, D27N, A40I, F51I, E56R, etc. Variation of position and the polynucleotides encoded therein are used to construct vector and host cell expression to form microcapsule compositions containing these variants.
Improves washing performance, reduces odor generation, extends storage stability and increases thermal stability, and extends the shelf life of the product.
Smart Images

Figure BDA0005038197550000101 
Figure BDA0005038197550000111 
Figure BDA0005038197550000471
Abstract
Description
[0001] This application is a divisional application of a Chinese patent application filed on September 25, 2018, with application number 201880061647.1 and invention name “Lipase variants and microcapsule compositions containing such lipase variants”.
[0002] References to sequence listings
[0003] This application contains a Sequence Listing in computer readable form, which is incorporated herein by reference. Technical Field
[0004] The present invention relates to lipase variants, polynucleotides encoding these variants and methods of producing said variants. The present invention also relates to compositions and microcapsule compositions comprising the lipase variants of the present invention and liquid products comprising the microcapsule compositions of the present invention. Background Art
[0005] Lipases are important biocatalysts that have been shown to be useful for various applications. TM Wild-type Thermomyces lanuginosus (synonym Humicola lanuginosa) lipase and variants thereof are commercially available as active ingredients in detergent compositions for the removal of lipid stains by hydrolyzing triglycerides to generate fatty acids.
[0006] Detergent, cleaning and / or fabric care compositions comprise active ingredients which interfere with the ability of lipase to remove lipid stains.Many known Thermomyces lanuginosus lipase variants with good wash performance form odor-producing short chain fatty acids during the wash and / or have short storage stability.
[0007] Therefore, there remains a need and desire for lipases having improved wash performance, reduced odor generation and / or improved storage stability / longer shelf life / increased thermostability. Summary of the invention
[0008] The present invention relates to a variant of a parent lipase, which has lipase activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, V60E,K, K98I, N101D, R118F, G163S, Y220F, T231R, N233R, T244E and P256T.
[0009] Furthermore, the present invention relates to compositions comprising the lipase variants of the present invention and their use in hydrolyzing lipid substrates. Furthermore, the present invention relates to polynucleotides encoding the variants of the present invention; nucleic acid constructs, vectors and host cells comprising these polynucleotides;
[0010] In one aspect, the present invention relates to a microcapsule composition, wherein the membrane of the microcapsule is produced by cross-linking multi-branched polyamines having a molecular weight above 1 kDa, wherein the microcapsule comprises the lipase variant of the present invention.
[0011] In yet another aspect, the present invention relates to microcapsule compositions comprising the lipase variants of the present invention trapped in compartments formed by a membrane produced by crosslinking (a) a multibranched polyamine having a molecular weight greater than 800 Da and (b) an aliphatic amine or aromatic amine having a molecular weight less than 300 Da; wherein the weight ratio of (a) / (b) is in the range of 0.1 to 1000.
[0012] Finally, the present invention relates to a liquid product comprising the microcapsule composition of the present invention.
[0013] definition
[0014] Lipase: The terms "lipase", "lipase enzyme", "lipolytic enzyme", "lipid esterase", "lipolytic polypeptide" and "lipolytic protein" refer to an enzyme in the EC 3.1.1 class as defined in the enzyme nomenclature. It may have lipase activity (triacylglycerol lipase, EC 3.1.1.3), cutinase activity (EC 3.1.1.74), sterol esterase activity (EC 3.1.1.13) and / or wax ester hydrolase activity (EC 3.1.1.50). For the purposes of the present invention, lipase activity is determined according to the procedure described in the Examples. In one aspect, the variants of the invention have at least 20%, e.g., at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or 100% of the lipase activity of the polypeptide of SEQ ID NO: 2.
[0015] Allelic variant: The term "allelic variant" means any of two or more alternative forms of a gene occupying the same chromosomal locus. Allelic variation occurs naturally through mutation and may lead to polymorphism within a population. Gene mutations may be silent (no change in the encoded polypeptide) or may encode a polypeptide with an altered amino acid sequence. An allelic variant of a polypeptide is a polypeptide encoded by an allelic variant of a gene.
[0016] cDNA: The term "cDNA" means a DNA molecule that can be prepared by reverse transcription from a mature, spliced mRNA molecule obtained from a eukaryotic or prokaryotic cell. cDNA lacks intron sequences that may be present in the corresponding genomic DNA. The initial primary RNA transcript is a precursor to mRNA that is processed through a series of steps, including splicing, before appearing as mature, spliced mRNA.
[0017] Coding sequence: The term "coding sequence" means a polynucleotide that directly specifies the amino acid sequence of a variant. The boundaries of the coding sequence are usually determined by an open reading frame that begins with a start codon (e.g., ATG, GTG, or TTG) and ends with a stop codon (e.g., TAA, TAG, or TGA). The coding sequence may be genomic DNA, cDNA, synthetic DNA, or a combination thereof.
[0018] Control sequences: The term "control sequences" means nucleic acid sequences necessary for the expression of a polynucleotide encoding a variant of the present invention. Each control sequence may be native (i.e., from the same gene) or exogenous (i.e., from a different gene) to the polynucleotide encoding the variant, or native or exogenous to each other. Such control sequences include, but are not limited to, leader sequences, polyadenylation sequences, propeptide sequences, promoters, signal peptide sequences, and transcription terminators. At a minimum, control sequences include promoters, and transcription and translation termination signals. Control sequences may be provided with linkers for the purpose of introducing specific restriction sites that facilitate the connection of control sequences to the coding region of the polynucleotide encoding the variant.
[0019] Expression: The term "expression" includes any step involved in the production of the variant including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion.
[0020] Expression vector: The term "expression vector" means a linear or circular DNA molecule that comprises a polynucleotide encoding a variant and is operably linked to control sequences that provide for its expression.
[0021] Fragment: The term "fragment" means a polypeptide having one or more (e.g., several) amino acids that are not present at the amino and / or carboxyl terminus of the polypeptide; wherein the fragment has lipase activity. In one aspect, the fragment comprises at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% of the number of amino acids 1 to 269 of SEQ ID NO: 2, but less than 100%.
[0022] High stringency conditions: The term "high stringency conditions" means that for probes of at least 100 nucleotides in length, standard Southern blotting procedures are followed, with prehybridization and hybridization at 42° C. for 12 to 24 hours in 5X SSPE, 0.3% SDS, 200 micrograms / ml sheared and denatured salmon sperm DNA, and 50% formamide. The carrier material is finally washed three times at 65° C. using 2X SSC, 0.2% SDS for 15 minutes each time.
[0023] Host cell: The term "host cell" means any cell type that is susceptible to transformation, transfection, transduction, etc. with a nucleic acid construct or expression vector comprising a polynucleotide of the present invention. The term "host cell" encompasses any progeny of a parent cell that is not identical to the parent cell due to mutations that occur during replication.
[0024] Improved properties: The term "improved properties" means characteristics associated with a variant that is improved relative to a parent lipase. Such improved properties include, but are not limited to, detergent stability, stability in a detergent with a protease present, protease stability, chemical stability, oxidative stability, pH stability, stability under storage conditions, and thermostability.
[0025] Isolated: The term "isolated" means a substance in a form or environment that does not exist in nature. Non-limiting examples of isolated substances include: (1) any non-naturally occurring substance, (2) any substance including but not limited to any enzyme, variant, nucleic acid, protein, peptide or cofactor, which is at least partially removed from one or more or all naturally occurring components associated with its properties; (3) any substance that has been artificially modified relative to the substance found in nature; or (4) any substance that has been modified by increasing the amount of the substance relative to other components with which it is naturally associated (e.g., multiple copies of a gene encoding the substance; use of a stronger promoter than the promoter naturally associated with the gene encoding the substance). The isolated substance may be present in a fermentation broth sample.
[0026] Low stringency conditions: The term "low stringency conditions" means that for probes of at least 100 nucleotides in length, standard Southern blotting procedures are followed, with prehybridization and hybridization at 42°C for 12 to 24 hours in 5X SSPE, 0.3% SDS, 200 micrograms / ml sheared and denatured salmon sperm DNA, and 25% formamide. The carrier material is finally washed three times at 50°C using 2X SSC, 0.2% SDS for 15 minutes each time.
[0027] Mature polypeptide: The term "mature polypeptide" means a polypeptide in its final form after translation and any post-translational modifications such as N-terminal processing, C-terminal truncation, glycosylation, phosphorylation, etc. In one aspect, the mature polypeptide is amino acids 1 to 269 of SEQ ID NO: 2. It is known in the art that a host cell can produce a mixture of two or more different mature polypeptides (i.e., having different C-terminal and / or N-terminal amino acids) expressed by the same polynucleotide.
[0028] Mature polypeptide coding sequence: The term "mature polypeptide coding sequence" means a polynucleotide encoding a mature polypeptide having lipase activity. In one aspect, the mature polypeptide coding sequence is nucleotides 1 to 807 of SEQ ID NO:1.
[0029] Moderate stringency conditions: The term "moderate stringency conditions" means that for probes of at least 100 nucleotides in length, standard Southern blotting procedures are followed, with prehybridization and hybridization at 42°C for 12 to 24 hours in 5X SSPE, 0.3% SDS, 200 micrograms / ml sheared and denatured salmon sperm DNA, and 35% formamide. The carrier material is finally washed three times at 55°C using 2X SSC, 0.2% SDS for 15 minutes each time.
[0030] Medium-high stringency conditions: The term "medium-high stringency conditions" means that for probes of at least 100 nucleotides in length, standard Southern blotting procedures are followed, with prehybridization and hybridization at 42°C for 12 to 24 hours in 5X SSPE, 0.3% SDS, 200 micrograms / ml sheared and denatured salmon sperm DNA, and 35% formamide. The carrier material is finally washed three times at 60°C using 2X SSC, 0.2% SDS for 15 minutes each time.
[0031] Mutant: The term "mutant" means a polynucleotide encoding a variant.
[0032] Nucleic acid construct: The term "nucleic acid construct" means a single-stranded or double-stranded nucleic acid molecule that is isolated from a naturally occurring gene, or modified in a manner not originally found in nature to contain a nucleic acid segment, or is synthesized, and contains one or more control sequences.
[0033] Operably linked: The term "operably linked" means a configuration in which a control sequence is placed at an appropriate position relative to the coding sequence of a polynucleotide such that the control sequence directs the expression of the coding sequence.
[0034] Parent or parent lipase: The term "parent" or "parent lipase" means a lipase that is altered to produce the enzyme variant of the present invention. The parent lipase may be a naturally occurring (wild-type) polypeptide or a variant or fragment thereof.
[0035] Sequence identity: The relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter "sequence identity".
[0036] For purposes of the present invention, the sequence identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J.Mol.Biol. [Journal of Molecular Biology] 48: 443-453), which is implemented in the Needle program of the EMBOSS software package (EMBOSS: European Molecular Biology Open Software Suite (The European Molecular Biology Open Software Suite), Rice et al., 2000, TrendsGenet. [Genetics Trend] 16: 276-277) (preferred 5.0.0 version or updated version). The parameters used are gap opening penalty 10, gap extension penalty 0.5 and EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix. The output (obtained using non-simplified (-nobrief) option) of the "longest identity" marked by Needle is used as the identity percentage and is calculated as follows:
[0037] (number of identical residues x 100) / (alignment length - total number of gaps in the alignment)
[0038] For the purpose of the present invention, the sequence identity between two deoxynucleotide sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, supra), which is implemented in the Needle program of the EMBOSS software package (EMBOSS: European Molecular Biology Open Software Suite, Rice et al., 2000, supra) (preferred 5.0.0 version or later). The parameters used are gap opening penalty 10, gap extension penalty 0.5, and EDNAFULL (EMBOSS version of NCBI NUC4.4) substitution matrix. The output (obtained using the non-simplified option) of the "longest identity" marked by Needle is used as the identity percentage and is calculated as follows:
[0039] (number of identical deoxyribonucleotides x 100) / (alignment length - total number of gaps in the alignment).
[0040] Stability: The stability of the lipase variants of the present invention can be expressed as the residual activity or residual performance of the lipase during or after exposure to different test conditions, such as storage in a detergent composition, at different temperatures, at different pH, in the presence of different components, such as proteases, chemicals, and / or oxidizing substances (stress conditions), or during use in a washing process. The stability of the lipase variant can be measured relative to the known activity or performance of the parent lipase (e.g., the lipase shown as SEQ ID NO: 2), or alternatively relative to the known activity or performance of the variant lipase when initially added to a detergent composition that is optionally stored refrigerated or frozen, or relative to the lipase variant stored refrigerated or frozen (non-stress conditions).
[0041] Subsequence: The term "subsequence" means a polynucleotide having one or more (e.g., several) nucleotides deleted from the 5' end and / or 3' end of a mature polypeptide coding sequence; wherein the subsequence encodes a fragment having lipase activity. In one aspect, the subsequence comprises at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% of the number of nucleotides 1 to 807 of SEQ ID NO: 1, but less than 100%.
[0042] Variant: The term "variant" means a polypeptide having lipase activity that comprises an alteration (i.e., substitution, insertion and / or deletion) at one or more (e.g., several) positions. Substitution means replacing the amino acid occupying a position with a different amino acid; deletion means removing the amino acid occupying a position; and insertion means adding an amino acid adjacent to and immediately following the amino acid occupying a position. These variants of the present invention have at least 20%, e.g., at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the lipase activity of the polypeptide of SEQ ID NO: 2.
[0043] Very high stringency conditions: The term "very high stringency conditions" means that for probes of at least 100 nucleotides in length, standard Southern blotting procedures are followed, with prehybridization and hybridization at 42° C. for 12 to 24 hours in 5X SSPE, 0.3% SDS, 200 micrograms / ml sheared and denatured salmon sperm DNA, and 50% formamide. The carrier material is finally washed three times at 70° C. with 2X SSC, 0.2% SDS for 15 minutes each time.
[0044] Very low stringency conditions: The term "very low stringency conditions" means that for probes of at least 100 nucleotides in length, standard Southern blotting procedures are followed, with prehybridization and hybridization at 42°C for 12 to 24 hours in 5X SSPE, 0.3% SDS, 200 micrograms / ml sheared and denatured salmon sperm DNA, and 25% formamide. The carrier material is finally washed three times at 45°C using 2X SSC, 0.2% SDS for 15 minutes each time.
[0045] Wild-type lipase: The term "wild-type" lipase means a lipase expressed by a naturally occurring microorganism found in nature, such as a bacterium, yeast, or filamentous fungus.
[0046] Variant naming conventions
[0047] For the purposes of the present invention, the polypeptide disclosed as SEQ ID NO:2 is used to determine the corresponding amino acid residue in another lipase. The amino acid sequence of another lipase is compared with SEQ ID NO:2, and based on the comparison, the amino acid position number corresponding to any amino acid residue in the polypeptide disclosed in SEQ ID NO:2 is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J.Mol.Biol. [Journal of Molecular Biology] 48:443-453), which is implemented in the Needle program of the EMBOSS software package (EMBOSS: European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. [Genetics Trend] 16:276-277) (preferably version 5.0.0 or later). The parameters used are gap opening penalty 10, gap extension penalty 0.5, and EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix.
[0048] The identity of the corresponding amino acid residue in another lipase can be determined by aligning multiple polypeptide sequences using several computer programs using their corresponding default parameters, including but not limited to MUSCLE (Multiple Sequence Comparison by Logarithmic Expectations; Version 3.5 or later; Edgar, 2004, Nucleic Acids Research 32:1792-1797), MAFFT (Version 6.857 or later; Katoh and Kuma, 2002, Nucleic Acids Research 30:3059-3066; Katoh et al., 2005, Nucleic Acids Research 33:511-518; Katoh and Toh, 2007, Bioinformatics 23:372-374; Katoh et al., 2009, Methods in Molecular Biology 23:372-374. Biology 537:39-64; Katoh and Toh, 2010, Bioinformatics 26:1899-1900) and EMBOSS EMMA (version 1.83 or later; Thompson et al., 1994, Nucleic Acids Research 22:4673-4680) using ClustalW.
[0049] When other enzymes deviate from the polypeptide of SEQ ID NO:2 so that traditional sequence-based comparison methods cannot detect their relationship (Lindahl and Elofsson, 2000, J. Mol. Biol. [Journal of Molecular Biology] 295: 613-615), other pairwise sequence comparison algorithms can be used. Higher sensitivity in sequence-based searches can be obtained using search programs that use probabilistic representations (profiles) of families of polypeptides to search databases. For example, the PSI-BLAST program generates multiple profiles through an iterative database search process and is capable of detecting distant homologs (Atschul et al., 1997, Nucleic Acids Res. [Nucleic Acids Research] 25: 3389-3402). Even higher sensitivity can be achieved if a family or superfamily of polypeptides has one or more representatives in a protein structure database. Programs such as GenTHREADER (Jones, 1999, J. Mol. Biol. 287:797-815; McGuffin and Jones, 2003, Bioinformatics 19:874-881) use information from a variety of sources (PSI-BLAST, secondary structure predictions, structural alignment spectra, and solvation potential) as input to a neural network that predicts the structural fold of a query sequence. Similarly, the method of Gough et al., 2000, J. Mol. Biol. 313:903-919 can be used to align sequences of unknown structure with superfamily models present in the SCOP database. These alignments can in turn be used to generate homology models for polypeptides, and the accuracy of such models can be assessed using a variety of tools developed for this purpose.
[0050] For proteins of known structure, several tools and resources can be used to retrieve and generate structural alignments. For example, the SCOP superfamily of proteins has been structurally aligned, and those alignments are accessible and downloadable. Multiple algorithms such as distance alignment matrices (Holm and Sander, 1998, Proteins [protein] 33: 88-96) or combinatorial extensions (Shindyalov and Bourne, 1998, Protein Engineering [protein engineering] 11: 739-747) can be used to align two or more protein structures, and the implementation of these algorithms can be used in addition to query structural databases with structures of interest to find possible structural homologues (e.g., Holm and Park, 2000, Bioinformatics [bioinformatics] 16: 566-567).
[0051] In describing the variants of the present invention, the nomenclature described below has been adapted for ease of reference. Accepted IUPAC single-letter or three-letter abbreviations for amino acids are used.
[0052] replace .For amino acid substitutions, the following nomenclature is used: original amino acid, position, substituted amino acid. Thus, the substitution of threonine at position 226 by alanine is represented as "Thr226Ala" or "T226A". Multiple mutations are separated by a plus sign ("+"), for example, "Gly205Arg+Ser411Phe" or "G205R+S411F" represents the substitution of glycine (G) and serine (S) at position 205 and position 411 by arginine (R) and phenylalanine (F), respectively.
[0053] Missing For amino acid deletions, the following nomenclature is used: original amino acid, position, * Thus, a deletion of glycine at position 195 is indicated as "Gly195*" or "G195*". Multiple deletions are separated by plus signs ("+"), for example, "Gly195*+Ser411*" or "G195*+S411*".
[0054] insert For amino acid insertions, the following nomenclature is used: original amino acid, position, original amino acid, inserted amino acid. Thus, the insertion of lysine after glycine at position 195 is represented as "Gly195GlyLys" or "G195GK". Insertions of multiple amino acids are represented as [original amino acid, position, original amino acid, inserted amino acid #1, inserted amino acid #2; etc.]. For example, the insertion of lysine and alanine after glycine at position 195 is represented as "Gly195GlyLysAla" or "G195GKA".
[0055] In such cases, the inserted amino acid residue(s) are numbered by adding lowercase letters to the position number of the amino acid residue preceding the inserted amino acid residue(s). In the above example, the sequence would therefore be:
[0056] <![CDATA[ Parents: ]]> <![CDATA[ Variants: ]]> 195 195 195a 195b G GKA
[0057] Various changes Variants containing multiple alterations are separated by plus signs ("+"), for example, "Arg170Tyr+Gly195Glu" or "R170Y+G195E" represent that arginine and glycine at positions 170 and 195 are replaced by tyrosine and glutamic acid, respectively.
[0058] Different changesWhen different changes can be introduced at one position, these different changes are separated by a comma, for example "Arg170Tyr,Glu" or "R170Y,E" represents that the arginine at position 170 is replaced by tyrosine or glutamic acid. Thus, "Tyr167Gly,Ala+Arg170Gly,Ala" represents the following variants:
[0059] "Tyr167Gly+Arg170Gly", "Tyr167Gly+Arg170Ala", "Tyr167Ala+Arg170Gly", and "Tyr167Ala+Arg170Ala". DETAILED DESCRIPTION
[0060] Variants of a parent lipase are disclosed, the variants having lipase activity and having at least 60% but less than 100% sequence identity to, for example, SEQ ID NO: 2 derived from Thermomyces lanuginosus.
[0061] Variants
[0062] The present invention provides a variant of a parent lipase, which has lipase activity, has at least 60% but less than 100% sequence identity to SEQ ID NO: 2, and comprises one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, V60E,K, K98I, N101D, R118F, G163S, Y220F, T231R, N233R, T244E and P256T.
[0063] Preferably, the lipase variant has at least 60% but less than 100% sequence identity with SEQ ID NO:2, and is included in one or more substitutions at the positions corresponding to G23S, D27N, A40I, F51I, L, E56R, D57N, V60E, K, K98I, N101D, R118F, G163S, Y220F, T244E and P256T. Preferably, the variant is included in the position corresponding to T231R and / or N233R and additionally comprises one or two substitutions.
[0064] Preferred variants contain substitutions at positions corresponding to G23S. Preferred variants contain substitutions at positions corresponding to D27N. Preferred variants contain substitutions at positions corresponding to A401. Preferred variants contain substitutions at positions corresponding to F51I,L. Preferred variants contain substitutions at positions corresponding to E56R. Preferred variants contain substitutions at positions corresponding to D57N. Preferred variants contain substitutions at positions corresponding to V60E,K. Preferred variants contain substitutions at positions corresponding to K98I. Preferred variants contain substitutions at positions corresponding to N101D. Preferred variants contain substitutions at positions corresponding to R118F. Preferred variants contain substitutions at positions corresponding to G163S. Preferred variants contain substitutions at positions corresponding to Y220F. Preferred variants contain substitutions at positions corresponding to T244E. Preferred variants contain substitutions at positions corresponding to P256T.
[0065] Preferred variants comprise one or more substitutions at positions corresponding to F51I,L, E56R and / or R118F.
[0066] In a preferred embodiment, the variant of the present invention comprises any one of the following group of substitutions:
[0067]
[0068]
[0069] In one embodiment, the variant comprises substitutions at positions corresponding to T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, V60E,K, K98I, N101D, R118F, G163S, Y220F, T244E, and P256T.
[0070] In a preferred embodiment, the variant comprises substitutions corresponding to E56R+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, D57N, V60E,K, K98I, N101D, R118F, G163S, Y220F, T244E and P256T.
[0071] In a preferred embodiment, the variant comprises substitutions at positions corresponding to R118F+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, V60E,K, K98I, N101D, G163S, Y220F, T244E, and P256T.
[0072] In a more preferred embodiment, the variant comprises substitutions at positions corresponding to E56R+R118F+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, D57N, V60E,K, K98I, N101D, G163S, Y220F, T244E, and P256T.
[0073] In an even more preferred embodiment, the variant comprises substitutions at positions corresponding to E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
[0074] In an even more preferred embodiment, the variant comprises substitutions at positions corresponding to F51I,L+E56R+R118F+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, D57N, V60E,K, K98I, N101D, G163S, Y220F, T244E, and P256T.
[0075] In an even more preferred embodiment, the variant comprises substitutions at positions corresponding to F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
[0076] In another more preferred embodiment, the variant comprises substitutions at positions corresponding to G23S+F51I,L+E56R+R118F+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to D27N, A40I, D57N, V60E,K, K98I, N101D, G163S, Y220F, T244E and P256T.
[0077] In yet an even more preferred embodiment, the variant comprises substitutions at positions corresponding to D27N+F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, A40I, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
[0078] In additional even more preferred embodiments, the variant comprises substitutions at positions corresponding to A40I+F51I,L+E56R+R118F+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, D57N, V60E,K, K98I, N101D, G163S, Y220F, T244E, and P256T.
[0079] In yet an even more preferred embodiment, the variant comprises substitutions at positions corresponding to D27N+F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, A40I, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
[0080] In additional even more preferred embodiments, the variant comprises substitutions at positions corresponding to A40I+F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
[0081] In yet an even more preferred embodiment, the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
[0082] In a further preferred embodiment, the variant comprises a substitution at a position corresponding to F51I,L+E56R+D57N+K98I+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, N101D, G163S, Y220F, and T244E. In yet another more preferred embodiment, the variant comprises a substitution at a position corresponding to F51I,L+E56R+D57N+K98I+R118F+G163S+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60EK, N101D, Y220F, and T244E.
[0083] In yet an even more preferred embodiment, the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+K98I+R118F+G163S+T231R+N233R+T244E+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, N101D, and Y220F.
[0084] In a further preferred embodiment, the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+V60E,K+K98I+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, N101D, G163S, Y220F, and T244E.
[0085] In a further preferred embodiment, the variant comprises a substitution at a position corresponding to F51I,L+E56R+D57N+V60E,K+K98I+N101D+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, G163S, Y220F, and T244E. In a further preferred embodiment, the variant comprises a substitution at a position corresponding to F51I,L+E56R+D57N+N101D+K98I+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, N101D, G163S, Y220F, and T244E.
[0086] Particularly preferred embodiments include variants comprising substitutions at positions corresponding to one of the following group of substitutions:
[0087] R118F+T231R+N233R+P256T;
[0088] A40I+R118F+T231R+N233R;
[0089] F51I+E56R+R118F+T231R+N233R;
[0090] F51L+E56R+R118F+T231R+N233R;
[0091] E56R+D57N+R118F+T231R+N233R;
[0092] E56R+V60K+R118F+T231R+N233R;
[0093] G23S+E56R+R118F+T231R+N233R;
[0094] D27N+E56R+R118F+T231R+N233R;
[0095] F51I+E56R+R118F+T231R+N233R;
[0096] E56R+R118F+T231R+N233R+P256T;
[0097] G23S+D27N+E56R+R118F+T231R+N233R;
[0098] G23S+F51I+E56R+R118F+T231R+N233R;
[0099] G23S+E56R+R118F+T231R+N233R+P256T;
[0100] D27N+F51I+E56R+R118F+T231R+N233R;
[0101] D27N+E56R+R118F+T231R+N233R+P256T;
[0102] F51I+E56R+R118F+T231R+N233R+P256T;
[0103] G23S+D27N+F51I+E56R+R118F+T231R+N233R;
[0104] G23S+D27N+E56R+R118F+T231R+N233R+P256T;
[0105] G23S+D27N+F51I+E56R+V60K+R118F+T231R+N233R+P256T;
[0106] G23S+D27N+F51I+E56R+V60E+R118F+T231R+N233R+P256T;
[0107] G23S+F51I+E56R+R118F+T231R+N233R+P256T;
[0108] D27N+F51I+E56R+R118F+T231R+N233R+P256T;
[0109] G23S+D27N+F51I+E56R+R118F+T231R+N233R+P256T;
[0110] A40I+E56R+R118F+T231R+N233R;
[0111] F51L+E56R+R118F+T231R+N233R;
[0112] D57N+E56R+R118F+T231R+N233R;
[0113] K98I+E56R+R118F+T231R+N233R;
[0114] G163S+E56R+R118F+T231R+N233R;
[0115] A40I+F51L+E56R+R118F+T231R+N233R;
[0116] A40I+D57N+E56R+R118F+T231R+N233R;
[0117] A40I+K98I+E56R+R118F+T231R+N233R;
[0118] A40I+G163S+E56R+R118F+T231R+N233R;
[0119] A40I+E56R+R118F+T231R+N233R+P256T;
[0120] F51L+D57N+E56R+R118F+T231R+N233R;
[0121] F51L+K98I+E56R+R118F+T231R+N233R;
[0122] F51L+G163S+E56R+R118F+T231R+N233R;
[0123] F51L+E56R+R118F+T231R+N233R+P256T;
[0124] D57N+K98I+E56R+R118F+T231R+N233R;
[0125] D57N+G163S+E56R+R118F+T231R+N233R;
[0126] D57N+E56R+R118F+T231R+N233R+P256T;
[0127] K98I+G163S+E56R+R118F+T231R+N233R;
[0128] K98I+E56R+R118F+T231R+N233R+P256T;
[0129] G163S+E56R+R118F+T231R+N233R+P256T;
[0130] A40I+F51L+D57N+E56R+R118F+T231R+N233R;
[0131] A40I+F51L+K98I+E56R+R118F+T231R+N233R;
[0132] A40I+F51L+G163S+E56R+R118F+T231R+N233R;
[0133] A40I+F51L+E56R+R118F+T231R+N233R+P256T;
[0134] A40I+D57N+K98I+E56R+R118F+T231R+N233R;
[0135] A40I+D57N+G163S+E56R+R118F+T231R+N233R;
[0136] A40I+D57N+E56R+R118F+T231R+N233R+P256T;
[0137] A40I+K98I+G163S+E56R+R118F+T231R+N233R;
[0138] A40I+K98I+E56R+R118F+T231R+N233R+P256T;
[0139] A40I+G163S+E56R+R118F+T231R+N233R+P256T;
[0140] F51L+D57N+K98I+E56R+R118F+T231R+N233R;
[0141] F51L+D57N+G163S+E56R+R118F+T231R+N233R;
[0142] F51L+D57N+E56R+R118F+T231R+N233R+P256T;
[0143] F51L+K98I+G163S+E56R+R118F+T231R+N233R;
[0144] F51L+K98I+E56R+R118F+T231R+N233R+P256T;
[0145] F51L+G163S+E56R+R118F+T231R+N233R+P256T;
[0146] D57N+K98I+G163S+E56R+R118F+T231R+N233R;
[0147] D57N+K98I+E56R+R118F+T231R+N233R+P256T;
[0148] D57N+G163S+E56R+R118F+T231R+N233R+P256T;
[0149] K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0150] A40I+F51L+D57N+K98I+E56R+R118F+T231R+N233R;
[0151] A40I+F51L+D57N+G163S+E56R+R118F+T231R+N233R;
[0152] A40I+F51L+D57N+E56R+R118F+T231R+N233R+P256T;
[0153] A40I+F51L+K98I+G163S+E56R+R118F+T231R+N233R;
[0154] A40I+F51L+K98I+E56R+R118F+T231R+N233R+P256T;
[0155] A40I+F51L+G163S+E56R+R118F+T231R+N233R+P256T;
[0156] A40I+D57N+K98I+G163S+E56R+R118F+T231R+N233R;
[0157] A40I+D57N+K98I+E56R+R118F+T231R+N233R+P256T;
[0158] A40I+D57N+G163S+E56R+R118F+T231R+N233R+P256T;
[0159] A40I+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0160] F51L+D57N+K98I+G163S+E56R+R118F+T231R+N233R;
[0161] F51L+D57N+K98I+E56R+R118F+T231R+N233R+P256T;
[0162] F51L+D57N+G163S+E56R+R118F+T231R+N233R+P256T;
[0163] F51L+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0164] D57N+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0165] A40I+F51L+D57N+K98I+G163S+E56R+R118F+T231R+N233R;
[0166] A40I+F51L+D57N+K98I+E56R+R118F+T231R+N233R+P256T;
[0167] A40I+F51L+D57N+G163S+E56R+R118F+T231R+N233R+P256T;
[0168] A40I+F51L+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0169] A40I+D57N+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0170] F51L+D57N+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0171] A40I+F51L+D57N+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0172] A40I+F51L+E56R+D57N+K98I+R118F+G163S+T231R+N233R+P256T;
[0173] A40I+E56R+R118F+T231R+N233R;
[0174] E56R+R118F+T231R+N233R+T244E;
[0175] G23S+D27N+E56R+R118F+T231R+N233R;
[0176] G23S+A40I+E56R+R118F+T231R+N233R;
[0177] G23S+F51I+E56R+R118F+T231R+N233R;
[0178] G23S+E56R+R118F+T231R+N233R+T244E;
[0179] G23S+E56R+R118F+T231R+N233R+P256T;
[0180] D27N+A40I+E56R+R118F+T231R+N233R;
[0181] D27N+F51I+E56R+R118F+T231R+N233R;
[0182] D27N+E56R+R118F+T231R+N233R+T244E;
[0183] D27N+E56R+R118F+T231R+N233R+P256T;
[0184] A40I+F51I+E56R+R118F+T231R+N233R;
[0185] A40I+E56R+R118F+T231R+N233R+T244E;
[0186] A40I+E56R+R118F+T231R+N233R+P256T;
[0187] F51I+E56R+R118F+T231R+N233R+T244E;
[0188] F51I+E56R+R118F+T231R+N233R+P256T;
[0189] E56R+R118F+T231R+N233R+T244E+P256T;
[0190] G23S+D27N+A40I+E56R+R118F+T231R+N233R;
[0191] G23S+D27N+A40I+E56R+V60K+R118F+T231R+N233R;
[0192] G23S+D27N+A40I+E56R+V60E+R118F+T231R+N233R;
[0193] G23S+D27N+F51I+E56R+R118F+T231R+N233R;
[0194] G23S+D27N+E56R+R118F+T231R+N233R+T244E;
[0195] G23S+D27N+E56R+R118F+T231R+N233R+P256T;
[0196] G23S+A40I+F51I+E56R+R118F+T231R+N233R;
[0197] G23S+A40I+E56R+R118F+T231R+N233R+T244E;
[0198] G23S+A40I+E56R+R118F+T231R+N233R+P256T;
[0199] G23S+F51I+E56R+R118F+T231R+N233R+T244E;
[0200] G23S+F51I+E56R+R118F+T231R+N233R+P256T;
[0201] G23S+E56R+R118F+T231R+N233R+T244E+P256T;
[0202] G23S+E56R+V60K+R118F+T231R+N233R+T244E+P256T;
[0203] G23S+E56R+V60E+R118F+T231R+N233R+T244E+P256T;
[0204] D27N+A40I+F51I+E56R+R118F+T231R+N233R;
[0205] D27N+A40I+E56R+R118F+T231R+N233R+T244E;
[0206] D27N+A40I+E56R+R118F+T231R+N233R+P256T;
[0207] D27N+F51I+E56R+R118F+T231R+N233R+T244E;
[0208] D27N+F51I+E56R+R118F+T231R+N233R+P256T;
[0209] D27N+E56R+R118F+T231R+N233R+T244E+P256T;
[0210] A40I+F51I+E56R+R118F+T231R+N233R+T244E;
[0211] A40I+F51I+E56R+R118F+T231R+N233R+P256T;
[0212] A40I+E56R+R118F+T231R+N233R+T244E+P256T;
[0213] F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0214] F51I+E56R+V60K+R118F+T231R+N233R+T244E+P256T;
[0215] F51I+E56R+V60E+R118F+T231R+N233R+T244E+P256T;
[0216] G23S+D27N+A40I+F51I+E56R+R118F+T231R+N233R;
[0217] G23S+D27N+A40I+F51I+E56R+V60K+R118F+T231R+N233R;
[0218] G23S+D27N+A40I+F51I+E56R+V60E+R118F+T231R+N233R;
[0219] G23S+D27N+A40I+E56R+R118F+T231R+N233R+T244E;
[0220] G23S+D27N+A40I+E56R+V60K+R118F+T231R+N233R+T244E;
[0221] G23S+D27N+A40I+E56R+V60E+R118F+T231R+N233R+T244E;
[0222] G23S+D27N+A40I+E56R+R118F+T231R+N233R+P256T;
[0223] G23S+D27N+F51I+E56R+R118F+T231R+N233R+T244E;
[0224] G23S+D27N+F51I+E56R+R118F+T231R+N233R+P256T;
[0225] G23S+D27N+E56R+R118F+T231R+N233R+T244E+P256T;
[0226] G23S+A40I+F51I+E56R+R118F+T231R+N233R+T244E;
[0227] G23S+A40I+F51I+E56R+R118F+T231R+N233R+P256T;
[0228] G23S+A40I+E56R+R118F+T231R+N233R+T244E+P256T;
[0229] G23S+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0230] D27N+A40I+F51I+E56R+R118F+T231R+N233R+T244E;
[0231] D27N+A40I+F51I+E56R+R118F+T231R+N233R+P256T;
[0232] D27N+A40I+E56R+R118F+T231R+N233R+T244E+P256T;
[0233] D27N+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0234] A40I+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0235] A40I+F51I+E56R+V60K+R118F+T231R+N233R+T244E+P256T;
[0236] A40I+F51I+E56R+V60E+R118F+T231R+N233R+T244E+P256T;
[0237] G23S+D27N+A40I+F51I+E56R+R118F+T231R+N233R+T244E;
[0238] G23S+D27N+A40I+F51I+E56R+V60K+R118F+T231R+N233R+T244E;G23S+D27N+A40I+F51I+E56R+R118F+T231R+N233R+P256T;
[0239] G23S+D27N+A40I+F51I+E56R+V60K+R118F+T231R+N233R+P256T;G23S+D27N+A40I+F51I+E56R+V60E+R118F+T231R+N233R+P256T;
[0240] G23S+D27N+A40I+E56R+R118F+T231R+N233R+T244E+P256T;
[0241] G23S+D27N+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0242] G23S+A40I+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0243] D27N+A40I+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0244] D27N+A40I+F51I+E56R+V60K+R118F+T231R+N233R+T244E+P256T;D27N+A40I+F51I+E56R+V60E+R118F+T231R+N233R+T244E+P256T;G23S+D27N+A40I+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0245] G23S+D27N+A40I+F51I+E56R+K98I+N101D+R118F+T231R+N233R+T244E+P256T;
[0246] G23S+D27N+A40I+F51I+E56R+V60K+R118F+T231R+N233R+T244E+P256T;
[0247] G23S+D27N+A40I+F51I+E56R+V60E+R118F+T231R+N233R+T244E+P256T;
[0248] F51I+E56R+R118F+T231R+N233R;
[0249] E56R+R118F+T231R+N233R+T244E;
[0250] D27N+F51I+E56R+R118F+T231R+N233R;
[0251] D27N+E56R+R118F+T231R+N233R+T244E;
[0252] F51I+E56R+R118F+T231R+N233R+T244E;
[0253] D27N+F51I+E56R+R118F+T231R+N233R+T244E;
[0254] G23S+E56R+R118F+T231R+N233R;
[0255] D27N+E56R+R118F+T231R+N233R;
[0256] K98I+E56R+R118F+T231R+N233R;
[0257] Y220F+E56R+R118F+T231R+N233R;
[0258] E56R+R118F+T231R+N233R+T244E;
[0259] G23S+D27N+E56R+R118F+T231R+N233R;
[0260] G23S+F51I+E56R+R118F+T231R+N233R;
[0261] G23S+K98I+E56R+R118F+T231R+N233R;
[0262] G23S+Y220F+E56R+R118F+T231R+N233R;
[0263] G23S+E56R+R118F+T231R+N233R+T244E;
[0264] G23S+E56R+R118F+T231R+N233R+P256T;
[0265] D27N+F51I+E56R+R118F+T231R+N233R;
[0266] D27N+K98I+E56R+R118F+T231R+N233R;
[0267] D27N+Y220F+E56R+R118F+T231R+N233R;
[0268] D27N+E56R+R118F+T231R+N233R+T244E;
[0269] D27N+E56R+R118F+T231R+N233R+P256T;
[0270] F51I+K98I+E56R+R118F+T231R+N233R;
[0271] F51I+Y220F+E56R+R118F+T231R+N233R;
[0272] F51I+E56R+R118F+T231R+N233R+T244E;
[0273] F51I+E56R+R118F+T231R+N233R+P256T;
[0274] K98I+Y220F+E56R+R118F+T231R+N233R;
[0275] K98I+E56R+R118F+T231R+N233R+T244E;
[0276] K98I+E56R+R118F+T231R+N233R+P256T;
[0277] Y220F+E56R+R118F+T231R+N233R+T244E;
[0278] Y220F+E56R+R118F+T231R+N233R+P256T;
[0279] E56R+R118F+T231R+N233R+T244E+P256T;
[0280] G23S+D27N+F51I+E56R+R118F+T231R+N233R;
[0281] G23S+D27N+K98I+E56R+R118F+T231R+N233R;
[0282] G23S+D27N+Y220F+E56R+R118F+T231R+N233R;
[0283] G23S+D27N+E56R+R118F+T231R+N233R+T244E;
[0284] G23S+D27N+E56R+R118F+T231R+N233R+P256T;
[0285] G23S+F51I+K98I+E56R+R118F+T231R+N233R;
[0286] G23S+F51I+Y220F+E56R+R118F+T231R+N233R;
[0287] G23S+F51I+E56R+R118F+T231R+N233R+T244E;
[0288] G23S+F51I+E56R+R118F+T231R+N233R+P256T;
[0289] G23S+K98I+Y220F+E56R+R118F+T231R+N233R;
[0290] G23S+K98I+E56R+R118F+T231R+N233R+T244E;
[0291] G23S+K98I+E56R+R118F+T231R+N233R+P256T;
[0292] G23S+Y220F+E56R+R118F+T231R+N233R+T244E;
[0293] G23S+Y220F+E56R+R118F+T231R+N233R+P256T;
[0294] G23S+E56R+R118F+T231R+N233R+T244E+P256T;
[0295] D27N+F51I+K98I+E56R+R118F+T231R+N233R;
[0296] D27N+F51I+Y220F+E56R+R118F+T231R+N233R;
[0297] D27N+F51I+E56R+R118F+T231R+N233R+T244E;
[0298] D27N+F51I+E56R+R118F+T231R+N233R+P256T;
[0299] D27N+K98I+Y220F+E56R+R118F+T231R+N233R;
[0300] D27N+K98I+E56R+R118F+T231R+N233R+T244E;
[0301] D27N+K98I+E56R+R118F+T231R+N233R+P256T;
[0302] D27N+Y220F+E56R+R118F+T231R+N233R+T244E;
[0303] D27N+Y220F+E56R+R118F+T231R+N233R+P256T;
[0304] D27N+E56R+R118F+T231R+N233R+T244E+P256T;
[0305] F51I+K98I+Y220F+E56R+R118F+T231R+N233R;
[0306] F51I+K98I+E56R+R118F+T231R+N233R+T244E;
[0307] F51I+K98I+E56R+R118F+T231R+N233R+P256T;
[0308] F51I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0309] F51I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0310] F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0311] K98I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0312] K98I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0313] K98I+E56R+R118F+T231R+N233R+T244E+P256T;
[0314] Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0315] G23S+D27N+F51I+K98I+E56R+R118F+T231R+N233R;
[0316] G23S+D27N+F51I+Y220F+E56R+R118F+T231R+N233R;
[0317] G23S+D27N+F51I+E56R+R118F+T231R+N233R+T244E;
[0318] G23S+D27N+F51I+E56R+R118F+T231R+N233R+P256T;
[0319] G23S+D27N+K98I+Y220F+E56R+R118F+T231R+N233R;
[0320] G23S+D27N+K98I+E56R+R118F+T231R+N233R+T244E;
[0321] G23S+D27N+K98I+E56R+R118F+T231R+N233R+P256T;
[0322] G23S+D27N+Y220F+E56R+R118F+T231R+N233R+T244E;
[0323] G23S+D27N+Y220F+E56R+R118F+T231R+N233R+P256T;
[0324] G23S+D27N+E56R+R118F+T231R+N233R+T244E+P256T;
[0325] G23S+F51I+K98I+Y220F+E56R+R118F+T231R+N233R;
[0326] G23S+F51I+K98I+E56R+R118F+T231R+N233R+T244E;
[0327] G23S+F51I+K98I+E56R+R118F+T231R+N233R+P256T;
[0328] G23S+F51I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0329] G23S+F51I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0330] G23S+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0331] G23S+K98I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0332] G23S+K98I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0333] G23S+K98I+E56R+R118F+T231R+N233R+T244E+P256T;
[0334] G23S+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0335] D27N+F51I+K98I+Y220F+E56R+R118F+T231R+N233R;
[0336] D27N+F51I+K98I+E56R+R118F+T231R+N233R+T244E;
[0337] D27N+F51I+K98I+E56R+R118F+T231R+N233R+P256T;
[0338] D27N+F51I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0339] D27N+F51I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0340] D27N+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0341] D27N+K98I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0342] D27N+K98I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0343] D27N+K98I+E56R+R118F+T231R+N233R+T244E+P256T;
[0344] D27N+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0345] F51I+K98I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0346] F51I+K98I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0347] F51I+K98I+E56R+R118F+T231R+N233R+T244E+P256T;
[0348] F51I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0349] K98I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0350] G23S+D27N+F51I+K98I+Y220F+E56R+R118F+T231R+N233R;
[0351] G23S+D27N+F51I+K98I+E56R+R118F+T231R+N233R+T244E;
[0352] G23S+D27N+F51I+K98I+E56R+R118F+T231R+N233R+P256T;
[0353] G23S+D27N+F51I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0354] G23S+D27N+F51I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0355] G23S+D27N+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[0356] G23S+D27N+K98I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0357] G23S+D27N+K98I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0358] G23S+D27N+K98I+E56R+R118F+T231R+N233R+T244E+P256T;
[0359] G23S+D27N+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0360] G23S+F51I+K98I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0361] G23S+F51I+K98I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0362] G23S+F51I+K98I+E56R+R118F+T231R+N233R+T244E+P256T;
[0363] G23S+F51I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0364] G23S+K98I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0365] D27N+F51I+K98I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0366] D27N+F51I+K98I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0367] D27N+F51I+K98I+E56R+R118F+T231R+N233R+T244E+P256T;
[0368] D27N+F51I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0369] D27N+K98I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0370] F51I+K98I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0371] G23S+D27N+F51I+K98I+Y220F+E56R+R118F+T231R+N233R+T244E;
[0372] G23S+D27N+F51I+K98I+Y220F+E56R+R118F+T231R+N233R+P256T;
[0373] G23S+D27N+F51I+K98I+E56R+R118F+T231R+N233R+T244E+P256T;
[0374] G23S+D27N+F51I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0375] G23S+D27N+K98I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0376] G23S+F51I+K98I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0377] D27N+F51I+K98I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0378] G23S+D27N+F51I+K98I+Y220F+E56R+R118F+T231R+N233R+T244E+P256T;
[0379] G23S+D27N+F51I+E56R+K98I+R118F+Y220F+T231R+N233R+T244E+P256T.
[0380] The lipase variants of the present invention have at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% identity, at least 96%, at least 97%, at least 98%, or at least 99% but less than 100% sequence identity with the parent lipase.
[0381] In a preferred embodiment, the variant of the present invention has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% identity, at least 96%, at least 97%, at least 98%, or at least 99% but less than 100% sequence identity with SEQ ID NO:2.
[0382] The variants of the invention may have 1-40, 1-30, 1-20, such as 1-12, such as 1-11, such as 1-10, such as 1-9, such as 1-8, such as 1-7, such as 1-6, such as 1-5, such as 1-4, such as 1-3, or such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 substitutions.
[0383] The variants of the present invention may have one or more of the following properties compared to the parent lipase: improved wash performance, reduced odor generation, improved storage stability, longer shelf life and / or increased thermostability.
[0384] The lipase variants of the invention may further comprise one or more additional substitutions at one or more (eg, several) other positions.
[0385] The amino acid changes may be of a minor nature, i.e., conservative amino acid substitutions or insertions that do not significantly affect the folding and / or activity of the protein; small deletions, typically 1-30 amino acids; small amino-terminal or carboxyl-terminal extensions, such as an amino-terminal methionine residue; small linker peptides of up to 20-25 residues; or small extensions that facilitate purification by altering the net charge or another function (e.g., a polyhistidine stretch, an antigenic epitope, or a binding domain).
[0386] Examples of conservative substitutions are within the following groups: basic amino acids (arginine, lysine and histidine), acidic amino acids (glutamic acid and aspartic acid), polar amino acids (glutamine and asparagine), hydrophobic amino acids (leucine, isoleucine and valine), aromatic amino acids (phenylalanine, tryptophan and tyrosine) and small amino acids (glycine, alanine, serine, threonine and methionine). Amino acid substitutions that generally do not alter specific activity are known in the art and are described, for example, by H. Neurath and RL Hill, 1979, in The Proteins, Academic Press, New York. Common substitutions are Ala / Ser, Val / Ile, Asp / Glu, Thr / Ser, Ala / Gly, Ala / Thr, Ser / Asn, Ala / Val, Ser / Gly, Tyr / Phe, Ala / Pro, Lys / Arg, Asp / Asn, Leu / Ile, Leu / Val, Ala / Glu, and Asp / Gly.
[0387] Alternatively, these amino acid changes have such a property that the physicochemical properties of the polypeptide are changed. For example, these amino acid changes can improve the thermal stability of the polypeptide, change the substrate specificity, change the optimal pH, etc.
[0388] Essential amino acids in a polypeptide can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine scanning mutagenesis (Cunningham and Wells, 1989, Science 244: 1081-1085). In the latter technique, single alanine mutations are introduced at every residue in the molecule, and the resulting mutant molecules are tested for lipase activity to identify amino acid residues that are critical to the activity of the molecule. See also, Hilton et al., 1996, J. Biol. Chem. 271: 4699-4708. The active site of an enzyme or other biological interaction can also be determined by physical analysis of the structure, such as by techniques such as nuclear magnetic resonance, crystallography, electron diffraction, or photoaffinity labeling, together with mutations to putative contact site amino acids. See, e.g., de Vos et al., 1992, Science 255:306-312; Smith et al., 1992, J. Mol. Biol. 224:899-904; Wlodaver et al., 1992, FEBS Lett. 309:59-64. The identities of essential amino acids can also be inferred from alignments with related polypeptides.
[0389] The variant may consist of or contain at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90% or at least 95% of the number of amino acids of SEQ ID NO:2.
[0390] Parent lipase
[0391] The parent lipase may be selected from the group consisting of:
[0392] a) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% identity, at least 96%, at least 97%, at least 98%, or at least 99%, or 100% sequence identity to SEQ ID NO: 2;
[0393] b) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions, medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions with (i) the polypeptide coding sequence of SEQ ID NO: 1 or (ii) the full-length complementary sequence of (i);
[0394] c) a polypeptide encoded by a polynucleotide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to SEQ ID NO: 1; and
[0395] d) A fragment of the polypeptide of SEQ ID NO:2.
[0396] In one aspect of the invention, the parent lipase has at least 60%, such as at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide of SEQ ID NO: 2 and has lipase activity.
[0397] In one aspect, the amino acid sequence of the parent differs from the polypeptide of SEQ ID NO:2 by up to 40 amino acids, e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, or 40.
[0398] In another aspect, the parent comprises or consists of the amino acid sequence of SEQ ID NO:2.
[0399] On the other hand, the parent is a fragment of the polypeptide of SEQ ID NO:2, which fragment contains at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% of the number of amino acids of SEQ ID NO:2.
[0400] In another embodiment, the parent is an allelic variant of the polypeptide of SEQ ID NO:2.
[0401] On the other hand, the parent lipase is encoded by a polynucleotide that hybridizes to (i) the polypeptide coding sequence of SEQ ID NO: 1, (ii) the full-length complementary sequence of (i) under very low stringency conditions, low stringency conditions, medium stringency conditions, medium-high stringency conditions, high stringency conditions or very high stringency conditions (Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, 2nd Edition, Cold Spring Harbor, New York).
[0402] The polynucleotide of SEQ ID NO:1 or its subsequence, together with the polypeptide of SEQ ID NO:2 or its fragment, can be used to design nucleic acid probes to identify and clone the DNA encoding the parent of the strain from different genera or species according to methods well known in the art. In particular, such probes can be used to hybridize with the genomic DNA or cDNA of the cell of interest, so as to identify and separate the corresponding gene therein, following standard Southern blotting procedures. Such probes can be significantly shorter than the complete sequence, but the length should be at least 15, such as at least 25, at least 35, or at least 70 nucleotides. Preferably, the nucleic acid probe is at least 100 nucleotides in length, for example, at least 200 nucleotides, at least 300 nucleotides, at least 400 nucleotides, at least 500 nucleotides, at least 600 nucleotides, at least 700 nucleotides, at least 800 nucleotides, or at least 900 nucleotides in length. Both DNA and RNA probes can be used. The probe is typically labeled (e.g., with 32 P. 3 H. 35 S, biotin, or avidin) for detecting the corresponding gene. Such probes are encompassed in the present invention.
[0403] Genomic DNA or cDNA libraries prepared by such other bacterial strains can be screened for DNA that hybridizes with the probe described above and encodes the parent. Genomic DNA or other DNA from such other bacterial strains can be separated by agarose or polyacrylamide gel electrophoresis or other separation techniques. DNA from the library or the separated DNA can be transferred to and fixed on nitrocellulose or other suitable carrier materials. In order to identify clones or DNA that hybridize with SEQ ID NO:1 or its subsequences, the carrier material is used in Southern blots.
[0404] For purposes of the present invention, hybridization means hybridization of a polynucleotide to a labeled nucleic acid probe corresponding to: (i) SEQ ID NO: 1; (ii) the polypeptide coding sequence of SEQ ID NO: 1; (iii) its full-length complementary sequence; or (iv) a subsequence thereof; the hybridization is carried out under very low to very high stringency conditions. Molecules that hybridize to the nucleic acid probe under these conditions can be detected using, for example, X-ray film or any other detection means known in the art.
[0405] In one aspect, the nucleic acid probe is the polypeptide coding sequence of SEQ ID NO: 1. In another aspect, the nucleic acid probe is at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90% or at least 95% of the number of nucleotides of SEQ ID NO: 1. In another aspect, the nucleic acid probe is a polynucleotide encoding: a polypeptide of SEQ ID NO: 2; a polypeptide thereof; or a fragment thereof. In another aspect, the nucleic acid probe is SEQ ID NO: 1.
[0406] In another embodiment, the parent is encoded by a polynucleotide having at least 60%, such as at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the polypeptide coding sequence of SEQ ID NO: 1.
[0407] The polypeptide may be a hybrid polypeptide in which a region of one polypeptide is fused at the N-terminus or C-terminus of a region of another polypeptide.
[0408] The parent lipase can be a fusion polypeptide or a cleavable fusion polypeptide, wherein another polypeptide is fused at the N-terminus or C-terminus of the polypeptide of the present invention. Fusion polypeptides are produced by fusing a polynucleotide encoding another polypeptide to a polynucleotide of the present invention. Techniques for producing fusion polypeptides are known in the art, and include connecting the coding sequence of the encoded polypeptide so that they conform to the reading frame, and the expression of the fusion polypeptide is under the control of one or more identical promoters and terminators. Fusion polypeptides can also be constructed using intein technology, wherein fusion polypeptides are produced after translation (Cooper et al., 1993, EMBO J. [Journal of the European Molecular Biology Association] 12: 2575-2583; Dawson et al., 1994, Science [Science] 266: 776-779).
[0409] The fusion polypeptide may further comprise a cleavage site between the two polypeptides. When the fusion protein is secreted, the site is cleaved, thereby releasing the two polypeptides. Examples of cleavage sites include, but are not limited to, those disclosed in the following literature: Martin et al., 2003, J. Ind. Microbiol. Biotechnol. [Industrial Microbiology Journal] 3:568-576; Svetina et al., 2000, J. Biotechnol. [Journal of Biotechnology] 76:245-251; Rasmussen-Wilson et al., 1997, Appl. Environ. Microbiol. [Applied and Environmental Microbiology] 63:3488-3493; Ward et al., 199 5, Biotechnology 13:498-503; and Contreras et al., 1991, Biotechnology 9:378-381; Eaton et al., 1986, Biochemistry 25:505-512; Collins-Racie et al., 1995, Biotechnology 13:982-987; Carter et al., 1989, Proteins: Structure, Function, and Genetics 6:240-248; and Stevens, 2003, Drug Discovery World 4:35-48.
[0410] The parent lipase can be obtained from microorganisms of any genus. For the purposes of the present invention, as used herein in conjunction with a given source, the term "obtained from" should mean that the parent encoded by the polynucleotide is produced by the source or by a strain into which the polynucleotide from the source has been inserted. On the one hand, the parent is secreted extracellularly.
[0411] The parent can be a bacterial lipase. For example, the parent can be a gram-positive bacterial polypeptide, such as Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Ocean Bacillus, Staphylococcus, Streptococcus, Streptomyces or Thermospora lipase; or a gram-negative bacterial polypeptide, such as Campylobacter, Escherichia coli, Flavobacterium, Fusobacterium, Helicobacter, Silvae, Neisseria, Pseudomonas, Salmonella or Ureaplasma lipase.
[0412] In one aspect, the parent is a Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus pumilus, Bacillus stearothermophilus, Bacillus subtilis, or Bacillus thuringiensis lipase.
[0413] In another aspect, the parent is a Streptococcus equisimilis, Streptococcus pyogenes, Streptococcus uberis, or Streptococcus equi subsp. Zooepidemicus lipase.
[0414] In another aspect, the parent is a Streptomyces achromogenes, Streptomyces avermitilis, Streptomyces coelicolor, Streptomyces griseus, or Streptomyces lividans lipase.
[0415] In another aspect, the parent is a Thermobifida alba or Thermobifida fusca (formerly Thermobifida fusca) lipase.
[0416] The parent can be a fungal lipase. For example, the parent can be a yeast lipase, such as Candida, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces or Yarrowia lipase; or a filamentous fungal lipase, such as Acremonium, Agaricus, Alternaria, Aspergillus, Short-stalked Atractylodes, Botryospaeria, Pseudomonas, Trichosporon, Chrysosporium, Claviceps, Coprinus, Coprinus, Coptis, Corydoraspermum, Claviceps, Cryptococcus, Cryptococcus, Diplosporus, Black Ear, Filosporin, etc. , Fusarium, Gibberellum, Holomagnem, Humicola, Rake Tooth, Lentinula, Leptospaeria, Magnaporthe, Melanocarpus, Meripilus, Mucor, Myceliophthora, Neotrichia, Neurospora, Paecilomyces, Penicillium, Flat Leather, Ruminochytrium, Poitrasia, Pseudomonas, Pseudo-Trichoderma, Rhizomucor, Schizophyllum, Columnar Acremonium, Talaromyces, Thermoascus, Thielavia, Toxoplasma, Trichoderma, Trichoderma, Verticillium, Agrocybe, or Xylaria lipase.
[0417] In another aspect, the parent is a Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasii, Saccharomyces kluyveri, Saccharomyces norbensis, or Saccharomyces oviformis lipase.
[0418] In another aspect, the parent is Acremonium cellulolyticus, Aspergillus aculeatus, Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae, Chrysosporium inops, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium merdarium, Chrysosporium pannicola, Chrysosporium queenslandicum), Chrysosporium tropicum, Chrysosporium zonatum, Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusarium pseudospore sporotrichioides), Fusarium sulphureum, Fusarium torulosum, Fusarium trichothecioides, Fusarium venenatum, Humicolagrisea), Humicola insolens, Humicola lanuginosa, Irpex lacteus, Mucor miehei, Myceliophthora thermophila, Neurosporacrassa, Penicillium funiculosum, Penicillium purpurogenum, Phanerochaete chrysosporium, Thielavia achromatica, Thielavia albomyces, Thielavia albopilosa, Thielavia australeinsis, Thielaviafimeti, Thielavia microspora, Thielavia ovata ovispora, Thielavia peruviana, Thielavia setosa, Thielavia spededonium, Thielavia subthermophila, Thielavia terrestris, Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei or Trichoderma viride lipase.
[0419] In another aspect, the parent is a Thermomyces lanuginosus lipase, eg, in particular the lipase of SEQ ID NO:2.
[0420] It should be understood that for the aforementioned species, the present invention encompasses perfect and imperfect states, and other taxonomic equivalents, such as anamorphs, regardless of the species name by which they are known. Those skilled in the art will readily recognize the identity of appropriate equivalents.
[0421] Strains of these species are readily available to the public at many culture collections, such as the American Type Culture Collection (ATCC), the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), the Netherlands Type Culture Collection (Centraalbureau Voor Schimmelcultures, CBS), and the Agricultural Research Service Patent Culture Collection, Northern Regional Research Center (NRRL).
[0422] The above probes can be used to identify the parent lipase and to obtain the parent from other sources, including from the microorganism separated from nature (for example, soil, compost, water, etc.), or directly obtain the DNA sample from natural materials (for example, soil, compost, water, etc.). The technology for directly separating microorganisms and DNA from natural habitats is well known in the art. The polynucleotide encoding the parent can then be obtained by similarly screening the genomic DNA or cDNA library of another microorganism or mixed DNA sample. Once the polynucleotide encoding the parent has been detected with one or more probes, the polynucleotide can be separated or cloned by utilizing technology known to those of ordinary skill in the art (see, for example, Sambrook et al., 1989, the same).
[0423] Preparation of variants
[0424] The present invention also relates to methods for obtaining lipase variants of the present invention, which methods comprise: (a) introducing substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, K98I, R118F, G163S, T231R, N233R, Y220F, T244E and P256T; (b) selecting a variant having lipase activity and having one of the above-listed desired properties compared to the parent lipase; and (c) recovering the variant.
[0425] Variants can be prepared using any mutagenesis procedure known in the art, such as site-directed mutagenesis, synthetic gene construction, semisynthetic gene construction, random mutagenesis, shuffling, and the like.
[0426] Site-directed mutagenesis is a technique for introducing one or more (eg, several) mutations at one or more defined sites in the polynucleotide encoding the parent lipase.
[0427] Site-directed mutagenesis can be achieved in vitro by PCR involving the use of oligonucleotide primers containing the desired mutation. In vitro site-directed mutagenesis can also be performed by cassette mutagenesis, which involves cutting at a site in a plasmid containing a polynucleotide encoding a parent lipase by a restriction enzyme and then connecting an oligonucleotide containing the mutation to the polynucleotide. Typically, the restriction enzymes that digest the plasmid and the oligonucleotide are the same, allowing the sticky ends of the plasmid and the insert to connect to each other. See, for example, Scherer and Davis, 1979, Proc. Natl. Acad. Sci. USA [Proceedings of the National Academy of Sciences of the United States] 76: 4949-4955; and Barton et al., 1990, Nucleic Acids Res. [Nucleic Acids Research] 18: 7349-4966.
[0428] Site-directed mutagenesis can also be achieved in vivo by methods known in the art. See, for example, US 2004 / 0171154; Storici et al., 2001, Nature Biotechnol. 19:773-776; Kren et al., 1998, Nat. Med. 4:285-290; and Calissano and Macino, 1996, Fungal Genet. Newslett. 43:15-16.
[0429] Any site-directed mutagenesis procedure may be used in the present invention.There are many commercially available kits that can be used to prepare variants.
[0430] Synthetic gene construction requires the in vitro synthesis of designed polynucleotide molecules to encode the polypeptide of interest. Gene synthesis can be performed using a variety of techniques, such as multiplexed microchip-based techniques described by Tian et al. (2004, Nature 432: 1050-1054), and similar techniques in which oligonucleotides are synthesized and assembled on optically programmable microfluidic chips.
[0431] Single or multiple amino acid substitutions, deletions and / or insertions can be made and tested using known mutagenesis, recombination and / or shuffling methods followed by relevant screening procedures, such as those disclosed by Reidhaar-Olson and Sauer, 1988, Science 241:53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86:2152-2156; WO 95 / 17413; or WO 95 / 22625. Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991, Biochemistry 30:10832-10837; U.S. Pat. No. 5,223,409; WO 92 / 06204), and region-directed mutagenesis (Derbyshire et al., 1986, Gene 46:145; Ner et al., 1988, DNA 7:127).
[0432] Mutagenesis / shuffling methods can be combined with high-throughput, automated screening methods to detect the activity of cloned, mutagenized polypeptides expressed by host cells (Ness et al., 1999, Nature Biotechnology 17:893-896). Mutagenized DNA molecules encoding active polypeptides can be recovered from host cells and rapidly sequenced using standard methods in the art. These methods allow the importance of individual amino acid residues in a polypeptide to be rapidly determined.
[0433] The many aspects of semi-synthetic gene construction are realized by combining synthetic gene construction and / or site-directed mutagenesis and / or random mutagenesis and / or reorganization. Semi-synthetic construction typically utilizes the process of synthetic polynucleotide fragments in conjunction with PCR technology. Therefore, the restricted area of gene can be synthesized from scratch, and other regions can use site-specific mutagenic primers to increase, and other regions can carry out fallibility PCR or non-fallibility PCR amplification. Then the polynucleotide subsequence can be reorganized.
[0434] Polynucleotide
[0435] The present invention also relates to isolated polynucleotides encoding the lipase variants of the present invention. In some aspects, the present invention relates to a nucleic acid construct comprising the polynucleotides of the present invention. In some aspects, the present invention relates to an expression vector comprising the polynucleotides of the present invention. In some aspects, the present invention relates to a host cell comprising the polynucleotides of the present invention. In some aspects, the present invention relates to a method for producing a lipase variant, the method comprising: (a) culturing the host cell of the present invention under conditions suitable for the expression of the variant; and (b) reclaiming the variant.
[0436] Nucleic acid construct
[0437] The present invention also relates to nucleic acid constructs comprising a polynucleotide encoding a variant of the present invention operably linked to one or more control sequences which direct the expression of the coding sequence in a suitable host cell under conditions compatible with the control sequences.
[0438] Polynucleotides can be manipulated in a variety of ways to provide expression of variants. Depending on the expression vector, manipulation of the polynucleotide prior to its insertion into the vector may be desirable or necessary. Techniques for modifying polynucleotides using recombinant DNA methods are well known in the art.
[0439] The control sequence may be a promoter, i.e. a polynucleotide recognized by a host cell for expression of the polynucleotide. The promoter comprises a transcriptional control sequence that mediates the expression of the variant. The promoter may be any polynucleotide that exhibits transcriptional activity in a host cell, including mutant, truncated and hybrid promoters, and may be obtained from genes encoding extracellular or intracellular polypeptides that are homologous or heterologous to the host cell.
[0440] Examples of suitable promoters for directing transcription of the nucleic acid construct of the invention in a bacterial host cell are promoters obtained from the following genes: Bacillus amyloliquefaciens alpha-amylase gene (amyQ), Bacillus licheniformis alpha-amylase gene (amyL), Bacillus licheniformis penicillinase gene (penP), Bacillus stearothermophilus maltogenic amylase gene (amyM), Bacillus subtilis levansucrase gene (sacB), Bacillus subtilis xylA and xylB genes, Bacillus thuringiensis cryIIIA gene (Agaisse and Lereclus, 1994, Molecular coli trc promoter (Egon et al., 1988, Gene 69:301-315), the Streptomyces coelicolor agar hydrolase gene (dagA) and the prokaryotic β-lactamase gene (Villa-Kamaroff et al., 1978, Proc. Natl. Acad. Sci. USA 75:3727-3731), and the tac promoter (DeBoer et al., 1983, Proc. Natl. Acad. Sci. USA 80:21-25). Other promoters are described in Gilbert et al., 1980, "Useful proteins from recombinant bacteria," Scientific American 242:74-94; and in Sambrook et al., 1989, supra. Examples of tandem promoters are disclosed in WO 99 / 43835.
[0441] Examples of suitable promoters for directing transcription of the nucleic acid constructs of the invention in a filamentous fungal host cell are promoters obtained from the genes for Aspergillus nidulans acetamidase, Aspergillus niger neutral alpha-amylase, Aspergillus niger acid-stable alpha-amylase, Aspergillus niger or Aspergillus awamori glucoamylase (glaA), Aspergillus oryzae TAKA amylase, Aspergillus oryzae alkaline protease, Aspergillus oryzae triose phosphate isomerase, Fusarium oxysporum trypsin-like protease (WO 96 / 00787), Fusarium venenatum amyloglucosidase (WO 00 / 56900), Fusarium venenatum Daria (WO 00 / 56900), Fusarium venenatum Quinn (WO 00 / 56900). 00 / 56900), Rhizomucor miehei lipase, Rhizomucor miehei aspartic proteinase, Trichoderma reesei β-glucosidase, Trichoderma reesei cellobiohydrolase I, Trichoderma reesei cellobiohydrolase II, Trichoderma reesei endoglucanase I, Trichoderma reesei endoglucanase II, Trichoderma reesei endoglucanase III, Trichoderma reesei endoglucanase IV, Trichoderma reesei endoglucanase V, Trichoderma reesei xylanase I, Trichoderma reesei xylanase II, Trichoderma reesei endoglucanase Trichoderma β-xylosidase, and the NA2-tpi promoter (a modified promoter from an Aspergillus neutral α-amylase gene in which the untranslated leader sequence is replaced by the untranslated leader sequence of an Aspergillus triose phosphate isomerase gene; non-limiting examples include a modified promoter from an Aspergillus niger neutral α-amylase gene in which the untranslated leader sequence has been replaced with the untranslated leader sequence from an Aspergillus nidulans or Aspergillus oryzae triose phosphate isomerase gene); and mutant, truncated, and hybrid promoters thereof.
[0442] In yeast hosts, useful promoters are obtained from the genes for Saccharomyces cerevisiae enolase (ENO-1), Saccharomyces cerevisiae galactokinase (GAL1), Saccharomyces cerevisiae alcohol dehydrogenase / glyceraldehyde-3-phosphate dehydrogenase (ADH1, ADH2 / GAP), Saccharomyces cerevisiae triosephosphate isomerase (TPI), Saccharomyces cerevisiae metallothionein (CUP1), and Saccharomyces cerevisiae 3-phosphoglycerate kinase. Other useful promoters for yeast host cells are described by Romanos et al., 1992, Yeast 8:423-488.
[0443] The control sequence may also be a transcription terminator that is recognized by the host cell to terminate transcription. The terminator sequence is operably linked to the 3'-end of the polynucleotide encoding the variant. Any terminator that is functional in the host cell may be used.
[0444] Preferred terminators for bacterial host cells are obtained from the genes for Bacillus clausii alkaline protease (aprH), Bacillus licheniformis alpha-amylase (amyL), and Escherichia coli ribosomal RNA (rrnB).
[0445] Preferred terminators for filamentous fungal host cells are obtained from the genes for Aspergillus nidulans anthranilate synthase, Aspergillus niger glucoamylase, Aspergillus niger alpha-glucosidase, Aspergillus oryzae TAKA amylase, and Fusarium oxysporum trypsin-like protease.
[0446] Preferred terminators for yeast host cells are obtained from the genes for Saccharomyces cerevisiae enolase, Saccharomyces cerevisiae cytochrome C (CYC1), and Saccharomyces cerevisiae glyceraldehyde-3-phosphate dehydrogenase. Other useful terminators for yeast host cells are described by Romanos et al. (1992, supra).
[0447] The control sequence may also be an mRNA stabilizer region downstream of the promoter and upstream of the coding sequence of a gene, which increases the expression of the gene.
[0448] Examples of suitable mRNA stabilizer regions are obtained from the Bacillus thuringiensis cryIIIA gene (WO94 / 25612) and the Bacillus subtilis SP82 gene (Hue et al., 1995, Journal of Bacteriology 177:3465-3471).
[0449] The control sequence may also be a leader sequence, i.e., a non-translated region of an mRNA that is important for translation by the host cell. The leader sequence is operably linked to the 5'-end of the polynucleotide encoding the variant. Any leader sequence that is functional in the host cell may be used.
[0450] Preferred leaders for filamentous fungal host cells are obtained from the genes for Aspergillus oryzae TAKA amylase and Aspergillus nidulans triose phosphate isomerase.
[0451] Suitable leaders for yeast host cells are obtained from the genes for Saccharomyces cerevisiae enolase (ENO-1), Saccharomyces cerevisiae 3-phosphoglycerate kinase, Saccharomyces cerevisiae alpha factor, and Saccharomyces cerevisiae alcohol dehydrogenase / glyceraldehyde-3-phosphate dehydrogenase (ADH2 / GAP).
[0452] The control sequence may also be a polyadenylation sequence, a sequence that is operably linked to the 3'-terminus of the variant coding sequence and, when transcribed, is recognized by the host cell as a signal to add polyadenylic acid residues to transcribed mRNA. Any polyadenylation sequence that is functional in the host cell may be used.
[0453] Preferred polyadenylation for filamentous fungal host cells is obtained from the genes for Aspergillus nidulans anthranilate synthase, Aspergillus niger glucoamylase, Aspergillus niger-alpha glucosidase, Aspergillus oryzae TAKA amylase, and Fusarium oxysporum trypsin-like protease.
[0454] Useful polyadenylation sequences for yeast host cells are described by Guo and Sherman, 1995, Mol. Cellular Biol. 15: 5983-5990.
[0455] The control sequence can also be a signal peptide coding region, which encodes a signal peptide connected to the N-terminus of the variant, and instructs the variant to enter the secretory pathway of the cell. The 5'-end of the coding sequence of the polynucleotide may inherently contain a signal peptide coding sequence, which is naturally connected to the segment of the coding sequence of the coding variant in the translation reading frame. Alternatively, the 5'-end of the coding sequence may contain a signal peptide coding sequence that is exogenous to the coding sequence. In the case where the coding sequence does not naturally contain a signal peptide coding sequence, an exogenous signal peptide coding sequence may be required. Alternatively, an exogenous signal peptide coding sequence may simply replace the natural signal peptide coding sequence to enhance the secretion of the variant. However, any signal peptide coding sequence that instructs the expressed variant to enter the secretory pathway of the host cell may be used.
[0456] Effective signal peptide coding sequences for bacterial host cells are those obtained from the genes for maltogenic amylase from Bacillus NCIB 11837, subtilisin from Bacillus licheniformis, beta-lactamase from Bacillus stearothermophilus, alpha-amylase from Bacillus stearothermophilus, neutral protease from Bacillus stearothermophilus (nprT, nprS, nprM), and prsA from Bacillus subtilis. Additional signal peptides are described by Simonen and Palva, 1993, Microbiological Reviews 57: 109-137.
[0457] Effective signal peptide coding sequences for filamentous fungal host cells are obtained from the genes for Aspergillus niger neutral amylase, Aspergillus niger glucoamylase, Aspergillus oryzae TAKA amylase, Humicola insolens cellulase, Humicola insolens endoglucanase V, Humicola lanuginosa lipase, and Rhizomucor miehei aspartic proteinase.
[0458] Useful signal peptides for yeast host cells are obtained from the genes for Saccharomyces cerevisiae alpha-factor and Saccharomyces cerevisiae invertase. Other useful signal peptide coding sequences are described by Romanos et al. (1992, supra).
[0459] The control sequence can also be a propeptide coding sequence encoding a propeptide at the N-terminus of the variant. The resulting polypeptide is referred to as a proenzyme or propolypeptide (or in some cases as a zymogen). Propolypeptides are generally inactive and can be converted into active polypeptides by catalytic cleavage or autocatalytic cleavage of the propeptide from the propolypeptide. The propeptide coding sequence can be obtained from the following genes: Bacillus subtilis alkaline protease (aprE), Bacillus subtilis neutral protease (nprT), thermophilic myceliophthora laccase (WO 95 / 33836), Rhizomucor manhei aspartic protease, and Saccharomyces cerevisiae alpha factor.
[0460] Where both a signal peptide sequence and a propeptide sequence are present, the propeptide sequence is positioned immediately adjacent to the N-terminus of the variant and the signal peptide sequence is positioned immediately adjacent to the N-terminus of the propeptide sequence.
[0461] It may also be necessary to add regulatory sequences that regulate the expression of the variant relative to the growth of the host cell. Examples of regulatory systems are those that cause the expression of the gene to be turned on or off in response to chemical or physical stimuli, including the presence of regulatory compounds. Regulatory systems in prokaryotic systems include lac, tac, and trp operator systems. In yeast, the ADH2 system or the GAL1 system can be used. In filamentous fungi, Aspergillus niger glucoamylase promoter, Aspergillus oryzae TAKA α-amylase promoter, and Aspergillus oryzae glucoamylase promoter can be used. Other examples of regulatory sequences are those that allow gene amplification. In eukaryotic systems, these regulatory sequences include dihydrofolate reductase genes amplified in the presence of methotrexate and metallothionein genes amplified with heavy metals. In these cases, the polynucleotide encoding the variant will be operably connected to the regulatory sequence.
[0462] Expression vector
[0463] The present invention further relates to a recombinant expression vector comprising a polynucleotide, a promoter and a transcription and translation termination signal for encoding a variant of the present invention. Various nucleotides and control sequences can be linked together to produce a recombinant expression vector, which can include one or more suitable restriction sites to allow the polynucleotides for inserting or replacing the encoding variants at such sites. Alternatively, the polynucleotides can be expressed by inserting a polynucleotide or a nucleic acid construct comprising the polynucleotide into a suitable vector for expression. When producing an expression vector, the encoding sequence is located in the vector so that the encoding sequence is operably connected to a suitable control sequence for expression.
[0464] The recombinant expression vector can be any vector (e.g., a plasmid or virus) that can be easily subjected to recombinant DNA procedures and can cause expression of the polynucleotide. The choice of vector will typically depend on the compatibility of the vector with the host cell into which the vector is to be introduced. The vector can be a linear or closed circular plasmid.
[0465] The vector can be an autonomously replicating vector, i.e. a vector existing as an extrachromosomal entity, which replicates independently of chromosomal replication, such as a plasmid, an extrachromosomal element, a minichromosome or an artificial chromosome. The vector can contain any means for ensuring self-replication. Alternatively, the vector can be a vector that, when introduced into the host cell, is integrated into the genome and replicates with one or more chromosomes integrated therein. In addition, a single vector or plasmid or two or more vectors or plasmids can be used, which contain the total DNA to be introduced into the host cell genome together, or a transposon can be used.
[0466] The vector preferably contains one or more selectable markers that permit easy selection of transformed cells, transfected cells, transduced cells, etc. A selectable marker is a gene whose product provides biocide or viral resistance, resistance to heavy metals, prototrophy to auxotrophs, etc.
[0467] Examples of bacterial selective markers are the dal genes of Bacillus licheniformis or Bacillus subtilis, or markers that confer antibiotic resistance such as ampicillin, chloramphenicol, kanamycin, neomycin, spectinomycin, or tetracycline resistance. Suitable markers for yeast host cells include, but are not limited to, ADE2, HIS3, LEU2, LYS2, MET3, TRP1, and URA3. Selectable markers for use in filamentous fungal host cells include, but are not limited to, amdS (acetamidase), argB (ornithine carbamoyltransferase), bar (phosphinothricin acetyltransferase), hph (hygromycin phosphotransferase), niaD (nitrate reductase), pyrG (orotidine-5'-phosphate decarboxylase), sC (sulfate adenyltransferase), and trpC (anthranilate synthase), as well as their equivalents. Preferred for use in Aspergillus cells are the amdS and pyrG genes of Aspergillus nidulans or Aspergillus oryzae and the bar gene of Streptomyces hygroscopicus.
[0468] The vector preferably contains one or more elements that permit integration of the vector into the host cell's genome or autonomous replication of the vector in the cell independent of the genome.
[0469] In order to be integrated into the host cell genome, the vector can rely on the polynucleotide sequence of the encoding variant or be used to be integrated into any other vector element in the genome by homologous or non-homologous recombination.Alternatively, the vector may contain other polynucleotides at the precise position for guiding the chromosome to be integrated into the host cell genome by homologous recombination.In order to increase the possibility of integration at the precise position, the integration element should contain a sufficient number of nucleic acids, such as 100 to 10,000 base pairs, 400 to 10,000 base pairs and 800 to 10,000 base pairs, and these nucleic acids have a high degree of sequence identity with the corresponding target sequence to enhance the probability of homologous recombination.The integration element can be any sequence homologous to the target sequence in the host cell genome.In addition, the integration element can be a non-coding or encoded polynucleotide.On the other hand, the vector can be integrated into the genome of the host cell by non-homologous recombination.
[0470] For autonomous replication, the vector may also additionally comprise an origin of replication, which enables autonomous replication of the vector in the host cell in question. The origin of replication may be any plasmid replicon mediating autonomous replication that functions in the cell. The term "origin of replication" or "plasmid replicon" means a polynucleotide that enables a plasmid or vector to replicate in vivo.
[0471] Examples of bacterial origins of replication are the origins of replication of plasmids pBR322, pUC19, pACYC177, and pACYC184 permitting replication in E. coli and pUB110, pE194, pTA1060, and pAMβ1 permitting replication in Bacillus.
[0472] Examples of origins of replication for use in a yeast host cell are the 2 micron origin of replication, ARS1, ARS4, the combination of ARS1 and CEN3, and the combination of ARS4 and CEN6.
[0473] Examples of replication origins useful in filamentous fungal cells are AMA1 and ANS1 (Gems et al., 1991, Gene 98: 61-67; Cullen et al., 1987, Nucleic Acids Res. 15: 9163-9175; WO 00 / 24883). Isolation of the AMA1 gene and construction of a plasmid or vector containing the gene can be accomplished according to the method disclosed in WO 00 / 24883.
[0474] More than one copy of the polynucleotide of the present invention can be inserted into the host cell to increase the production of variants. The increased copy number of the polynucleotide can be obtained by integrating at least one additional copy of the sequence into the host cell genome or by including an amplifiable selectable marker gene together with the polynucleotide, wherein cells containing amplified copies of the selectable marker gene and thus additional copies of the polynucleotide can be selected by culturing the cells in the presence of an appropriate selective agent.
[0475] The procedures used to ligate the elements described above to construct the recombinant expression vectors of the present invention are well known to those skilled in the art (see, eg, Sambrook et al., 1989, supra).
[0476] Host cells
[0477] The present invention also relates to recombinant host cells, which comprise polynucleotides encoding variants of the present invention, operably linked to one or more control sequences, which instruct the production of variants of the present invention. The construct or vector comprising the polynucleotides is introduced into the host cell so that the construct or vector is maintained as a chromosomal integrant or as an autonomously replicating extrachromosomal vector, as described earlier. The term "host cell" encompasses any parent cell progeny that is not identical to the parent cell due to mutations that occur during replication. The selection of host cells will depend to a large extent on the gene encoding the variant and its source.
[0478] The host cell may be any cell useful in the recombinant production of the variant, eg, a prokaryotic or eukaryotic cell.
[0479] Prokaryotic host cells can be any Gram-positive or Gram-negative bacteria. Gram-positive bacteria include but are not limited to: Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Oceanobacillus, Staphylococcus, Streptococcus and Streptomyces. Gram-negative bacteria include but are not limited to Campylobacter, Escherichia coli, Flavobacterium, Fusobacterium, Helicobacter, Silene Bacillus, Neisseria, Pseudomonas, Salmonella and Ureaplasma.
[0480] The bacterial host cell can be any Bacillus cell, including but not limited to Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus fluorescens, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus brevis, Bacillus stearothermophilus, Bacillus subtilis, and Bacillus thuringiensis cells.
[0481] The bacterial host cell may also be any Streptococcus cell, including but not limited to Streptococcus equisimilis, Streptococcus pyogenes, Streptococcus uberis, and Streptococcus equi subsp. Zooepidemicus cells.
[0482] The bacterial host cell may also be any Streptomyces cell, including, but not limited to, Streptomyces achromogenes, Streptomyces avermitilis, Streptomyces coelicolor, Streptomyces griseus, and Streptomyces lividans cells.
[0483] Introduction of DNA into Bacillus cells can be achieved by protoplast transformation (see, e.g., Chang and Cohen, 1979, Mol. Gen. Genet. 168: 111-115), transformation of competent cells (see, e.g., Young and Spizizen, 1961, J. Bacteriol. 81: 823-829; or Dubnau and Davidoff-Abelson, 1971, J. Mol. Biol. 56: 209-221), electroporation (see, e.g., Shigekawa and Dower, 1988, Biotechniques 6: 742-751), or conjugation (see, e.g., Koehler and Thorne, 1987, J. Bacteriol. 169: 5271-5278). Introduction of DNA into E. coli cells can be achieved by protoplast transformation (see, e.g., Hanahan, 1983, J. Mol. Biol. 166:557-580) or electroporation (see, e.g., Dower et al., 1988, Nucleic Acids Res. 16:6127-6145). Introduction of DNA into Streptomyces cells can be achieved by protoplast transformation, electroporation (see, e.g., Gong et al., 2004, Folia Microbiol. (Praha) 49:399-405), conjugation (see, e.g., Mazodier et al., 1989, J. Bacteriol. 171:3583-3585), or transduction (see, e.g., Burke et al., 2001, Proc. Natl. Acad. Sci. USA 98:6289-6294). Introduction of DNA into Pseudomonas cells can be achieved by electroporation (see, e.g., Choi et al., 2006, J. Microbiol. Methods 64:391-397) or conjugation (see, e.g., Pinedo and Smets, 2005, Appl. Environ. Microbiol. 71:51-57).Introduction of DNA into Streptococcus cells can be achieved by methods such as natural competence (see, e.g., Perry and Kuramitsu, 1981, Infect. Immun. 32: 1295-1297), protoplast transformation (see, e.g., Catt and Jollick, 1991, Microbios 68: 189-207), electroporation (see, e.g., Buckley et al., 1999, Appl. Environ. Microbiol. 65: 3800-3804), or conjugation (see, e.g., Clewell, 1981, Microbiol. Rev. 45: 409-436). However, any method known in the art for introducing DNA into a host cell may be used.
[0484] The host cell may also be a eukaryotic organism, such as a mammalian, insect, plant, or fungal cell.
[0485] The host cell may be a fungal cell. "Fungi" as used herein includes Ascomycota, Basidiomycota, Chytridiomycota, and Zygomycota, as well as Oomycota and all mitotic spore fungi (as defined by Hawksworth et al. in Ainsworth and Bisby's Dictionary of The Fungi, 8th ed., 1995, CAB International, University Press, Cambridge, UK).
[0486] The fungal host cell can be a yeast cell. "Yeast" as used herein includes ascosporogenous yeast (Endomycetales), basidiosporogenous yeast, and yeast belonging to Fungi Imperfecti (Blastomycetes). Since the classification of yeast may change in the future, for the purposes of the present invention, yeast should be defined as described in Biology and Activities of Yeast [Biology and Activity of Yeast] (Skinner, Passmore and Davenport, ed., Soc. App. Bacteriol. Symposium Series No. 9 [Society for Applied Bacteriology Special Paper Collection Series 9], 1980).
[0487] The yeast host cell can be a Candida cell, a Hansenula cell, a Kluyveromyces cell, a Pichia cell, a Saccharomyces cell, a Schizosaccharomyces cell, or a Yarrowia cell, such as a Kluyveromyces lactis cell, a Saccharomyces carlsbergensis cell, a Saccharomyces cerevisiae cell, a Saccharomyces diastaticus cell, a Saccharomyces douglasii cell, a Saccharomyces kluyveri cell, a Saccharomyces norbensis cell, a Saccharomyces oviformis cell, or a Yarrowia lipolytica cell. lipolytica) cells.
[0488] The fungal host cell may be a filamentous fungal cell. "Filamentous fungi" include all filamentous forms of the subphylum of Eumycota and Oomycota (as defined by Hawksworth et al., 1995 (supra)). Filamentous fungi are generally characterized by a mycelial wall composed of chitin, cellulose, glucan, chitosan, mannan and other complex polysaccharides. Vegetative growth is carried out by hyphae extension, and carbon catabolism is obligate aerobic. In contrast, the vegetative growth of yeast (such as Saccharomyces cerevisiae) is carried out by budding of a unicellular thallus, and carbon catabolism can be fermentative.
[0489] The filamentous fungal host cell can be an Acremonium, Aspergillus, Bjerkandera, Ceroplastes, Chrysosporium, Coprinus, Coriolus, Cryptococcus, Filibasidium, Fusarium, Humicola, Pyrospora, Mucor, Myceliophthora, Neotrichia, Neurospora, Paecilomyces, Penicillium, Pseudocerviphora, Phlebia, Chytridium, Pleurotus, Schizophyllum, Talaromyces, Thermoascus, Thielavia, Toxicodendron, Trametes, or Trichoderma cell.
[0490] For example, the filamentous fungal host cell can be Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae, Bjerkandera adusta, Ceriporiopsis a eirina, Ceriporiopsis caregiea, Ceriporiopsis gilvescens, Ceriporiopsis pannocinta, Ceriporiopsis rivulosa, Ceriporiopsis subrufa, Ceriporiopsis subvermispora, Chrysosporium inops, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium feces, or Chrysosporium spp. merdarium), rent spore, Chrysosporium queenslandicum, tropical chrysosporium, Chrysosporium zonatum, Coprinus cinereus, Coriolushirsutus, rod-shaped fusarium, cereal fusarium, Kuwei fusarium, broadsword fusarium, graminearum fusarium, graminearum fusarium, heterospore fusarium, albizia fusarium, oxyspore fusarium, multi-branch fusarium, pink fusarium, elder fusarium, color fusarium, pseudo-branch spore fusarium, sulfur-colored fusarium, round fusarium, pseudo-hyphomycete fusarium, embellished fusarium, insolens humicola, lanuginosa humicola, rice black mucor, thermophilic myceliophthora, rough neurospora, purple-producing penicillium, yellow spore original hair leather fungus, radiating vein fungus (Phlebia radiata), Pleurotus eryngii, Trametes terrestris, Trametes villosa, Trametes versicolor, Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, or Trichoderma viride cells.
[0491] Fungal cells can be transformed in a manner known per se by methods involving protoplast formation, protoplast transformation, and cell wall regeneration. Suitable procedures for transforming Aspergillus and Trichoderma host cells are described in EP 238023 and Yelton et al., 1984, Proc. Natl. Acad. Sci. USA [Proceedings of the National Academy of Sciences of the United States] 81: 1470-1474 and Christensen et al., 1988, Bio / Technology [Biology / Technology] 6: 1419-1422. Suitable methods for transforming Fusarium species are described by Malardier et al., 1989, Gene [Gene] 78: 147-156, and WO 96 / 00787. Yeast can be transformed using the procedures described by Becker and Guarente, in Abelson, JN and Simon, MI, eds., Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology, Vol. 194, pp. 182-187, Academic Press, Inc., New York); Ito et al., 1983, J. Bacteriol. 153:163; and Hinnen et al., 1978, Proc. Natl. Acad. Sci. USA 75:1920.
[0492] Generation method
[0493] The present invention also relates to methods of producing the lipase variants of the present invention, comprising: (a) culturing the host cell of the present invention under conditions suitable for expression of the variant; and (b) recovering the variant.
[0494] Host cells can be cultured in a nutrient medium suitable for producing variants using methods known in the art. For example, cells can be cultured by shaking bottles, or in a suitable medium and under conditions allowing variant expression and / or separation, small-scale or large-scale fermentation (including continuous fermentation, batch fermentation, batch-fed fermentation or solid-state fermentation) can be carried out in a laboratory or industrial fermentor tank to culture cells. Using procedures as known in the art, cultivation occurs in a suitable nutrient medium comprising carbon and nitrogen sources and inorganic salts. Suitable medium can be obtained from commercial suppliers or can be prepared according to disclosed composition (for example, in the catalog of American Type Culture Collection). If variant is secreted into the nutrient medium, variant can be directly recovered from the medium. If variant is not secreted, it can be recovered from cell lysate.
[0495] Variants can be detected using methods known in the art that are specific for these variants. These detection methods include, but are not limited to, the use of specific antibodies, the formation of an enzyme product, or the disappearance of an enzyme substrate. For example, enzyme assays can be used to determine the activity of the variant (such as those described in the Examples).
[0496] The variant can be recovered using methods known in the art. For example, the variant can be recovered from the nutrient medium by a variety of conventional procedures including, but not limited to, collection, centrifugation, filtration, extraction, spray drying, evaporation or precipitation.
[0497] Variants may be purified by a variety of procedures known in the art to obtain substantially pure variants, including, but not limited to, chromatography (e.g., ion exchange chromatography, affinity chromatography, hydrophobic interaction chromatography, chromatofocusing, and size exclusion chromatography), electrophoretic procedures (e.g., preparative isoelectric focusing), differential solubility (e.g., ammonium sulfate precipitation), SDS-PAGE, or extraction (see, e.g., Protein Purification, Janson and Ryden, eds., VCH Publishers, New York, 1989).
[0498] In alternative aspects, rather than recovering the variant, a host cell of the invention expressing the variant is used as a source of the variant.
[0499] Composition
[0500] The present invention also encompasses compositions comprising the lipase variants of the present invention.
[0501] In certain aspects, the present invention relates to a composition comprising a variant of a parent lipase, which variant has lipase activity, has at least 60% but less than 100% sequence identity to SEQ ID NO:2, and comprises one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, K98I, R118F, G163S, T231R, N233R, Y220F, T244E and P256T.
[0502] In certain aspects, the composition comprises substitutions at positions corresponding to R118F+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, K98I, G163S, Y220F, T244E, and P256T.
[0503] In certain aspects, the variants have improved wash performance, reduced odor generation, and / or improved storage stability / longer shelf life / increased thermal stability.
[0504] The non-limiting list of composition components set forth below is suitable for use in these compositions, and the method herein may be conveniently incorporated into certain embodiments of the present invention, such as to assist or enhance cleaning performance, for processing substrates to be cleaned, or to modify the aesthetics of the composition in the case of spices, colorants, dyes, etc. The level of any such component incorporated into any composition is in addition to any material previously cited for incorporation. The precise nature of these other components and their incorporation levels will depend on the physical form of the composition and the properties of the cleaning operations in which the composition will be used. Although the components mentioned below are classified by general headings according to specific functionality, this is not to be construed as limiting, because as will be understood by those of ordinary skill, components may include other functionality.
[0505] Unless otherwise indicated, amounts in percentages are by weight of the composition (wt %). Suitable component materials include, but are not limited to, surfactants, builders, chelating agents, dye transfer inhibiting agents, dispersants, enzymes, and enzyme stabilizers, catalytic materials, bleach activators, hydrogen peroxide, hydrogen peroxide sources, preformed peracids, polymeric dispersants, clay removal / anti-redeposition agents, brighteners, foam inhibitors, dyes, hueing dyes, perfumes, perfume delivery systems, structural elastic agents, fabric softeners, carriers, hydrotropes, processing aids, solvents and / or pigments. In addition to the following disclosure, suitable examples of such other components and usage levels are found in US 5576282, US 6306812, and US 6326348, which are hereby incorporated by reference.
[0506] Thus, in certain embodiments, the present invention does not include one or more of the following adjunct materials: surfactants, soaps, builders, chelating agents, dye transfer inhibitors, dispersants, additional enzymes, enzyme stabilizers, catalytic materials, bleach activators, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric dispersants, clay removal / anti-redeposition agents, brighteners, foam inhibitors, dyes, perfumes, perfume delivery systems, structural elastic agents, fabric softeners, carriers, hydrotropes, processing aids, solvents and / or pigments. However, when one or more components are present, such one or more components may be present as detailed below:
[0507] Surfactants - The composition according to the invention may comprise a surfactant or a surfactant system, wherein the surfactant may be selected from nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, zwitterionic surfactants, semi-polar nonionic surfactants and mixtures thereof. When present, the surfactant is typically present at a level of from 0.1 wt% to 60wt%, from 0.2wt% to 40wt%, from 0.5wt% to 30wt%, from 1wt% to 50wt%, from 1wt% to 40wt%, from 1wt% to 30wt%, from 1wt% to 20wt%, from 3wt% to 10wt%, from 3wt% to 5wt%, from 5wt% to 40wt%, from 5wt% to 30wt%, from 5wt% to 15wt%, from 3wt% to 20wt%, from 3wt% to 10wt%, from 8wt% to 12wt%, from 10wt% to 12wt%, from 20wt% to 25wt%, or from 25wt%-60wt%.
[0508] Suitable anionic detersive surfactants include sulfate and sulphonate detersive surfactants.
[0509] Suitable sulfonate detersive surfactants include alkyl benzene sulfonates, in one aspect C 10-13 Alkylbenzene sulfonate. Suitable alkylbenzene sulfonate (LAS) can be obtained by sulfonating commercially available linear alkylbenzene (LAB); suitable LABs include low 2-phenyl LABs such as or Other suitable LABs include high 2-phenyl LABs such as Suitable anionic detersive surfactants are alkylbenzene sulfonates obtained by the DETAL catalytic process, but other synthetic routes (such as HF) may also be suitable. In one aspect, the magnesium salt of LAS is used.
[0510] Suitable sulfate detersive surfactants include alkyl sulfates, in one aspect C8-18 Alkyl sulfates, or mainly C 12 Alkyl sulfate.
[0511] Other suitable sulfate detersive surfactants are alkyl alkoxylated sulfates, in one aspect alkyl ethoxylated sulfates, in one aspect C 8-18 Alkyl alkoxylated sulfates, on the other hand, are C 8-18 Alkyl ethoxylated sulfates, typically the alkyl alkoxylated sulfates have an average degree of alkoxylation of from 0.5 to 20 or from 0.5 to 10, typically the alkyl alkoxylated sulfates are C 8-18 Alkyl ethoxylated sulfates having an average degree of ethoxylation of from 0.5 to 10, from 0.5 to 7, from 0.5 to 5, or from 0.5 to 3.
[0512] The alkyl sulfates, alkyl alkoxylated sulfates and alkyl benzene sulfonates may be linear or branched, substituted or unsubstituted.
[0513] The detersive surfactant can be a mid-chain branched detersive surfactant, in one aspect a mid-chain branched anionic detersive surfactant, in one aspect a mid-chain branched alkyl sulfate and / or a mid-chain branched alkylbenzene sulfonate, such as a mid-chain branched alkyl sulfate. In one aspect, the mid-chain branch is C 1-4 The alkyl group is typically methyl and / or ethyl.
[0514] Non-limiting examples of anionic surfactants include sulfates and sulfonates, in particular, linear alkylbenzene sulfonates (LAS), isomers of LAS, branched alkylbenzene sulfonates (BABS), phenylalkanesulfonates, alpha-olefin sulfonates (AOS), olefin sulfonates, alkene sulfonates, alkane-2,3-diylbis(sulfates), hydroxyalkanesulfonates and disulfonates, alkyl sulfates (AS) such as sodium dodecyl sulfate (SDS), fatty alcohol sulfates (FAS), primary alcohol sulfates (PAS ), alcohol ether sulfates (AES or AEOS or FES, also known as alcohol ethoxy sulfates or fatty alcohol ether sulfates), secondary alkane sulfonates (SAS), paraffin sulfonates (PS), ester sulfonates, sulfonated fatty acid glycerides, α-sulfonic fatty acid methyl esters (α-SFMe or SES) (including methyl sulfonate (MES)), alkyl succinic acid or alkenyl succinic acid, dodecenyl / tetradecenyl succinic acid (DTSA), fatty acid derivatives of amino acids, diesters and monoesters of sulfosuccinic acid or soap, and combinations thereof.
[0515] Suitable nonionic detersive surfactants are selected from the group consisting of: C8-C 18 Alkyl ethoxylates, e.g. C6-C 12Alkylphenol alkoxylates, wherein the alkoxylate units may be ethyleneoxy units, propyleneoxy units or mixtures thereof; C 12 -C 18 Alcohol and C6-C 12 Condensation products of alkylphenols with ethylene oxide / propylene oxide block polymers, e.g. C 14 -C 22 Medium chain branched alcohol; C 14 -C 22 Mid-chain branched alkyl alkoxylates, typically having an average degree of alkoxylation of from 1 to 30; alkyl polysaccharides, in one aspect alkyl polyglycosides; polyhydroxy fatty acid amides; ether-terminated poly(alkoxylated) alcohol surfactants; and mixtures thereof.
[0516] Suitable nonionic detersive surfactants include alkyl polyglycosides and / or alkyl alkoxylated alcohols.
[0517] In one aspect, the nonionic detersive surfactant comprises an alkyl alkoxylated alcohol, in one aspect C 8-18 Alkyl alkoxylated alcohols, such as C 8-18 The alkyl ethoxylated alcohol may have an average degree of alkoxylation of from 1 to 50, from 1 to 30, from 1 to 20, or from 1 to 10. In one aspect, the alkyl alkoxylated alcohol may be C 8-18 Alkyl ethoxylated alcohols having an average degree of ethoxylation of from 1 to 10, from 1 to 7, more preferably from 1 to 5 or from 3 to 7. The alkyl alkoxylated alcohols may be linear or branched, and substituted or unsubstituted. Suitable nonionic surfactants include
[0518] Non-limiting examples of nonionic surfactants include alcohol ethoxylates (AE or AEO), alcohol propoxylates, propoxylated fatty alcohols (PFA), alkoxylated fatty acid alkyl esters (such as ethoxylated and / or propoxylated fatty acid alkyl esters), alkylphenol ethoxylates (APE), nonylphenol ethoxylates (NPE), alkyl polyglycosides (APG), alkoxylated amines, fatty acid monoethanolamide (FAM), fatty acid diethanolamide (FADA), ethoxylated fatty acid monoethanolamide (EFAM), propoxylated fatty acid monoethanolamide (PFAM), polyhydroxyalkyl fatty acid amides, or N-acyl N-alkyl derivatives of glucosamine (glucamide (GA), or fatty acid glucamide (FAGA)), and products available under the trade names SPAN and TWEEN, and combinations thereof.
[0519] Suitable cationic detersive surfactants include alkyl pyridinium compounds, alkyl quaternary ammonium compounds, alkyl quaternary phosphonium compounds, alkyl trisulfonium compounds and mixtures thereof.
[0520] Suitable cationic detersive surfactants are quaternary ammonium compounds having the general formula: (R)(R1)(R2)(R3)N + X - , wherein R is a linear or branched, substituted or unsubstituted C 6-18 An alkyl or alkenyl moiety, R1 and R2 are independently selected from methyl or ethyl moieties, R3 is a hydroxyl, hydroxymethyl or hydroxyethyl moiety, and X is an anion providing charge neutrality, suitable anions include halides, such as chlorides; sulfates; and sulfonates. Suitable cationic detersive surfactants are mono-C 6-18 Alkyl mono-hydroxyethyl dimethyl quaternary ammonium chloride. Highly suitable cationic detersive surfactants are mono-C 8-10 Alkyl mono-hydroxyethyl dimethyl quaternary ammonium chloride, mono-C 10-12 Alkyl mono-hydroxyethyl dimethyl quaternary ammonium chloride and mono-C 10 Alkyl mono-hydroxyethyl dimethyl quaternary ammonium chloride.
[0521] Non-limiting examples of cationic surfactants include alkyl dimethylethanol quaternary ammonium (ADMEAQ), cetyl trimethyl ammonium bromide (CTAB), dimethyl distearylammonium chloride (DSDMAC), and alkyl benzyl dimethyl ammonium, alkyl quaternary ammonium compounds, alkoxylated quaternary ammonium (AQA) compounds, ester quaternary ammonium, and combinations thereof.
[0522] Suitable amphoteric surfactants / zwitterionic surfactants include amine oxides and betaines (such as alkyl dimethyl betaines, sulfobetaines), or combinations thereof. The amine-neutralized anionic surfactants of the present invention-anionic surfactants and auxiliary anionic co-surfactants can exist in acid form, and the acid form can be neutralized to form surfactant salts that are desired for use in the detergent composition of the present invention. Typical agents for neutralization include metal counterion bases, such as hydroxides, such as NaOH or KOH. Other preferred agents for neutralizing the anionic surfactants of the present invention and auxiliary anionic surfactants or co-surfactants in their acid form include ammonia, amines or alkanolamines. Alkanolamines are preferred. Suitable non-limiting examples include monoethanolamine, diethanolamine, triethanolamine, and other linear or branched alkanolamines known in the art; for example, highly preferred alkanolamines include 2-amino-1-propanol, 1-aminopropanol, monoisopropanolamine, or 1-amino-3-propanol. Amine neutralization may be performed to a complete or partial extent, for example, part of the anionic surfactant mixture may be neutralized with sodium or potassium, and part of the anionic surfactant mixture may be neutralized with an amine or alkanolamine.
[0523] Non-limiting examples of semi-polar surfactants include amine oxides (AO), such as alkyl dimethyl amine oxides.
[0524] Surfactant systems comprising a mixture of one or more anionic surfactants, and additionally one or more nonionic surfactants, and optionally additional surfactants such as cationic surfactants may be preferred. Preferred weight ratios of anionic to nonionic surfactants are at least 2:1, or at least 1:1 to 1:10.
[0525] In one aspect, the surfactant system can include a mixture of isoprenoid surfactants represented by Formula A and Formula B:
[0526]
[0527] wherein Y is CH2 or absent, and Z may be selected such that the resulting surfactant is selected from the group consisting of alkyl carboxylates, alkyl polyalkoxys, alkyl anionic polyalkoxy sulfates, alkyl glyceryl sulfonates, alkyl dimethyl amine oxides, alkyl polyhydroxy-based surfactants, alkyl phosphates, alkyl glyceryl sulfonates, alkyl polyglucosides, alkyl polyphosphates, alkyl phosphonates, alkyl polyglycosides, alkyl monoglycosides, alkyl diglycosides, alkyl sulfosuccinates, alkyl disulfates, alkyl disulfonic acids. Ester surfactants, alkyl sulfonated succinate surfactants, alkyl glucose amide surfactants, alkyl taurate surfactants, alkyl sarcosinate surfactants, alkyl glycine ester surfactants, alkyl hydroxyethyl sulfonate surfactants, alkyl dialkanolamide surfactants, alkyl monoalkanolamide surfactants, alkyl monoalkanolamide sulfate surfactants, alkyl dihydroxyacetamide surfactants, alkyl dihydroxyacetamide sulfate surfactants, alkyl glyceride surfactants, alkyl glyceride sulfate surfactants, alkyl glyceryl ether surfactants, alkyl glyceryl ether sulfate surfactants, alkyl methyl ester sulfonate surfactants, alkyl polyglyceryl ether surfactants, alkyl polyglyceryl ether sulfate surfactants Surfactants, alkyl sorbitan ester surfactants, alkyl amino alkane sulfonate surfactants, alkyl amide propyl betaine surfactants, alkyl allylated quaternary ammonium salt-based surfactants, alkyl monohydroxyalkyl-di-alkylated quaternary ammonium salt-based surfactants, alkyl di-hydroxyalkyl monoalkyl quaternary ammonium salt-based surfactants, alkylated quaternary ammonium salt surfactants, alkyl trimethyl ammonium quaternary ammonium salt surfactants, alkyl polyhydroxyalkyloxypropyl quaternary ammonium salt-based surfactants, alkyl glyceride quaternary ammonium salt surfactants, alkyl glycol amine quaternary ammonium salt surfactants, alkyl monomethyl dihydroxyethyl quaternary ammonium surfactants, alkyl dimethyl monohydroxyethyl quaternary ammonium surfactants, alkyl trimethyl ammonium surfactants, alkyl imidazoline-based surfactants, olefin-2-yl-succinate surfactants, alkyl α-sulfonated carboxylic acid surfactants, alkyl α-sulfonated carboxylic acid alkyl ester surfactants, α-olefin sulfonate surfactants, alkyl phenol ethoxylate surfactants, alkyl benzene sulfonate surfactants, alkyl sulfobetaine surfactants, alkyl hydroxysulfobetaine surfactants, alkyl ammonium carboxylic acid betaine surfactants, alkyl sucrose ester surfactants, alkyl alkanolamide surfactants, alkyl di(polyoxyethylene)monoalkylammonium surfactants, alkyl mono(polyoxyethylene)dialkylammonium surfactants, alkyl benzyldimethylammonium surfactants, alkylaminopropionate surfactants, alkylamidopropyldimethylamine surfactants, or mixtures thereof;And if Z is a charged moiety, Z is charge balanced by a suitable metal or organic counterion. Suitable counterions include metal counterions, amines, or alkanolamines, such as C1-C6 alkanol ammonium. More specifically, suitable counterions include Na+, Ca+, Li+, K+, Mg+, such as monoethanolamine (MEA), diethanolamine (DEA), triethanolamine (TEA), 2-amino-l-propanol, 1-aminopropanol, methyldiethanolamine, dimethylethanolamine, monoisopropanolamine, triisopropanolamine, l-amino-3-propanol, or mixtures thereof. In one embodiment, these compositions comprise 5% to 97% of one or more non-isoprenoid surfactants; and one or more auxiliary cleaning additives; wherein the weight ratio of the surfactant of formula A to the surfactant of formula B is from 50:50 to 95:5. ;
[0528] Soap - The compositions herein may contain soap. Without being limited by theory, it may be desirable to include soap because it acts partly as a surfactant and partly as a builder, and can be used to suppress foam, and in addition, can advantageously interact with the various cationic compounds of the composition to enhance the softness of the textile fabrics treated with the composition of the present invention. Any soap known in the art for use in laundry detergents can be utilized. In one embodiment, these compositions contain from 0wt% to 20wt%, from 0.5wt% to 20wt%, from 4wt% to 10wt%, or from 4wt% to 7wt% soap.
[0529] Examples of soaps useful herein include oleic acid soaps, palmitic acid soaps, palm kernel fatty acid soaps, and mixtures thereof. Typical soaps are in the form of mixtures of fatty acid soaps having varying chain lengths and degrees of substitution. One such mixture is topped palm kernel fatty acid.
[0530] In one embodiment, the soap is selected from free fatty acids. Suitable fatty acids are saturated and / or unsaturated and can be obtained from natural sources such as plant or animal esters (e.g., palm kernel oil, palm oil, coconut oil, babassu oil, safflower oil, tall oil, castor oil, tallow and fish oils, greases, and mixtures thereof), or synthetically prepared (e.g., via oxidation of petroleum or via hydrogenation of carbon monoxide by the Fischer Tropsch process).
[0531] Examples of suitable saturated fatty acids for use in the compositions of the present invention include capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid and behenic acid. Suitable unsaturated fatty acids include: palmitoleic acid, oleic acid, linoleic acid, linolenic acid and ricinoleic acid. Preferred examples of lipid acid are saturated Cn fatty acids, saturated C12-C14 fatty acids and saturated or undersaturated Cn to C18 fatty acids and mixtures thereof.
[0532] When present, the weight ratio of fabric softening cationic co-surfactant to fatty acid is preferably from about 1:3 to about 3:1, more preferably from about 1:1.5 to about 1.5:1, most preferably about 1:1.
[0533] The levels of soap and non-soap anionic surfactants herein are percentages by weight of the detergent composition specified on an acid basis. However, as is generally understood in the art, in practice anionic surfactants and soaps are neutralized using sodium, potassium or alkanolammonium bases such as sodium hydroxide or monoethanolamine.
[0534] Water-soluble additives - The composition of the invention may comprise one or more hydrotropes. A hydrotrope is a compound that dissolves hydrophobic compounds in aqueous solution (or conversely, polar substances in a non-polar environment). Typically, a hydrotrope has both hydrophilic and hydrophobic characteristics (so-called amphiphilic properties, as known from surfactants); however, the molecular structure of a hydrotrope is generally not conducive to spontaneous self-aggregation, see for example the review by Hodgdon and Kaler (2007), Current Opinion in Colloid & Interface Science 12: 121-128. Hydrotropes do not show a critical concentration above which self-aggregation occurs as found for surfactants and lipids form micelles, lamellae or other well-defined mesophases. Instead, many hydrotropes show a continuous type of aggregation process, in which the size of the aggregates grows with increasing concentration. However, many hydrotropes modify the phase behavior, stability, and colloidal properties of systems containing substances of polar and non-polar character, including mixtures of water, oils, surfactants, and polymers. Hydrotropes are routinely used in various industries ranging from pharmacy, personal care, food to technical applications. The use of hydrotropes in detergent compositions allows, for example, more concentrated surfactant formulations (such as in the process of compacting liquid detergents by removing water) without causing undesirable phenomena, such as phase separation or high viscosity.
[0535] The detergent may contain from 0 to 10 wt%, such as from 0 to 5 wt%, 0.5 wt% to 5 wt%, or from 3 wt% to 5 wt% of a hydrotrope. Any hydrotrope known in the art for use in a detergent may be utilized. Non-limiting examples of hydrotropes include sodium benzene sulfonate, sodium p-toluene sulfonate (STS), sodium xylene sulfonate (SXS), sodium cumene sulfonate (SCS), sodium cymene sulfonate, amine oxides, alcohols and polyethylene glycol ethers, sodium hydroxynaphthoate, sodium hydroxynaphthalene sulfonate, sodium ethylhexyl sulfonate, and combinations thereof.
[0536] Detergent-The compositions of the present invention may comprise one or more builders, co-builders, builder systems or mixtures thereof. When a builder is used, the cleaning composition will typically comprise from 0 to 65 wt%, at least 1 wt%, from 2 wt% to 60 wt% or from 5 wt% to 10 wt% of the builder. In dishwashing cleaning compositions, the level of builder is typically 40 wt% to 65 wt% or 50 wt% to 65 wt%. The composition may be substantially free of builder; substantially free means "no intentionally added" zeolite and / or phosphate. Typical zeolite builders include zeolite A, zeolite P and zeolite MAP. A typical phosphate builder is sodium tripolyphosphate.
[0537] The builder and / or co-builder may specifically be a chelating agent that forms a water-soluble complex with Ca and Mg. Any builder and / or co-builder known in the art for use in detergents may be used. Non-limiting examples of builders include zeolites, diphosphates (pyrophosphates), triphosphates such as sodium triphosphate (STP or STPP), carbonates such as sodium carbonate, soluble silicates such as sodium metasilicate, layered silicates (e.g., SKS-6 from Hoechst), ethanolamines (e.g., 2-aminoethane-1-ol (MEA), iminodiethanol (DEA), and 2,2',2"-nitrilotriethanol (TEA)), and carboxymethyl inulin (CMI), and combinations thereof.
[0538] The cleaning composition can include a co-builder individually or in combination with a builder (e.g., a zeolite builder). Non-limiting examples of co-builders include homopolymers of polyacrylates or copolymers thereof, such as poly(acrylic acid) (PAA) or co-(acrylic acid / maleic acid) (PAA / PMA). Other non-limiting examples include citrates, chelating agents (e.g., aminocarboxylates, aminopolycarboxylates, and phosphates), and alkyl succinic acids or alkenyl succinic acids. Further specific examples include 2,2',2"-nitrilotriacetic acid (NTA), ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), iminodisuccinic acid (IDS), ethylenediamine-N,N'-disuccinic acid (EDDS), methylglycinediacetic acid (MGDA), glutamic acid-N,N-diacetic acid (GLDA), 1-hydroxyethane-1,1-diylbis(phosphonic acid) (HEDP), ethylenediaminetetra(methylene)tetra(phosphonic acid) (EDTMPA), diethylenetriaminepenta(methylene)penta(phosphonic acid) (DTPMPA), N-(2-hydroxyethyl)iminodiacetic acid (EDG), aspartic acid-N-monoacetic acid (ASMA), aspartic acid-N,N-diacetic acid (ASDA), aspartic acid-N-monopropionic acid (ASMP), iminodisuccinic acid (IDA), N-(2-sulfomethyl)aspartic acid (SMAS), N-(2-sulfoethyl)aspartic acid (SE AS), N-(2-sulfomethyl)glutamic acid (SMGL), N-(2-sulfoethyl)glutamic acid (SEGL), N-methyliminodiacetic acid (MIDA), α-alanine-N,N-diacetic acid (α-ALDA), serine-N,N-diacetic acid (SEDA), isoserine-N,N-diacetic acid (ISDA), phenylalanine-N,N-diacetic acid (PHDA), anthranilic acid-N,N-diacetic acid (ANDA), para-aminobenzenesulfonic acid-N,N-diacetic acid (SLDA), taurine-N,N-diacetic acid (TUDA) and sulfomethyl-N,N-diacetic acid (SMDA), N-(hydroxyethyl)-ethylenediaminetriacetic acid (HEDTA), diethanolglycine (DEG), diethylenetriaminepenta(methylenephosphonic acid) (DTPMP), aminotri(methylenephosphonic acid) (ATMP), and combinations and salts thereof. Additional exemplary builders and / or co-builders are described, for example, in WO 09 / 102854, US 5977053.
[0539] Chelating agents and crystal growth inhibitors- The compositions herein may contain chelating agents and / or crystal growth inhibitors. Suitable molecules include copper, ion and / or manganese chelating agents and mixtures thereof. Suitable molecules include DTPA (diethylenetriaminepentaacetic acid), HEDP (hydroxyethanediphosphonic acid), DTPMP (diethylenetriaminepenta(methylenephosphonic acid)), 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt hydrate, ethylenediamine, diethylenetriamine, ethylenediamine disuccinic acid (EDDS), N-hydroxyethylethylenediaminetriacetic acid (HEDTA), triethylenetetraaminehexaacetic acid (TTHA), N-hydroxyethyliminodiacetic acid (HEIDA), dihydroxyethylglycine (DHEG), ethylenediaminetetrapropionic acid (EDTP), carboxymethyl inulin and 2-phosphonobutane 1,2,4-tricarboxylic acid ( Typically, the composition may contain from 0.005wt% to 15wt%, or from 3.0wt% to 10wt% of a chelating agent or crystal growth inhibitor.
[0540] Bleaching components - Suitable bleaching components for incorporation into the methods and compositions of the present invention include one or a mixture of more than one bleaching components. Suitable bleaching components include bleaching catalysts, photobleaches, bleach activators, hydrogen peroxide, hydrogen peroxide sources, preformed peracids and mixtures thereof. Typically, when a bleaching component is used, the composition of the present invention may contain from 0 to 30 wt%, from 0.00001 wt% to 90 wt%, 0.0001 wt% to 50 wt%, from 0.001 wt% to 25 wt% or from 1 wt% to 20 wt%. Examples of suitable bleaching components include:
[0541] (1) Preformed Peracids: Suitable preformed peracids include, but are not limited to, compounds selected from the group consisting of: preformed peroxyacids or salts thereof, typically peroxycarboxylic acids or salts thereof, or peroxysulfuric acid or salts thereof.
[0542] The preformed peroxyacid or salt thereof is preferably a peroxycarboxylic acid or salt thereof, typically having a chemical structure corresponding to the following formula:
[0543]
[0544] Where: R 14 is selected from an alkyl group, an aralkyl group, a cycloalkyl group, an aryl group or a heterocyclic group; R 14 The group may be linear or branched, substituted or unsubstituted; and Y is any suitable counterion to achieve charge neutrality, preferably, Y is selected from hydrogen, sodium or potassium. Preferably, R 14 is a straight chain or branched, substituted or unsubstituted C 6-9Preferably, the peroxy acid or its salt is selected from peroxycaproic acid, peroxyheptanoic acid, peroxyoctanoic acid, peroxynonanoic acid, peroxydecanoic acid, and salts thereof, or any combination thereof. Particularly preferred peroxy acid is phthalimido-peroxy-alkanoic acid, in particular ε-phthalimidoperoxycaproic acid (PAP). Preferably, the peroxy acid or its salt has a melting point in the range of from 30°C to 60°C.
[0545] The preformed peroxyacid or salt thereof may also be peroxysulfuric acid or a salt thereof, typically having a chemical structure corresponding to the following formula:
[0546]
[0547] Where: R 15 is selected from an alkyl group, an aralkyl group, a cycloalkyl group, an aryl group or a heterocyclic group; R 15 The group may be linear or branched, substituted or unsubstituted; and Z is any suitable counterion to achieve charge neutrality, preferably, Z is selected from hydrogen, sodium or potassium. Preferably, R 15 is a straight chain or branched, substituted or unsubstituted C 6-9 Preferably, such bleaching components may be present in the composition of the present invention in an amount of from 0.01 wt% to 50 wt% or from 0.1 wt% to 20 wt%.
[0548] (2) Hydrogen peroxide sources include, for example, inorganic perhydrate salts, including alkali metal salts, such as perborate (usually monohydrate or tetrahydrate), percarbonate, persulfate, perphosphate, sodium salt of persilicate and mixtures thereof. In one aspect of the present invention, inorganic perhydrate salts are, for example, those selected from the group consisting of perborate, sodium salt of percarbonate and mixtures thereof. When used, inorganic perhydrate salts are typically present in an amount of 0.05wt% to 40wt% or 1wt% to 30wt% of the overall composition and are typically incorporated into such compositions as crystalline solids that can be coated. Suitable coatings include: inorganic salts, such as alkali metal silicates, carbonates or borates or mixtures thereof, or organic materials, such as water-soluble or water-dispersible polymers, waxes, oils or fatty soaps. Preferably, such bleaching components may be present in the composition of the present invention in an amount of 0.01wt% to 50wt% or 0.1wt% to 20wt%.
[0549] (3) The term bleach activator means herein a compound which reacts with hydrogen peroxide to form a peracid via a perhydrolysis reaction. The peracid formed in this way constitutes the activated bleach. Suitable bleach activators to be used herein include those belonging to the class of esters, amides, imides or anhydrides. Suitable bleach activators are those having R-(C=O)-L, wherein R is an alkyl group (preferably branched) having from 6 to 14 carbon atoms, or from 8 to 12 carbon atoms when the bleach activator is hydrophobic, and having less than 6 carbon atoms or less than 4 carbon atoms when the bleach activator is hydrophilic; and L is a leaving group. Examples of suitable leaving groups are benzoic acid and its derivatives - especially benzene sulfonates. Suitable bleach activators include dodecanoyloxybenzenesulfonate, decanoyloxybenzenesulfonate, decanoyloxybenzoic acid or its salts, 3,5,5-trimethylhexanoyloxybenzenesulfonate, tetraacetylethylenediamine (TAED), sodium 4-[(3,5,5-trimethylhexanoyl)oxy]benzene-1-sulfonate (ISONOBS), 4-(dodecanoyloxy)benzene-1-sulfonate (LOBS), 4-(decanoyloxy)benzene-1-sulfonate, 4-(decanoyloxy)benzoate (DOBS or DOBA), 4-(nonanoyloxy)benzene-1-sulfonate (NOBS)), and / or those disclosed in WO 98 / 17767. A family of bleach activators is disclosed in EP 624154 and particularly preferred in that family is acetyl triethyl citrate (ATC). ATC or short chain triglycerides (like triacetin) have the advantage that it is environmentally friendly. In addition, acetyl triethyl citrate and triacetin have good hydrolytic stability in the product during storage and are effective bleach activators. Finally, ATC is multifunctional because the citrate released in the perhydrolysis reaction can act as a builder. Alternatively, the bleaching system can include peroxy acids of the amide, imide or sulfone type, for example. The bleaching system can also include peracids, such as 6-(phthalimido)perhexanoic acid (PAP). Suitable bleach activators are also disclosed in WO98 / 17767. Although any suitable bleach activator can be used, in one aspect of the present invention, the subject cleaning composition can include NOBS, TAED or a mixture thereof. When present, peracids and / or bleach activators are typically present in the composition in an amount of 0.1wt% to 60wt%, 0.5wt% to 40wt% or 0.6wt% to 10wt%, based on the fabric and home care composition. One or more hydrophobic peracids or their precursors can be used in combination with one or more hydrophilic peracids or their precursors. Preferably, such bleaching components may be present in the compositions of the present invention in an amount of from 0.01 wt% to 50 wt% or from 0.1 wt% to 20 wt%.
[0550] The amounts of hydrogen peroxide source and peracid or bleach activator may be selected so that the molar ratio of available oxygen (from the peroxide source) to peracid is from 1:1 to 35:1, or even 2:1 to 10:1.
[0551] (4) Diacyl Peroxides - Preferred diacyl peroxide bleaching species include those selected from the group consisting of diacyl peroxides having the following general formula: R 1 -C(O)-OO-(O)CR 2 , where R 1 Indicates C6-C 18 An alkyl group, preferably a straight chain having at least 5 carbon atoms and optionally containing one or more substituents (e.g., -N + (CH3)3, -COOH or -CN) and / or one or more interrupting moieties (e.g., -CONH- or -CH=CH-) inserted between adjacent carbon atoms of the alkyl group. 12 alkyl group, and R 2 represents an aliphatic group that is compatible with the peroxide portion so that R 1 and R 2 Together they contain a total of 8 to 30 carbon atoms. In a preferred aspect, R 1 and R 2 It is a straight chain unsubstituted C6-C 12 Most preferably, R 1 and R 2 are the same. 1 and R 2 All are C6-C 12 alkyl groups) are particularly preferred. Preferably, at least one, most preferably only one of the R groups (R1 or R2) does not contain a branched or pendant ring at the α position, or preferably does not contain a branched or pendant ring at either the α position or the β position, or most preferably does not contain a branched or pendant ring at either the α position, the β position, or the γ position. In an additional preferred embodiment, the DAP may be asymmetric, such that the R1 acyl group preferably hydrolyzes rapidly to produce a peracid, but the R2 acyl group hydrolyzes slowly.
[0552] The tetraacyl peroxide bleaching species are preferably selected from tetraacyl peroxides of the following general formula: R 3 -C(O)-OO-C(O)-(CH2)nC(O)-OO-C(O)-R 3 , where R 3 represents a C1-C9 alkyl group or a C3-C7 group, and n represents an integer from 2 to 12 or 4 to 10 both inclusive.
[0553] Preferably, diacyl and / or tetraacyl peroxide bleaching species are present in an amount sufficient to provide at least 0.5 ppm, at least 10 ppm, or at least 50 ppm of washing liquid by weight. In a preferred embodiment, these bleaching species are present in an amount sufficient to provide from 0.5 ppm to 300 ppm, from 30 ppm to 150 ppm of washing liquid by weight.
[0554] Preferably, the bleach component comprises a bleach catalyst (5 and 6).
[0555] (5) Preferred are organic (non-metallic) bleach catalysts, including bleach catalysts that are capable of accepting an oxygen atom from a peroxyacid and / or its salt and transferring the oxygen atom to an oxidizable substrate. Suitable bleach catalysts include, but are not limited to, iminium cations and polyions; iminium zwitterions; modified amines; modified amine oxides; N-sulfonyl imides; N-phosphoryl imides; N-acyl imides; thiadiazole dioxides; perfluoroimines; cyclic sugar ketones and mixtures thereof.
[0556] Suitable iminium cations and polyions include, but are not limited to, N-methyl-3,4-dihydroisoquinolinium tetrafluoroborate, prepared as described in Tetrahedron (1992), 49(2), 423-38 (see, e.g., Compound 4, page 433); N-methyl-3,4-dihydroisoquinolinium p-toluenesulfonate, prepared as described in US 5360569 (e.g., column 11, Example 1); and n-octyl-3,4-dihydroisoquinolinium p-toluenesulfonate, prepared as described in US 5360568 (e.g., column 10, Example 3).
[0557] Suitable iminium zwitterions include, but are not limited to, N-(3-sulfopropyl)-3,4-dihydroisoquinolinium, inner salt, prepared as described in US 5576282 (e.g., column 31, Example II); N-[2-(sulfooxy)dodecyl]-3,4-dihydroisoquinolinium, inner salt, prepared as described in US 5817614 (e.g., column 32, Example V); 2-[3-[(2-ethylhexyl)oxy]-2-(sulfooxy)propyl]-3,4-dihydroisoquinolinium, inner salt, prepared as described in WO 05 / 047264 (e.g., page 18, Example 8), and 2-[3-[(2-butyloctyl)oxy]-2-(sulfooxy)propyl]-3,4-dihydroisoquinolinium, inner salt.
[0558] Suitable modified amine oxygen transfer catalysts include, but are not limited to, 1,2,3,4-tetrahydro-2-methyl-1-isoquinolinol, which can be prepared according to the procedure described in Tetrahedron Letters (1987), 28(48), 6061-6064. Suitable modified amine oxide oxygen transfer catalysts include, but are not limited to, sodium 1-hydroxy-N-oxo-N-[2-(sulfoxy)decyl]-1,2,3,4-tetrahydroisoquinoline.
[0559] Suitable N-sulfonylimine oxygen transfer catalysts include, but are not limited to, 3-methyl-1,2-benzisothiazole 1,1-dioxide, which can be prepared according to the procedures described in Journal of Organic Chemistry (1990), 55(4), 1254-61.
[0560] Suitable N-phosphonyl imine oxygen transfer catalysts include, but are not limited to, [R-(E)]-N-[(2-chloro-5-nitrophenyl)methylene]-p-phenyl-p-(2,4,6-trimethylphenyl)phosphinic acid amide, which can be prepared according to the procedures described in Journal of the Chemical Society, Chemical Communications (1994), (22), 2569-70.
[0561] Suitable N-acylimine oxygen transfer catalysts include, but are not limited to, [N(E)]-N-(phenylmethylene)acetamide, which can be prepared according to the procedure described in Polish Journal of Chemistry (2003), 77(5), 577-590.
[0562] Suitable thiadiazole dioxide oxygen transfer catalysts include, but are not limited to, 3-methyl-4-phenyl-1,2,5-thiadiazole 1,1-dioxide, which can be prepared according to the procedure described in US Pat. No. 5,753,599 (column 9, Example 2).
[0563] Suitable perfluoroimine oxygen transfer catalysts include, but are not limited to, (Z)-2,2,3,3,4,4,4-heptafluoro-N-(nonafluorobutyl)butyrimidinium fluoride, which can be prepared according to the procedure described in Tetrahedron Letters (1994), 35(34), 6329-30.
[0564] Suitable cyclic sugar ketone oxygen transfer catalysts include, but are not limited to, 1,2:4,5-di-O-isopropylidene-D-erythro-2,3-hexodiuro-2,6-pyranose as prepared in US 6649085 (column 12, example 1).
[0565] Preferably, the bleaching catalyst comprises an iminium ion and / or a carbonyl functional group and is typically capable of forming an oxaziridinium and / or a dioxirane functional group upon acceptance of an oxygen atom, especially from a peroxyacid and / or its salt. Preferably, the bleaching catalyst comprises an oxaziridinium functional group and / or is capable of forming an oxaziridinium functional group upon acceptance of an oxygen atom, especially from a peroxyacid and / or its salt. Preferably, the bleaching catalyst comprises a cyclic iminium functional group, preferably wherein the cyclic portion has a ring size of from five to eight atoms (including nitrogen atoms), preferably six atoms. Preferably, the bleaching catalyst comprises an aryl iminium functional group, preferably a dicyclic aryl imine functional group, preferably a 3,4-dihydroisoquinolinium functional group. Typically, the imine functional group is a quaternary imine functional group and is typically capable of forming a quaternary oxaziridinium functional group upon accepting an oxygen atom, especially upon accepting an oxygen atom from a peroxyacid and / or a salt thereof. In another aspect, the detergent composition comprises a logP of no greater than 0, no greater than -0.5, no greater than -1.0, no greater than -1.5, no greater than -2.0, no greater than -2.5, no greater than -3.0, or no greater than -3.5. o / w The following is a more detailed description of the method for determining logP o / w method.
[0566] Typically, the bleaching ingredients are capable of producing an X of from 0.01 to 0.30, from 0.05 to 0.25, or from 0.10 to 0.20. SO The following is a more detailed description of the method for determining X SO For example, a bleaching component having an isoquinolinium structure can generate a bleaching species having an oxaziridinium structure. In this example, X SO It is a type of oxadiazine bleaching SO .
[0567] Preferably, the bleach catalyst has a chemical structure corresponding to the following formula:
[0568]
[0569] Wherein: n and m are independently 0 to 4, preferably n and m are both 0; each R 1independently selected from substituted or unsubstituted groups selected from the group consisting of hydrogen, alkyl, cycloalkyl, aryl, fused aryl, heterocycle, fused heterocycle, nitro, halide, cyano, sulfonate, alkoxy, keto, carboxyl and alkoxycarbonyl; and any two vicinal R 1 The substituents may be combined to form a fused aryl, fused carbocyclic or fused heterocyclic ring; each R 2 independently selected from substituted or unsubstituted groups, the groups independently selected from the group consisting of hydrogen, hydroxy, alkyl, cycloalkyl, alkaryl, aryl, aralkyl, alkylene, heterocycle, alkoxy, arylcarbonyl, carboxyalkyl and amide groups; any R 2 Can be used with any other R 2 Combined together to form part of a common ring; any geminal R 2 can combine to form a carbonyl group; and any two R 2 can be combined to form a substituted or unsubstituted fused unsaturated moiety; R 3 C1 to C 20 Substituted or unsubstituted alkyl; R 4 is hydrogen or Q t -A moiety, wherein: Q is a branched or unbranched olefin, t=0 or 1, and A is an anionic group selected from the group consisting of: OSO3 - 、SO3 - 、CO2 - 、OCO2 - 、OPO3 2- 、OPO3H - and OPO2 - ; R 5 is hydrogen or -CR 11 R 12 -YG b -Y c -[(CR 9 R 10 ) y -O] k -R 8 moiety, wherein: each Y is independently selected from the group consisting of: O, S, NH or NR 8 ; and each R 8 is independently selected from the group consisting of alkyl, aryl and heteroaryl, the moiety being substituted or unsubstituted, and whether substituted or unsubstituted, the moiety has less than 21 carbons; each G is independently selected from the group consisting of CO, SO2, SO, PO and PO2; R 9 and R 10 are independently selected from the group consisting of: H and C1-C4 alkyl; R 11 and R 12independently selected from the group consisting of: H and alkyl, or when put together can combine to form a carbonyl; b = 0 or 1; c can be = 0 or 1, but if b = 0, c must be = 0; y is an integer from 1 to 6; k is an integer from 0 to 20; R 6 is H, or an alkyl, aryl or heteroaryl moiety; said moiety is substituted or unsubstituted; and if X is present, it is a suitable charge-balancing counterion, when R 4 When X is hydrogen, it is preferably present. Suitable X include, but are not limited to, chloride, bromide, sulfate, methylsulfate, sulfonate, p-toluenesulfonate, boron tetrafluoride phosphate.
[0570] In one embodiment of the present invention, the bleach catalyst has a structure corresponding to the following general formula:
[0571]
[0572] Where R 13 is a branched alkyl group containing from three to 24 carbon atoms (including branched carbon atoms) or a straight chain alkyl group containing from one to 24 carbon atoms; preferably, R 13 is a branched alkyl group containing from eight to 18 carbon atoms or a straight chain alkyl group containing from eight to eighteen carbon atoms; preferably, R 13 is selected from the group consisting of 2-propylheptyl, 2-butyloctyl, 2-pentylnonyl, 2-hexyldecyl, n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, isononyl, isodecyl, isotridecyl and isopentadecyl; preferably, R 13 Selected from the group consisting of 2-butyloctyl, 2-pentylnonyl, 2-hexyldecyl, iso-tridecyl and iso-pentadecyl.
[0573] Preferably, the bleaching component comprises, in addition to a bleaching catalyst, in particular an organic bleaching catalyst, a peracid source. The peracid source may be selected from (a) preformed peracids; (b) percarbonates, perborates or persulfates (hydrogen peroxide sources), preferably in combination with a bleach activator; and (c) perhydrolases and esters for in situ formation of peracids in the presence of water in the textile or hard surface treatment step.
[0574] When present, the peracid and / or bleach activator is typically present in the composition in an amount of from 0.1 wt% to 60 wt%, from 0.5 wt% to 40 wt% or from 0.6 wt% to 10 wt%, based on the composition. One or more hydrophobic peracids or precursors thereof may be used in combination with one or more hydrophilic peracids or precursors thereof.
[0575] The amounts of hydrogen peroxide source and peracid or bleach activator may be selected so that the molar ratio of available oxygen (from the peroxide source) to peracid is from 1:1 to 35:1, or 2:1 to 10:1.
[0576] (6) Metal-containing bleach catalysts - the bleach component may be provided by a catalytic metal complex. One type of metal-containing bleach catalyst is a catalyst system comprising a transition metal cation having defined bleach catalytic activity (e.g., copper, iron, titanium, ruthenium, tungsten, molybdenum or manganese cations), an auxiliary metal cation having little or no bleach catalytic activity (e.g., zinc or aluminum cations), and a spacer having defined stability constants for the catalytic and auxiliary metal cations, in particular ethylenediaminetetraacetic acid, ethylenediaminetetra(methylenephosphonic acid) and water-soluble salts thereof. Such catalysts are disclosed in US 4430243. Preferred catalysts are described in WO 09 / 839406, US 6218351 and WO 00 / 012667. Particularly preferred are transition metal catalysts or ligands thereof as cross-linked multidentate N-donor ligands.
[0577] If desired, the compositions herein may be catalyzed with the aid of manganese compounds. Such compounds and usage levels are well known in the art and include, for example, the manganese-based catalysts disclosed in US 5576282.
[0578] Cobalt bleach catalysts useful herein are known and are described, for example, in US 5597936; US 5595967. Such cobalt catalysts may be readily prepared by known procedures, such as, for example, those taught in US 5597936 and US 5595967.
[0579] The compositions herein may also suitably include transition metal complexes of ligands such as bispidone (US 7501389) and / or polycyclic rigid ligands - abbreviated as "MRLs". As a practical matter and not by way of limitation, the compositions and methods herein may be adjusted to provide about at least one part per hundred million of active MRL species in an aqueous wash medium, and will typically provide from 0.005 ppm to 25 ppm, from 0.05 ppm to 10 ppm, or from 0.1 ppm to 5 ppm of MRL in the wash liquor.
[0580] Suitable transition metals in the transition metal bleach catalyst of the present invention include, for example, manganese, iron and chromium. Suitable MRLs include 5,12-diethyl-1,5,8,12-tetraazabicyclo[6.6.2]hexadecane. Suitable transition metal MRLs can be readily prepared by known procedures, such as those taught in, for example, US 6225464 and WO 00 / 32601.
[0581] (7) Photobleaches - Suitable photobleaches include, for example, sulfonated zinc phthalocyanine, sulfonated aluminium phthalocyanine, xanthene dyes and mixtures thereof. Preferred bleaching components for use in the compositions of the present invention comprise a hydrogen peroxide source, a bleach activator and / or an organic peroxyacid, optionally generated in situ by reaction of a hydrogen peroxide source and a bleach activator in combination with a bleach catalyst. Preferred bleaching components comprise a bleach catalyst, preferably an organic bleach catalyst as described above.
[0582] Particularly preferred bleaching components are bleach catalysts, especially organic bleach catalysts.
[0583] Exemplary bleaching systems are also described in, for example, WO 2007 / 087258, WO 2007 / 087244, WO 2007 / 087259 and WO 2007 / 087242.
[0584] Fabric Toner -The composition may comprise a fabric hueing agent. Suitable fabric hueing agents include dyes, dye-clay conjugates, and pigments. Suitable dyes include small molecule dyes and polymeric dyes. Suitable small molecule dyes include small molecule dyes selected from the group consisting of dyes belonging to the following color index (CI) classification: direct blue, direct red, direct violet, acid blue, acid red, acid violet, basic blue, basic violet and basic red or a mixture thereof.
[0585] In another aspect, suitable small molecule dyes include small molecule dyes selected from the group consisting of: Colorimetric Index (Society of Dyers and Colorists, Bradford, UK) numbers Direct Violet 9, Direct Violet 35, Direct Violet 48, Direct Violet 51, Direct Violet 66, Direct Violet 99, Direct Blue 1, Direct Blue 71, Direct Blue 80, Direct Blue 279, Acid Red 17, Acid Red 73, Acid Red 88, Acid Red 150, Acid Violet 15, Acid Violet 17, Acid Violet 24, Acid Violet 43, Acid Red 52, Acid Violet 49, Acid Violet 50 , Acid Blue 15, Acid Blue 17, Acid Blue 25, Acid Blue 29, Acid Blue 40, Acid Blue 45, Acid Blue 75, Acid Blue 80, Acid Blue 83, Acid Blue 90 and Acid Blue 113, Acid Black 1, Basic Violet 1, Basic Violet 3, Basic Violet 4, Basic Violet 10, Basic Violet 35, Basic Blue 3, Basic Blue 16, Basic Blue 22, Basic Blue 47, Basic Blue 66, Basic Blue 75, Basic Blue 159 and mixtures thereof. On the other hand, suitable small molecule dyes include small molecule dyes selected from the group consisting of: Color Index (Institute of Dyers and Colorists, Bradford, UK) No. Acid Violet 17, Acid Violet 43, Acid Red 52, Acid Red 73, Acid Red 88, Acid Red 150, Acid Blue 25, Acid Blue 29, Acid Blue 45, Acid Blue 113, Acid Black 1, Direct Blue 1, Direct Blue 71, Direct Violet 51, and mixtures thereof. On the other hand, suitable small molecule dyes include small molecule dyes selected from the group consisting of: Color Index (Institute of Dyers and Colorists, Bradford, UK) No. Acid Violet 17, Direct Blue 71, Direct Violet 51, Direct Blue 1, Acid Red 88, Acid Red 150, Acid Blue 29, Acid Blue 113, or mixtures thereof.
[0586] Suitable polymeric dyes include polymeric dyes selected from the group consisting of polymers containing a conjugated chromogen (dye-polymer conjugate) and polymers in which the chromogen is copolymerized into the polymer backbone, and mixtures thereof.
[0587] In another aspect, suitable polymeric dyes include polymeric dyes selected from the group consisting of: (Milliken), a dye-polymer conjugate formed from at least one reactive dye and a polymer selected from the group consisting of: a polymer comprising a moiety selected from the group consisting of a hydroxyl moiety, a primary amine moiety, a secondary amine moiety, a thiol moiety, and mixtures thereof. On the other hand, suitable polymeric dyes include polymeric dyes selected from the group consisting of: Violet CT, carboxymethylcellulose (CMC) conjugated with reactive blue, reactive violet or reactive red dyes such as CMC conjugated with CI Reactive Blue 19 (sold by Megazyme, Wicklow, Ireland under the product name AZO-CM-CELLULOSE, product code S-ACMC), alkoxylated triphenyl-methane polymeric colorants, alkoxylated thiophene polymeric colorants, and mixtures thereof.
[0588] Preferred hueing dyes include the brighteners found in WO 08 / 87497. These brighteners can be characterized by the following structure (I):
[0589]
[0590] Wherein R1 and R2 can be independently selected from:
[0591] a)[(CH2CR'HO) x (CH2CR"HO) y H]
[0592] Wherein R' is selected from the group consisting of: H, CH3, CH2O (CH2CH2O) z H, and mixtures thereof; wherein R" is selected from the group consisting of: H, CH2O (CH2CH2O) z H, and mixtures thereof; wherein x+y≤5; wherein y≥1; and wherein z=0 to 5;
[0593] b) R1 = alkyl, aryl or arylalkyl, and R2 = [(CH2CR'HO) x (CH2CR"HO) y H]
[0594] Wherein R' is selected from the group consisting of: H, CH3, CH2O (CH2CH2O) z H, and mixtures thereof; wherein R" is selected from the group consisting of: H, CH2O (CH2CH2O) z H, and mixtures thereof; wherein x+y≤10; wherein y≥1; and wherein z=0 to 5;
[0595] c) R1=[CH2CH2(OR3)CH2OR4] and R2=[CH2CH2(OR3)CH2OR4]
[0596] Wherein R3 is selected from the group consisting of: H, (CH2CH2O) z H and mixtures thereof; and wherein z = 0 to 10;
[0597] Wherein R4 is selected from the group consisting of: (C1-C16 ) alkyl groups, aryl groups, and mixtures thereof; and
[0598] d) wherein R1 and R2 may be independently selected from the amino addition products of styrene oxide, glycidyl methyl ether, isobutyl glycidyl ether, isopropyl glycidyl ether, tert-butyl glycidyl ether, 2-ethylhexyl glycidyl ether, and glycidyl hexadecyl ether, followed by the addition of from 1 to 10 alkylene oxide units.
[0599] The preferred brighteners of the present invention can be characterized by the following structure (II):
[0600]
[0601] Wherein R' is selected from the group consisting of: H, CH3, CH2O (CH2CH2O) z H, and mixtures thereof; wherein R" is selected from the group consisting of: H, CH2O (CH2CH2O) z H, and mixtures thereof; wherein x+y≤5; wherein y≥1; and wherein z=0 to 5.
[0602] Another preferred brightener of the present invention can be characterized by the following structure (III):
[0603]
[0604] Typically a mixture having a total of 5 EO groups is included. Suitable preferred molecules are those in structure I having the following pendant groups in "part a" above.
[0605] Table 1
[0606] R1 R2 R’ R” X y R’ R” x y A H H 3 1 H H 0 1 B H H 2 1 H H 1 1 c=b H H 1 1 H H 2 1 d=a H H 0 1 H H 3 1
[0607] Additional brighteners for use include those described in US 2008 / 34511 (Unilever). A preferred agent is "Violet 13".
[0608] Suitable dye clay conjugates include dye clay conjugates selected from the group consisting of at least one cationic / basic dye and smectite and mixtures thereof. On the other hand, suitable dye clay conjugates include dye clay conjugates selected from the group consisting of: a cationic / basic dye selected from the group consisting of CI Basic Yellow 1 to 108, CI Basic Orange 1 to 69, CI Basic Red 1 to 118, CI Basic Violet 1 to 51, CI Basic Blue 1 to 164, CI Basic Green 1 to 14, CI Basic Brown 1 to 23, CI Basic Black 1 to 11; and a clay selected from the group consisting of montmorillonite clay, hectorite clay, saponite clay and mixtures thereof. In yet another aspect, suitable dye clay conjugates include dye clay conjugates selected from the group consisting of: montmorillonite basic blue B7 CI42595 conjugate, montmorillonite basic blue B9 CI52015 conjugate, montmorillonite basic violet V3 CI42555 conjugate, montmorillonite basic green G1 CI42040 conjugate, montmorillonite basic red R1 CI45160 conjugate, montmorillonite CI basic black 2 conjugate, hectorite basic blue B7 CI42595 conjugate, hectorite basic blue B9 CI52015 conjugate, hectorite basic violet V3 CI42555 conjugate, hectorite basic green G1 CI42040 conjugate, hectorite basic red R1 CI45160 conjugate, hectorite CI basic black 2 conjugate, saponite basic blue B7 CI42595 conjugate, CI42595 conjugate, saponite basic blue B9 C.I.52015 conjugate, saponite basic violet V3 C.I.42555 conjugate, saponite basic green G1 CI42040 conjugate, saponite basic red R1 CI45160 conjugate, saponite CI basic black 2 conjugate and mixtures thereof.
[0609] Suitable pigments include pigments selected from the group consisting of flavonol, indanthrone, chlorine-containing indanthrone containing from 1 to 4 chlorine atoms, pyranthrone, dichloropyranthrone, monobromodichloropyranthrone, dibromodichloropyranthrone, tetrabromopyranthrone, perylene-3,4,9,10-tetracarboxylic acid diimide (wherein the imide groups may be unsubstituted or substituted by C1-C3-alkyl or phenyl or heterocyclic groups, and where the phenyl and heterocyclic groups may additionally carry substituents which do not impart solubility in water), anthrapyrimidinecarboxylic acid amides, anthrone violet, isoanthrone violet, dioxazine pigments, copper phthalocyanine which may contain up to 2 chlorine atoms per molecule, polychloro-copper phthalocyanine or polybrominated chloro-copper phthalocyanine containing up to 14 bromine atoms per molecule, and mixtures thereof.
[0610] In another aspect, suitable pigments include pigments selected from the group consisting of Ultramarine Blue (CI Pigment Blue 29), Ultramarine Violet (CI Pigment Violet 15), and mixtures thereof.
[0611] The above fabric hueing agents may be used in combination (any mixture of fabric hueing agents may be used). Suitable hueing agents are described in more detail in US 7208459. The preferred level of dye in the composition of the present invention is 0.00001wt% to 0.5wt%, or 0.0001wt% to 0.25wt%. The concentration of dye preferably used in the treatment and / or cleaning step in water is from 1ppb to 5ppm, 10ppb to 5ppm or 20ppb to 5ppm. In a preferred composition, the concentration of surfactant will be from 0.2 to 3g / l.
[0612] Encapsulated - The composition may comprise an encapsulate. In one aspect, the encapsulate comprises a core, a shell having an inner surface and an outer surface, said shell encapsulating said core.
[0613] In one aspect of the encapsulate, the core may comprise a material selected from the group consisting of: perfume brighteners; dyes; insect repellents; silicones; waxes; flavorings; vitamins; fabric softeners; skin care agents; in one aspect, paraffin; enzymes; antibacterial agents; bleaches; sensates; and mixtures thereof; and the shell may comprise a material selected from the group consisting of: polyethylene; polyamides; polyvinyl alcohol, optionally containing other comonomers; polystyrene; polyisoprene; polycarbonates; polyesters; polyacrylates; aminoplasts, in one aspect, the aminoplasts may comprise polyureas, polyurethanes and / or polyurea polyurethanes, in one aspect, the polyureas may comprise polyoxymethylene ureas and / or melamine formaldehyde; polyolefins; polysaccharides, in one aspect, the polysaccharides may comprise alginate and / or chitosan; gelatin; shellac; epoxy resins; vinyl polymer water-insoluble inorganics; silicones; and mixtures thereof.
[0614] In one aspect of the encapsulate, the core may comprise a flavor.
[0615] In one aspect of the encapsulate, the shell may comprise melamine formaldehyde and / or cross-linked melamine formaldehyde.
[0616] In one aspect, suitable encapsulates are disclosed that may include a core material and a shell that at least partially surrounds the core material. At least 75%, 85%, or 90% of the encapsulates may have a breaking strength of from 0.2 MPa to 10 MPa, from 0.4 MPa to 5 MPa, from 0.6 MPa to 3.5 MPa, or from 0.7 MPa to 3 MPa; and have a beneficial agent leakage of from 0% to 30%, from 0% to 20%, or from 0% to 5%.
[0617] In one aspect, at least 75%, 85%, or 90% of the encapsulates may have a particle size of from 1 micron to 80 microns, from 5 microns to 60 microns, from 10 microns to 50 microns, or from 15 microns to 40 microns.
[0618] In one aspect, at least 75%, 85%, or 90% of the encapsulates may have a particle wall thickness of from 30 to 250 nm, from 80 to 180 nm, or from 100 to 160 nm.
[0619] In one aspect, the core material of the encapsulate may include a material selected from the group consisting of flavor raw materials, and / or optionally includes a material selected from the group consisting of: vegetable oils, including pure vegetable oils and / or blended vegetable oils, including castor oil, coconut oil, cottonseed oil, grapeseed oil, rapeseed, soybean oil, corn oil, palm oil, linseed oil, safflower oil, olive oil, peanut oil, coconut oil, palm kernel oil, castor oil, oil), lemon oil and mixtures thereof; esters of vegetable oils, esters including dibutyl adipate, dibutyl phthalate, butyl benzyl adipate, octyl benzyl adipate, tricresyl phosphate, trioctyl phosphate and mixtures thereof; straight or branched chain hydrocarbons including those having a boiling point above about 80°C; partially hydrogenated terphenyls, dialkyl phthalates, alkyl biphenyls (including monoisopropyl biphenyl), alkylated naphthalenes (including dipropyl naphthalene), petroleum spirits (including kerosene), mineral oils and mixtures thereof; aromatic solvents including benzene, toluene and mixtures thereof; silicone oils; and mixtures thereof.
[0620] On the one hand, the wall material of the encapsulated object can include a suitable resin, which includes the reaction product of an aldehyde and an amine, and a suitable aldehyde includes formaldehyde. Suitable amines include melamine, urea, benzoguanamine, glycoluril and mixtures thereof. Suitable melamines include methylol melamine, methylated methylol melamine, imino melamine and mixtures thereof. Suitable ureas include dimethylol urea, methylated dimethylol urea, urea-resorcinol and mixtures thereof.
[0621] In one aspect, suitable formaldehyde scavengers can be used with the encapsulates, for example in a capsule slurry, and / or added to such compositions before, during or after the encapsulates are added to the composition. Suitable capsules can be made by following the teachings of US2008 / 0305982, and / or US2009 / 0247449.
[0622] In a preferred aspect, the composition may further comprise a deposition aid, preferably consisting of the group comprising cationic or nonionic polymers. Suitable polymers include cationic starch, cationic hydroxyethylcellulose, polyvinyl formaldehyde, locust bean gum, mannan, xyloglucan, tamarind gum, polyethylene glycol terephthalate, and polymers containing dimethylaminoethyl methacrylate, optionally with one or more monomers selected from the group comprising acrylic acid and acrylamide.
[0623] spices- In one aspect, the composition comprises a perfume, which comprises one or more perfume raw materials selected from the group consisting of: 1,1'-oxybis-2-propanol; diethyl 1,4-cyclohexanedicarboxylate; (ethoxymethoxy)cyclododecane; 1,3-nonanediol monoacetate; (3-methylbutoxy)acetic acid 2-propenyl ester; β-methylcyclododecaneethanol; 2-methyl-3-[(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)oxy]-1-propanol; oxacyclohexadecane-2-one; α-methyl-benzyl alcohol acetate; trans-3-ethoxy-1,1,5-trimethylcyclohexane; 4 -(1,1-dimethylethyl)cyclohexanol acetate; dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan; β-methylphenylpropionaldehyde; β-methyl-3-(1-methylethyl)phenylpropionaldehyde; 4-phenyl-2-butanone; ethyl 2-methylbutyrate; benzaldehyde; 1-methylethyl 2-methylbutyrate; dihydro-5-pentyl-2(3H)furanone; (2E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one; dodecanal; undecanal; 2-ethyl-α,α-dimethylphenylpropionaldehyde; decanal; α,α-dimethylphenylethanol acetate; 2- (phenylmethylene)octanal; methyl 2-[[3-[4-(1,1-dimethylethyl)phenyl]-2-methylpropylidene]amino]benzoate; 1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-2-buten-1-one; 2-pentylcyclopentanone; methyl 3-oxo-2-pentylcyclopentaneacetate; 4-hydroxy-3-methoxybenzaldehyde; 3-ethoxy-4-hydroxybenzaldehyde; 2-heptylcyclopentanone; 1-(4-methylphenyl)ethanone; (3E)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one; (3E)-4-(2,6,6- trimethyl-2-cyclohexen-1-yl)-3-buten-2-one; phenylethyl alcohol; 2H-1-benzopyran-2-one; 4-methoxybenzaldehyde; 10-undecenal; benzyl propionate; β-methylphenylpentanol; 1,1-diethoxy-3,7-dimethyl-2,6-octadiene; α,α-dimethylphenylethyl alcohol; (2E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one; benzyl acetate; 2-propenyl cyclohexylpropionate; 2-propenyl hexanoate; 1,2-dimethoxy-4-(2-propenyl)benzene; 1,5-dimethyl-bicyclo[3.2.1] octane-8-one oxime; 4-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carbaldehyde; 3-butene-2-ol; 2-[[[2,4(or 3,5)-dimethyl-3-cyclohexen-1-yl]methylene]amino]benzoic acid methyl ester; 8-cyclohexadecene-1-one; methyl ionone; 2,6-dimethyl-7-octen-2-ol; 2-methoxy-4-(2-propenyl)phenol; (2E)-3,7-dimethyl-2,6-octadiene- 1-ol; 2-hydroxy-benzoic acid (3Z)-3-hexenyl ester; 2-tridecenenitrile; 4-(2,2-dimethyl-6-methylenecyclohexyl)-3-methyl-3-buten-2-one; tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran; (2-methylbutoxy)acetic acid-2-propenyl ester; 2-hydroxy-3-methylbutyl benzoate; (Z)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butene- 1-Ketone; 2-hexyl-3-oxocyclopentanecarboxylic acid methyl ester; 4-ethyl-α,α-dimethyl-phenylpropanal; 3-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carbaldehyde; 1-(2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1H-3a,7-oxomethylazulen-5-yl)-[3R-(3α,3aβ,7β,8aα)]-ethanone; 2-methyl-2H-pyran-2-one 6-butyltetrahydro-undecene aldehyde; 4-(1,1-dimethylethyl)-α-methyl-phenylpropanal; 5-heptyldihydro-2(3H)-furanone; 2-[(7-hydroxy-3,7-dimethyloctylene)amino]benzoic acid methyl ester; 2-hydroxy-benzoic acid benzyl ester; 2-methoxynaphthalene; 2-hexyl-2-cyclopenten-1-one; 5-hexyldihydro-2(3H)-furanone; 3-methyl-3-phenyl-oxiranecarboxylic acid ethyl ester; 1,3,3-trimethyl-2-oxabicyclo[2.2.2] octane; γ-methyl-phenylpentanol; 3,7-dimethyl-3-octanol; 3,7-dimethyl-2,6-octadienenitrile; 3,7-dimethyl-6-octen-1-ol; terpineol acetate; 2-methyl-6-methylene-7-octen-2-ol dihydro derivative; 3a,4,5,6,7,7a-hexahydro-4,7-methylene-1H-inden-6-ol propionate; 3-methyl-2-butene-1-ol acetate; (Z)-3-hexene-1- alcohol acetate; 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol; 4-(octahydro-4,7-methano-5H-inden-5-ylidene)-butyraldehyde; 3-2,4-dimethyl-cyclohexene-1-carbaldehyde; 1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalene)-ethanone; 2-hydroxy-benzoic acid methyl ester; 2-hydroxy-benzoic acid hexyl ester; 2-phenoxy -ethanol; 2-hydroxy-benzoic acid amyl ester; 2,3-heptanedione; 2-hexen-1-ol; 2,6-dimethyl-6-octen-2-ol; damascenone (α, β, γ or δ or a mixture thereof), 3a,4,5,6,7,7a-hexahydro-4,7-endomethylene-1H-inden-6-ol acetate; 9-undecenal; 8-undecenal; isocyclocitral; 1-(1,2,3,5,6,7,8,8a-octahydro-2,3,8,8-tetramethyl- 2-naphthyl)-ethanone; 3,5-dimethyl-3-cyclohexene-1-carbaldehyde; 2,4-dimethyl-3-cyclohexene-1-carbaldehyde; 3,7-dimethyl-1,6-octadien-3-ol; 3,7-dimethyl-1,6-octadien-3-ol acetate; pt-Bucinal, and 2-[2-(4-methyl-3-cyclohexen-1-yl)propyl]-cyclopentanone and 1-methyl-4-(1-methylvinyl)cyclohexene and mixtures thereof.
[0624] In one aspect, the composition may comprise encapsulated perfume particles comprising water-soluble hydroxyl compounds or melamine-formaldehyde or modified polyvinyl alcohol. In one aspect, the encapsulate comprises (a) an at least partially water-soluble solid matrix comprising one or more water-soluble hydroxyl compounds, preferably starch; and (b) perfume oil encapsulated by the solid matrix.
[0625] In another aspect, the fragrance may be pre-complexed with a polyamine, preferably polyethyleneimine, to form a Schiff base.
[0626] polymer- The composition may comprise one or more polymers. Examples are carboxymethylcellulose, poly(vinyl-pyrrolidone), poly(ethylene glycol), poly(vinyl alcohol), poly(vinylpyridine-N-oxide), poly(vinylimidazole), polycarboxylates (such as polyacrylates), maleic acid / acrylic acid copolymers, and lauryl methacrylate / acrylic acid copolymers.
[0627] The composition may include one or more amphiphilic cleaning polymers, such as compounds having the following general structure: bis((C2H5O)(C2H4O)n)(CH3)-N + -C x H 2x -N + -(CH3)-bis((C2H5O)(C2H4O)n), wherein n=from 20 to 30, and x=from 3 to 8, or sulfated or sulfonated variants thereof.
[0628] The composition may comprise amphiphilic alkoxylated grease cleaning polymers having balanced hydrophilic and hydrophobic properties such that they remove grease particles from fabrics and surfaces. Specific embodiments of the amphiphilic alkoxylated grease cleaning polymers of the present invention comprise a core structure and a plurality of alkoxylated groups attached to the core structure. These may comprise alkoxylated polyalkylenimines, preferably having inner polyethylene oxide blocks and outer polypropylene oxide blocks.
[0629] Alkoxylated polycarboxylates (e.g., those prepared from polyacrylates) may be used herein to provide additional grease removal properties. Such materials are described in WO 91 / 08281 and PCT 90 / 01815. Chemically, these materials include polyacrylates having one ethoxy side chain per 7-8 acrylate units. The side chains have the formula -(CH2CH2O) m (CH2) n CH3, wherein m is 2-3 and n is 6-12. The side chains are ester-linked to the polyacrylate "backbone" to provide a "comb-like" polymer type structure. The molecular weight may vary, but is typically in the range of 2000 to 50,000. Such alkoxylated polycarboxylates may comprise from 0.05 wt % to 10 wt % of the composition herein.
[0630] The isoprenoid derived surfactants of the present invention, and mixtures formed with other co-surfactants and other adjuvant ingredients are particularly suitable for use with amphiphilic graft copolymers, preferably the amphiphilic graft copolymers contain (i) a polyethylene glycol backbone; and (ii) and at least one pendant portion selected from polyvinyl acetate, polyvinyl alcohol and mixtures thereof. A preferred amphiphilic graft copolymer is Sokalan HP22 supplied by BASF. Suitable polymers include random graft copolymers, preferably polyvinyl acetate grafted polyethylene oxide copolymers, having a polyethylene oxide backbone and multiple polyvinyl acetate side chains. The molecular weight of the polyethylene oxide backbone is preferably 6000, and the weight ratio of polyethylene oxide to polyvinyl acetate is 40 to 60, and there are no more than 1 grafting point per 50 ethylene oxide units.
[0631] Carboxylate polymers - The composition of the invention further comprises one or more carboxylate polymers, such as maleate / acrylate random copolymers or polyacrylate homopolymers. In one aspect, the carboxylate polymer is a polyacrylate homopolymer having a molecular weight of from 4,000Da to 9,000Da or from 6,000Da to 9,000Da.
[0632] Soil Release Polymers - The compositions of the present invention may also include one or more soil release polymers having a structure as defined by one of the following structures (I), (II) or (III):
[0633] (I)-[(OCHR 1 -CHR 2 ) a -O-OC-Ar-CO-] d
[0634] (II)-[(OCHR 3 -CHR 4 ) b -O-OC-sAr-CO-] e
[0635] (III)-[(OCHR 5 -CHR 6 ) c -OR 7 ] f
[0636] in:
[0637] a, b and c are from 1 to 200;
[0638] d, e and f are from 1 to 50;
[0639] Ar is 1,4-substituted phenylene;
[0640] sAr is a 1,3-substituted phenylene group, which is substituted at the 5-position by SO3Me;
[0641] Me is Li, K, Mg / 2, Ca / 2, Al / 3, ammonium, monoalkylammonium, dialkylammonium, trialkylammonium or tetraalkylammonium, wherein the alkyl group is C1-C 18 Alkyl or C2-C 10 Hydroxyalkyl, or a mixture thereof;
[0642] R 1 , R 2 , R 3 , R 4 , R 5 and R 6 Independently selected from H or C1-C 18 n-alkyl or isoalkyl; and
[0643] R 7 Is a straight or branched C1-C 18 Alkyl, or linear or branched C2-C 30 alkenyl, or a cycloalkyl group having 5 to 9 carbon atoms, or a C8-C 30 Aryl, or C6-C 30 Arylalkyl.
[0644] Suitable soil release polymers are polyester soil release polymers, such as Repel-o-tex polymers, including Repel-o-tex, SF-2 and SRP6, supplied by Rhodia. Other suitable soil release polymers include Texcare polymers, including Texcare SRA100, SRA300, SRN100, SRN170, SRN240, SRN300 and SRN325, supplied by Clariant. Other suitable soil release polymers are Marloquest polymers, such as Marloquest SL, supplied by Sasol.
[0645] Cellulose polymer - The composition of the present invention further comprises one or more cellulosic polymers, including those selected from alkyl celluloses, alkyl alkoxyalkyl celluloses, carboxyalkyl celluloses, alkyl carboxyalkyl celluloses. In one aspect, the cellulosic polymer is selected from the group comprising carboxymethyl cellulose, methyl cellulose, methyl hydroxyethyl cellulose, methyl carboxymethyl cellulose and mixtures thereof. In one aspect, the carboxymethyl cellulose has a degree of carboxymethyl substitution of from 0.5 to 0.9 and a molecular weight of from 100,000 Da to 300,000 Da.
[0646] Enzyme-composition can comprise one or more enzymes providing cleaning performance and / or fabric care benefits.The example of suitable enzyme includes but is not limited to hemicellulase, peroxidase, protease, cellulase, xylanase, lipase, phospholipase, esterase, cutinase, pectinase, mannanase, pectin lyase, keratinase, reductase, oxidase, phenoloxidase, lipoxygenase, ligninase, pullulanase, tannase, pentosylase, malanase (malanase), beta-glucanase, arabinosidase, hyaluronidase, chondroitinase, laccase, chlorophyllase, amylase or its mixture.Typical combination is enzyme mixture, can comprise for example protease and lipase together with amylase.When present in composition, aforementioned other enzyme can exist by the weight of composition with the level of from 0.00001wt% to 2wt%, from 0.0001wt% to 1wt% or from 0.001wt% to 0.5wt% enzyme protein.
[0647] Generally, the properties of the enzyme or enzymes selected should be compatible with the selected detergent (ie, pH optimum, compatibility with other enzymes and non-enzyme ingredients, etc.), and the enzyme or enzymes should be present in an effective amount.
[0648] On the one hand, preferred enzymes will include cellulases. Suitable cellulases include those of bacterial or fungal origin. Include chemically modified mutants or protein engineered mutants. Suitable cellulases include cellulases from the genus Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, such as the fungal cellulases produced by Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4435307, US 5648263, US 5691178, US 5776757 and WO 89 / 09259.
[0649] Particularly suitable cellulases are alkaline or neutral cellulases having color care benefits. Examples of such cellulases are cellulases described in EP 0495257, EP 0531372, WO 96 / 11262, WO 96 / 29397, WO 98 / 08940. Other examples are cellulase variants such as those described in WO 94 / 07998, EP 0531315, US 5457046, US 5686593, US 5763254, WO 95 / 24471, WO 98 / 12307 and PCT / DK98 / 00299.
[0650] Commercially available cellulases include Celluzyme TM and Carezyme TM (Novozymes A / S), ClazinaseTM and Puradax HA TM (Genencor International Inc.) and KAC-500(B) TM (Kao Corporation).
[0651] On the one hand, preferred enzymes will include proteases. Suitable proteases include those of bacterial, fungal, plant, viral or animal origin, such as plant or microbial origin. Microbial origin is preferred. Chemically modified mutants or protein engineered mutants are included. It can be an alkaline protease, such as a serine protease or a metalloprotease. The serine protease can be, for example, a S1 family (such as trypsin) or a S8 family (such as subtilisin). Metalloproteases can be, for example, thermolysin or other metalloproteases from, for example, an M4 family, such as those from an M5, M7 or M8 family.
[0652] The term "subtilase" refers to a subgroup of serine proteases according to Siezen et al., Protein Engng. 4 (1991) 719-737 and Siezen et al., Protein Science 6 (1997) 501-523. Serine proteases are a subgroup of proteases characterized by having a serine in the active site that forms a covalent adduct with the substrate. Subtilases can be divided into six subdivisions, namely, the subtilisin family, the thermophilic protease (Thermitase) family, the proteinase K family, the lantibiotic peptidase (Lantibiotic peptidase) family, the Kexin family and the Pyrolysin family.
[0653] Examples of subtilases are those derived from the genus Bacillus, such as Bacillus lentus, Bacillus alkalophilus, Bacillus subtilis, Bacillus amyloliquefaciens, Bacillus pumilus and Bacillus gibsonii described in US 7262042 and WO 09 / 021867; and subtilisin lentus, subtilisin Novo, subtilisin Carlsberg, Bacillus licheniformis, subtilisin BPN', subtilisin 309, subtilisin 147 and subtilisin 168 described in WO 89 / 06279 and protease PD138 described in (WO 93 / 18140). Other useful proteases may be those described in WO 92 / 175177, WO 01 / 016285, WO 02 / 026024 and WO02 / 016547. Examples of trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease (described in WO 89 / 06270, WO 94 / 25583 and WO 05 / 040372), and chymotrypsin from Cellumonas (described in WO 05 / 052161 and WO 05 / 052146).
[0654] Further preferred proteases are the alkaline protease from Bacillus lentus DSM 5483 (as described, for example, in WO 95 / 23221) and variants thereof (described in WO 92 / 21760, WO 95 / 23221, EP 1921147 and EP 1921148).
[0655] Examples of metalloproteases are neutral metalloproteases as described in WO 07 / 044993 (Genencor International), such as those derived from Bacillus amyloliquefaciens.
[0656] Examples of useful proteases are the variants described in WO 92 / 19729, WO 96 / 034946, WO 98 / 20115, WO 98 / 20116, WO 99 / 011768, WO 01 / 44452, WO 03 / 006602, WO 04 / 03186, WO 04 / 041979, WO 07 / 006305, WO 11 / 036263, WO 11 / 036264, in particular variants having substitutions at one or more of the following positions: 3, 4, 9, 15, 27, 36, 57, 68, 76, 87, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 106, 118, 120, 123, 128, 129, 130, 160, 167, 170, 194, 195, 199, 205, 206, 217, 218, 222, 224, 232, 235, 236, 245, 248, 252, and 274, using BPN' for numbering. More preferably, the subtilase variant may comprise the following mutations: S3T, V4I, S9R, A15T, K27R, *36D, V68A, N76D, N87S,R, *97E, A98S, S99G,D,A, S99AD, S101G,M,R S103A, V104I,Y,N, S106A, G118V,R, H120D,N, N123S, S128L, P129Q, S130A, G160D, Y167A, R170S, A194P, G195E, V199M, V205I, L217D, N218D, M222S, A232V, K235L, Q236H, Q245R, N252K, T274A (use BPN' for numbering).
[0657] Suitable commercially available proteases include those sold under the trade names Duralase Tm 、Durazym Tm , Ultra, Ultra, Ultra, Ultra, as well as Those sold, all of which can be (Novozymes); those sold under the following trade names: Purafect Prefer Tm 、Purafect Purafect Purafect Effect Tm , as well as (Danisco / DuPont), Axapem TM (Gist-Brocases NV), BLAP (sequence shown in Figure 29 of US5352604) and its variants (Henkel AG), and KAP (alkalophilic Bacillus subtilisin) from Kao Corporation.
[0658] In one aspect, preferred enzymes will include amylases. Suitable amylases may be alpha-amylases or glucoamylases and may be of bacterial or fungal origin. Chemically modified mutants or protein engineered mutants are included. Amylases include, for example, alpha-amylases obtained from Bacillus, such as the alpha-amylases of a particular strain of Bacillus licheniformis described in more detail in GB1296839.
[0659] Suitable amylases include those having SEQ ID NO: 3 in WO 95 / 10603 or variants thereof having 90% sequence identity to SEQ ID NO: 3. Preferred variants are described in WO 94 / 02597, WO 94 / 18314, WO 97 / 43424 and SEQ ID NO: 4 in WO 99 / 019467, for example variants having substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 178, 179, 181, 188, 190, 197, 201, 202, 207, 208, 209, 211, 243, 264, 304, 305, 391, 408 and 444.
[0660] Various suitable amylases include those having SEQ ID NO: 6 in WO 02 / 010355 or variants thereof having 90% sequence identity to SEQ ID NO: 6. Preferred variants of SEQ ID NO: 6 are those having deletions in positions 181 and 182 and a substitution in position 193.
[0661] Other suitable amylases are hybrid alpha-amylases comprising residues 1-33 of an alpha-amylase derived from Bacillus amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006 / 066594 and residues 36-483 of a Bacillus licheniformis alpha-amylase shown in SEQ ID NO: 4 of WO 2006 / 066594, or variants thereof having 90% sequence identity. Preferred variants of this hybrid alpha-amylase are those having a substitution, deletion or insertion in one or more of the following positions: G48, T49, G107, H156, A181, N190, M197, 1201, A209 and Q264. Most preferred variants of the hybrid alpha-amylase comprising residues 1-33 of the alpha-amylase derived from Bacillus amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006 / 066594 and residues 36-483 of SEQ ID NO: 4 are those having the following substitutions:
[0662] M197T;
[0663] H156Y+A181T+N190F+A209V+Q264S; or
[0664] G48A+T49I+G107A+H156Y+A181T+N190F+I201F+A209V+Q264S.
[0665] Suitable additional amylases are those having SEQ ID NO: 6 in WO 99 / 019467 or variants thereof having 90% sequence identity to SEQ ID NO: 6. Preferred variants of SEQ ID NO: 6 are those having substitutions, deletions or insertions in one or more of the following positions: R181, G182, H183, G184, N195, I206, E212, E216 and K269. Particularly preferred amylases are those having deletions in positions R181 and G182, or positions H183 and G184.
[0666] Additional amylases that may be used are those having SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 2 or SEQ ID NO: 7 of WO 96 / 023873 or variants thereof having 90% sequence identity thereto. Preferred variants of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 7 are those having substitutions, deletions or insertions in one or more of the following positions: 140, 181, 182, 183, 184, 195, 206, 212, 243, 260, 269, 304 and 476. More preferred variants are those having deletions at positions 181 and 182 or positions 183 and 184. Most preferred amylase variants of SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 7 are those having deletions in positions 183 and 184 and substitutions in one or more of positions 140, 195, 206, 243, 260, 304 and 476.
[0667] Other amylases that can be used are those having SEQ ID NO: 2 in WO 08 / 153815, SEQ ID NO: 10 in WO 01 / 66712, or variants thereof having 90% sequence identity to SEQ ID NO: 2 of WO 08 / 153815 or 90% sequence identity to SEQ ID NO: 10 in WO 01 / 66712. Preferred variants of SEQ ID NO: 10 in WO 01 / 66712 are those having substitutions, deletions or insertions in one or more of the following positions: 176, 177, 178, 179, 190, 201, 207, 211 and 264.
[0668] Additional suitable amylases are those having SEQ ID NO: 2 in WO 09 / 061380, or variants thereof having 90% sequence identity to SEQ ID NO: 2. Preferred variants of SEQ ID NO: 2 are those having C-terminal truncations and / or substitutions, deletions or insertions in one or more of the following positions: Q87, Q98, S125, N128, T131, T165, K178, R180, S181, T182, G183, M201, F202, N225, S243, N272, N282, Y305, R309, D319, Q320, Q359, K444, and G475. More preferred variants of SEQ ID NO: 2 are those with substitutions at one or more of the following positions: Q87E, R, Q98R, S125A, N128C, T131I, T165I, K178L, T182G, M201L, F202Y, N225E, R, N272E, R, S243Q, A, E, D, Y305R, R309A, Q320R, Q359E, K444E and G475K, and / or those with deletions at positions R180 and / or S181 or T182 and / or G183. The most preferred amylase variants of SEQ ID NO: 2 are those with the following substitutions:
[0669] N128C+K178L+T182G+Y305R+G475K;
[0670] N128C+K178L+T182G+F202Y+Y305R+D319T+G475K;
[0671] S125A+N128C+K178L+T182G+Y305R+G475K; or
[0672] S125A+N128C+T131I+T165I+K178L+T182G+Y305R+G475K, wherein these variants are C-terminally truncated and optionally further comprise a substitution at position 243 and / or a deletion at position 180 and / or position 181.
[0673] Other suitable amylases are alpha-amylases having SEQ ID NO: 12 in WO 01 / 66712 or variants having at least 90% sequence identity to SEQ ID NO: 12. Preferred amylase variants are those having substitutions, deletions or insertions in one or more of the following positions in SEQ ID NO: 12 in WO 01 / 66712: R28, R118, N174; R181, G182, D183, G184, G186, W189, N195, M202, Y298, N299, K302, S303, N306, R310, N314; R320, H324, E345, Y396, R400, W439, R444, N445, K446, Q449, R458, N471, N484. Particularly preferred amylases include variants having deletions of D183 and G184 and having substitutions R118K, N195F, R320K and R458K, and variants additionally having substitutions in one or more positions selected from the group consisting of: M9, G149, G182, G186, M202, T257, Y295, N299, M323, E345 and A339, most preferably variants additionally having substitutions in all of these positions.
[0674] Other examples are amylase variants as described in WO 2011 / 098531, WO 2013 / 001078 and WO 2013 / 001087.
[0675] Commercially available amylase is Duramyl TM Termamyl TM ,Termamyl Ultra TM 、Fungamyl TM 、Ban TM 、Stainzyme TM 、Stainzyme Plus TM , Supramyl TM 、Natalase TM , Liquozyme X and BAN TM (from Novozymes), (at 9000 Biozym Biotech Trading GmbH, Wehlistrasse 27b, A-1200 Vienna, Austria), and Rapidase TM 、Purastar TM / Effect TM, Powerase, PreferenzS100, Preferenx S110, OPTISIZE HT and PURASTAR (Danisco / DuPont) and (Kao Co., Ltd.).
[0676] Suitable lipases and cutinases include those of bacterial or fungal origin. Chemically modified or protein engineered mutant enzymes are included. Examples include lipases from thermophilic fungi, e.g., from Thermomyces lanuginosus (formerly named Humicola lanuginosus) as described in EP 258068 and EP 305216; cutinases from Humicola, e.g., Humicola insolens (WO 96 / 13580); lipases from strains of Pseudomonas (some of these now renamed Burkholderia), e.g., Pseudomonas alcaligenes or Pseudomonas pseudoalcaligenes (EP 218272), Pseudomonas cepacia (EP 331376), Pseudomonas strain SD705 (WO 95 / 06720 & WO 96 / 27002), Pseudomonas wisconsinensis (WO 96 / 12012); GDSL-type Streptomyces lipase (WO 10 / 065455); a cutinase from Magnaporthe grisea (WO 10 / 107560); a cutinase from Pseudomonas mendocinae (US 5,389,536); a lipase from Thermobifida fusca (WO 11 / 084412, WO 13 / 033318); a Geobacillus stearothermophilus lipase (WO 11 / 084417); a lipase from Bacillus subtilis (WO 11 / 084599); and lipases from Streptomyces griseus (WO 11 / 150157) and Streptomyces pristinaespiralis (WO 12 / 137147).
[0677] Other examples are lipase variants as described in EP 407225, WO 92 / 05249, WO 94 / 01541, WO 94 / 25578, WO 95 / 14783, WO 95 / 30744, WO 95 / 35381, WO 95 / 22615, WO 96 / 00292, WO 97 / 04079, WO 97 / 07202, WO 00 / 34450, WO 00 / 60063, WO 01 / 92502, WO 07 / 87508 and WO 09 / 109500.
[0678] Preferred commercial lipase products include Lipolase TM 、Lipex TM ;Lipolex TM and Lipoclean TM (Novozymes), Lumafast (from Genencor), and Lipomax (from Gistbrocades).
[0679] Still other examples are lipases sometimes referred to as acyltransferases or perhydrolases, such as acyltransferases with homology to Candida antarctica lipase A (WO 10 / 111143), acyltransferases from Mycobacterium smegmatis (WO 05 / 56782), perhydrolases from the CE 7 family (WO 09 / 67279) and variants of the Mycobacterium smegmatis perhydrolase, in particular the S54V variant used in the commercial product Gentle Power Bleach from Huntsman Textile Effects Pte Ltd (WO 10 / 100028).
[0680] In one aspect, other preferred enzymes include endoglucanases (EC 3.2.1.4) of microbial origin exhibiting endo-β-1,4-glucanase activity, including bacterial polypeptides endogenous to members of the genus Bacillus (the polypeptide having a sequence at least 90%, 94%, 97% or 99% identical to the amino acid sequence SEQ ID NO: 2 in US 7141403) and mixtures thereof. Suitable endoglucanases are sold under the trade name (Novozymes) sales.
[0681] Other preferred enzymes include those sold under the trade name Pectin lyases sold under the trade name (Novozymes) and Mannanase sold by (Danisco / DuPont).
[0682] One or more detergent enzymes can be included in the detergent composition by adding a single additive containing one or more enzymes, or by adding a combined additive containing all of these enzymes. The detergent additive of the present invention, i.e., the additive alone or in combination, can be formulated, for example, as granules, liquids, slurries, etc. Preferred detergent additive formulations are granules, especially non-dusting granules; liquids, especially stabilized liquids; or slurries.
[0683] Dust-free particles can be manufactured as disclosed in, for example, US 4106991 and US 4661452, and can optionally be coated by methods known in the art. Examples of waxy coating materials are poly(ethylene oxide) products (polyethylene glycol, PEG) with an average molecular weight of 1000 to 20000; ethoxylated nonylphenols with 16 to 50 ethylene oxide units; ethoxylated fatty alcohols, wherein the alcohol contains 12 to 20 carbon atoms, and wherein there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and monoglycerides, diglycerides, and triglycerides of fatty acids. Examples of film-forming coating materials suitable for use by fluidized bed technology are given in GB1483591. Liquid enzyme preparations can be stabilized, for example, by adding polyols (such as propylene glycol), sugars or sugar alcohols, lactic acid or boric acid according to established methods. Protected enzymes can be prepared according to the method disclosed in EP 238216.
[0684] Dye transfer inhibitors - The compositions of the present invention may also include one or more dye transfer inhibitors. Suitable polymeric dye transfer inhibitors include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof. When present in the composition, the dye transfer inhibitors may be present at a level of from 0.0001 wt% to 10 wt%, from 0.01 wt% to 5 wt% or from 0.1 wt% to 3 wt%.
[0685] Brightener - The compositions of the invention may also contain additional ingredients which may impart colour to the items being cleaned, such as optical brighteners.
[0686] The composition may include a CI fluorescent brightener 260 in α-crystal form having the following structure:
[0687]
[0688] In one aspect, the brightener is a cold water soluble brightener, such as a CI fluorescent brightener in α-crystalline form 260. In one aspect, the brightener is primarily in α-crystalline form, meaning typically at least 50 wt%, at least 75 wt%, at least 90 wt%, at least 99 wt%, or even substantially all of the CI fluorescent brightener 260 is in α-crystalline form.
[0689] The brightener is typically in the form of micronized particles having a weighted average primary particle size of from 3 to 30 microns, from 3 to 20 microns, or from 3 to 10 microns.
[0690] The composition may include a CI fluorescent brightener 260 in β-crystal form, and the weight ratio of (i) CI fluorescent brightener 260 in α-crystal form to (ii) CI fluorescent brightener 260 in β-crystal form may be at least 0.1 or at least 0.6. BE 680847 relates to a method for preparing a CI fluorescent brightener 260 in α-crystal form.
[0691] Commercial optical brighteners that can be used in the present invention can be divided into several subgroups, which include but are not necessarily limited to: diphenylethylene, pyrazoline, coumarin, carboxylic acid, methine cyanine, dibenzothiophene-5,5-dioxide, azoles, derivatives of 5- and 6-membered heterocycles, and other miscellaneous agents. Examples of such brighteners are disclosed in "The Production and Application of Fluorescent Brightening Agents", M. Zahradnik, published by John Wiley & Sons, New York (1982). Specific non-limiting examples of optical brighteners that can be used in the compositions of the present invention are those identified in US 4790856 and US 3646015.
[0692] Another suitable brightener has the following structure:
[0693]
[0694] Suitable fluorescent brightener levels include lower levels of from 0.01 wt%, from 0.05 wt%, from 0.1 wt% or from 0.2 wt% to higher levels of 0.5 wt% or 0.75 wt%.
[0695] In one aspect, the brightener can be loaded on the clay to form particles. Silicate - The composition of the present invention may also contain a silicate, such as sodium silicate or potassium silicate. The composition may contain from 0 wt% to less than 10 wt% silicate, to 9 wt%, or to 8 wt%, or to 7 wt%, or to 6 wt%, or to 5 wt%, or to 4 wt%, or to 3 wt%, or even to 2 wt%, and from above 0 wt%, or from 0.5 wt%, or from 1 wt% silicate. A suitable silicate is sodium silicate.
[0696] Dispersants - The compositions of the invention may also contain a dispersant. Suitable water-soluble organic materials include the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated from each other by not more than two carbon atoms.
[0697] Enzyme Stabilizer-Enzymes used in the composition can be stabilized by various techniques. Enzymes used herein can be stabilized by the presence of water-soluble sources of calcium and / or magnesium ions. Examples of conventional stabilizing agents are, for example, polyols such as propylene glycol or glycerol, sugars or sugar alcohols, peptide aldehydes, lactic acid, boric acid or boric acid derivatives such as aromatic borate esters, or phenylboronic acid derivatives such as 4-formylphenylboronic acid, and the composition can be formulated as described in, for example, WO 92 / 19709 and WO 92 / 19708. In the case of aqueous compositions comprising proteases, reversible protease inhibitors can be added to further improve stability, the reversible protease inhibitors being, for example, boron compounds including borates, 4-formylphenylboronic acid, phenylboronic acid and derivatives thereof; or compounds such as calcium formate, sodium formate and 1,2-propylene glycol. The peptide aldehyde may have the formula B2-B1-B0-R, wherein: R is hydrogen, CH3, CX3, CHX2 or CH2X, wherein X is a halogen atom; B0 is a phenylalanine residue having an OH substituent at the para position and / or at the meta position; B1 is a single amino acid residue; and B2 consists of one or more amino acid residues, optionally comprising an N-terminal protecting group. Preferred peptide aldehydes include, but are not limited to, Z-RAY-H, Ac-GAY-H, Z-GAY-H, Z-GAL-H, Z-GAF-H, Z-GAV-H, Z-RVY-H, Z-LVY-H, Ac-LGAY-H, Ac-FGAY-H, Ac-YGAY-H, Ac-FGVY-H or Ac-WLVY-H, wherein Z is benzyloxycarbonyl and Ac is acetyl.
[0698] Solvents - Suitable solvents include water and other solvents such as lipophilic fluids. Examples of suitable lipophilic fluids include siloxanes, other silicones, hydrocarbons, glycol ethers, glycerol derivatives (e.g., glycerol ethers), perfluorinated amines, perfluorinated and hydrofluoroether solvents, low volatility non-fluorinated organic solvents, glycol solvents, other environmentally friendly solvents, and mixtures thereof.
[0699] Structuring agent / thickener-Structured liquids can be structured from the inside, whereby the structure is formed by primary ingredients (e.g., surfactant materials), and / or structured from the outside by providing a three-dimensional matrix structure using secondary ingredients (e.g., polymers, clays and / or silicate materials). The composition can include from 0.01wt% to 5wt%, or from 0.1wt% to 2.0wt% of a structurant. The structurant is typically selected from the group consisting of: diglycerides and triglycerides, stearic acid ethylene glycol diesters, microcrystalline cellulose, cellulose-based materials, microfiber cellulose, hydrophobically modified alkali swellable emulsions (e.g., Polygel W30 (3V Sigma)), biopolymers, xanthan gum, gellan gum and mixtures thereof. Suitable structurants include hydrogenated castor oil and non-ethoxylated derivatives thereof. Suitable structurants are disclosed in US6855680. Such structurants have a thread-like structuring system that has a certain range of aspect ratios. Other suitable structurants and methods for making them are described in WO 10 / 034736.
[0700] Conditioner -The composition of the present invention may include a high melting point fatty compound. The high melting point fatty compound useful herein has a melting point of 25°C or higher and is selected from the group consisting of: fatty alcohols, fatty acids, fatty alcohol derivatives, fatty acid derivatives and mixtures thereof. Such compounds with low melting points are not intended to be included in this section. Non-limiting examples of high melting point compounds are found in International Cosmetic Ingredient Dictionary [International Cosmetic Ingredient Dictionary], Fifth Edition, 1993, and CTFA Cosmetic Ingredient Handbook [CTFA Cosmetic Ingredient Handbook], Second Edition, 1992.
[0701] In view of providing improved conditioning benefits such as slippery feel during application to wet hair, softness and moisturized feel to dry hair, high melting point fatty compounds are included in the composition at levels of from 0.1 wt% to 40 wt%, from 1 wt% to 30 wt%, from 1.5 wt% to 16 wt%, from 1.5 wt% to 8 wt%.
[0702] The composition of the present invention can contain cationic polymers. The concentration of cationic polymers in the composition typically ranges from 0.05wt% to 3wt%, from 0.075wt% to 2.0wt%, or from 0.1wt% to 1.0wt%. At the pH of the intended use composition, suitable cationic polymers will have a cationic charge density of at least 0.5meq / gm, at least 0.9meq / gm, at least 1.2meq / gm, at least 1.5meq / gm, or less than 7meq / gm, and less than 5meq / gm, and the range of pH will generally be from pH 3 to pH 9 or between pH 4 and pH 8. Herein, the "cationic charge density" of a polymer refers to the ratio of the number of positive charges on the polymer to the molecular weight of the polymer. The average molecular weight of such suitable cationic polymers will generally be between 10,000 and 10,000,000, between 50,000 and 5,000,000, or between 100,000 and 3,000,000.
[0703] Suitable cationic polymers for use in the compositions of the present invention contain cationic nitrogen-containing moieties, such as quaternary ammonium or cationic protonated amino moieties. Any anionic counterions may be used in association with the cationic polymers, as long as the polymer remains dissolved in water, in the composition, or in the condensed phase of the composition, and as long as the counterions are physically and chemically compatible with the major components of the composition or otherwise do not unduly impair composition performance, stability, or aesthetics. Non-limiting examples of such counterions include halides (e.g., chlorides, fluorides, bromides, iodides), sulfates, and methylsulfates.
[0704] Non-limiting examples of such polymers are described in the CTFA Cosmetic Ingredient Dictionary, 3rd Edition, edited by Estrin, Crosley and Haynes (The Cosmetic, Toiletry, and Fragrance Association, Inc., Washington, DC (1982)).
[0705] Other suitable cationic polymers for use in the composition include polysaccharide polymers, cationic guar gum derivatives, cellulose ethers containing quaternary nitrogen, synthetic polymers, copolymers of etherified cellulose, guar gum and starch. When used, the cationic polymers herein are soluble in the composition or in the complex coacervate phase soluble in the composition, which is formed by the cationic polymers described above and anionic, amphoteric and / or zwitterionic surfactant components. The complex coacervate of the cationic polymer can also be formed with other charged materials in the composition. Suitable cationic polymers are described in US3962418, US3958581 and US2007 / 0207109.
[0706] The compositions of the present invention may contain nonionic polymers as conditioning agents. Polyalkylene glycols having a molecular weight greater than 1000 are useful herein. Those having the following general formula are useful:
[0707]
[0708] Where R 95 Selected from the group consisting of: H, methyl and mixtures thereof. Regulators, and particularly silicones, may be included in the composition. Regulators for the composition of the present invention typically include water-insoluble, water-dispersible, non-volatile liquids that form emulsified liquid particles. Suitable regulators for use in the composition are those that are generally characterized as follows: silicones (e.g., silicone oils, cationic silicones, silicone gums, high-refractive silicones and silicone resins), organic conditioning oils (e.g., hydrocarbon oils, polyolefins and fatty esters) or combinations thereof, or those regulators that otherwise form liquid dispersed particles in the aqueous surfactant matrix of this article. Such regulators should be physically and chemically compatible with the main component of the composition, and should not otherwise improperly damage composition stability, aesthetics or performance.
[0709] The concentration of the conditioning agent in the composition should be sufficient to provide the desired conditioning benefit. Such concentration may vary depending on the conditioning agent, the desired conditioning properties, the average size of the conditioning agent particles, the type and concentration of other components, and other similar factors.
[0710] The concentration of silicone conditioning agents typically ranges from 0.01 wt% to 10 wt%. Non-limiting examples of suitable silicone conditioning agents and optional suspending agents for silicone are described in the following references: U.S. Reissue Patent No. 34,584, U.S. Pat. No. 5,104,646, U.S. Pat. No. 5,106,609, U.S. Pat. No. 4,152,416, U.S. Pat. No. 2,826,551, U.S. Pat. No. 3,964,500, U.S. Pat. No. 4,364,837, U.S. Pat. No. 6,607,717, U.S. Pat. No. 6,482,969, U.S. Pat. No. 5,807,956, U.S. Pat. No. 5,981,681, U.S. Pat. No. 6,207,782, U.S. Pat. No. 7,465,439, U.S. Pat. No. 7,041,767, U.S. Pat. No. 7,217,777, U.S. Pat. No. 2007 / 0286837A1, U.S. Pat. No. 2005 / 0048549A1, U.S. Pat. No. 2007 / 0041929A1, GB849433, DE10036533, all of which are incorporated herein by reference; Chemistry and Technology of Silicones, Academic Press, New York (1968); General Electric Silicone Rubber Product Data Sheets SE 30, SE 33, SE 54, and SE 76; Silicon Compounds, Petrarch Systems, Inc. (1984); and Encyclopedia of Polymer Science and Engineering, Vol. 15, 2d ed., pp. 204-308, John Wiley & Sons, Inc. (1989).
[0711] The composition of the present invention may also contain from 0.05 wt % to 3 wt % of at least one organic conditioning oil as a conditioning agent, alone or in combination with other conditioning agents such as silicones (described herein). Suitable conditioning oils include hydrocarbon oils, polyolefins, and fatty esters. Also suitable for use in the composition herein are conditioning agents described in US 5674478 and US 5750122 or in US 4529586; US 4507280; US 4663158; US 4197865; US 4217914; US 4381919; and US 4422853.
[0712] Hygiene and bad smell - The composition of the present invention may also contain zinc ricinoleate, thymol, quaternary ammonium salts (such as ), polyethyleneimine (e.g. from BASF ) and zinc complexes thereof, silver and silver compounds (especially those designed to slowly release Ag +or nanosilver dispersions).
[0713] Prebiotics - The composition may comprise a prebiotic, such as those described in WO 09 / 043709.
[0714] Foam enhancer - If high foaming is desired, a foaming agent (e.g. C 10 -C 16 Alkanolamide or C 10 -C 14 Alkyl sulfate) can typically be incorporated into the composition at a level of 1 wt% to 10 wt%. 10 -C 14 Monoethanol and diethanolamides illustrate typical classes of such suds boosters. Such suds boosters are also advantageously used with high foaming adjunct surfactants (e.g., the amine oxides, betaines, and sultaines mentioned above). If desired, water-soluble magnesium and / or calcium salts (e.g., MgCl2, MgSO4, CaCl2, CaSO4, etc.) may be added typically at levels of 0.1 wt% to 2 wt% to provide additional foam and to enhance grease removal performance.
[0715] Foam Inhibitor - Compounds for reducing or inhibiting foam formation can be incorporated into the compositions of the present invention. Foam inhibition may be particularly important in so-called "high concentration cleaning processes" as described in US 4489455 and US 4489574 and in front-loading-style washing machines. A wide variety of materials can be used as foam inhibitors, and foam inhibitors are well known to those skilled in the art. See, for example, Kirk Othmer Encyclopedia of Chemical Technology, 3rd edition, Vol. 7, pp. 430-447 (John Wiley & Sons, 1979). Examples of foam inhibitors include monocarboxylic fatty acids and soluble salts thereof, high molecular weight hydrocarbons such as paraffin, fatty acid esters (e.g., fatty acid triglycerides), fatty acid esters of monovalent alcohols, aliphatic C 18 -C 40Ketones (e.g., stearone), N-alkylated aminotriazines, wax hydrocarbons preferably having a melting point below about 100° C., silicone foam inhibitors, and secondary alcohols. Foam inhibitors are described in US2954347, US4265779, US4265779, US3455839, US3933672, US4652392, US4978471, US4983316, US5288431, US4639489, US4749740, US4798679, US4075118, EP89307851.9, EP150872, and DOS2,124,526.
[0716] For any detergent composition to be used in an automatic washing machine, suds should not form to the extent that they overflow the washing machine. When used, suds suppressors are preferably present in a "suds suppressing amount." "Suds suppressing amount" means that the formulator of the composition can select an amount of such suds control agent that will sufficiently control suds to result in a low sudsing laundry detergent for use in an automatic washing machine.
[0717] The compositions herein will typically contain from 0 to 10 wt% of a foam suppressor. When used as a foam suppressor, monocarboxylic fatty acids and salts thereof will typically be present in amounts up to 5 wt%. Preferably, from 0.5 wt% to 3 wt% of a fatty monocarboxylic ester foam suppressor is used. Silicone foam suppressors are typically used in amounts up to 2.0 wt%, although higher amounts may be used. Monostearoyl phosphate foam suppressors are typically used in amounts ranging from 0.1 wt% to 2 wt%. Hydrocarbon foam suppressors are typically used in amounts ranging from 0.01 wt% to 5.0 wt%, although higher levels may be used. Alcohol foam suppressors are typically used at 0.2 wt% to 3 wt%.
[0718] The compositions herein can have cleaning activity over a wide range of pH. In certain embodiments, these compositions have cleaning activity from pH 4 to pH 11.5. In other embodiments, these compositions have activity from pH 6 to pH 11, from pH 7 to pH 11, from pH 8 to pH 11, from pH 9 to pH 11, or from pH 10 to pH 11.5.
[0719] The compositions herein may have cleaning activity over a wide range of temperatures, for example from 10° C. or less to 90° C. Preferably, the temperature will be below 50° C. or 40° C. or even 30° C. In certain embodiments, the optimum temperature range for these compositions is from 10° C. to 20° C., from 15° C. to 25° C., from 15° C. to 30° C., from 20° C. to 30° C., from 25° C. to 35° C., from 30° C. to 40° C., from 35° C. to 45° C., or from 40° C. to 50° C.
[0720] Form of composition
[0721] The compositions described herein are advantageously used, for example, in laundry applications, hard surface cleaning, dishwashing applications, as well as cosmetic applications such as dentures, teeth, hair and skin. The compositions of the present invention are particularly solid or liquid cleaning and / or treatment compositions. In one aspect, the present invention relates to a composition, wherein the form of the composition is selected from the group consisting of: a regular, compressed or concentrated liquid; a gel; a paste; a soap bar; a regular or compressed powder; a granular solid; a uniform or multilayer tablet having two or more layers (same or different phases); a bag having one or more compartments; a single or multiple compartment unit dosage form; or any combination thereof.
[0722] The form of the composition can physically separate components in multiple compartments (such as water-soluble bags, for example) or in different layers of a tablet from each other. Thus, undesirable storage interactions between components can be avoided. Different dissolution profiles of each compartment can also cause delayed dissolution of selected components in the wash solution.
[0723] The bag can be configured as a single chamber or multiple chambers. It can have any form, shape and material suitable for holding the composition, such as not allowing the composition to be released from the bag before contact with water. The bag is made of a water-soluble film, which includes an internal volume. The internal volume can be divided into the chambers of the bag. The preferred film is a polymer material, preferably a polymer forming a film or sheet. Preferred polymers, copolymers or derivatives thereof are selected from polyacrylates and water-soluble acrylate copolymers, methylcellulose, carboxymethylcellulose, sodium dextrin, ethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, maltodextrin, polymethacrylates, most preferably polyvinyl alcohol copolymers and hydroxypropylmethylcellulose (HPMC). Preferably, the level of polymer in the film, such as PVA, is at least about 60%. The preferred average molecular weight will typically be about 20,000 to about 150,000. The film can also be a blended composition comprising a hydrolytically degradable and water-soluble polymer blend such as polylactic acid and polyvinyl alcohol (known under trade reference M8630, such as sold by MonoSol LLC, Indiana, USA) plus a plasticizer such as glycerol, ethylene glycol, propylene glycol, sorbitol and mixtures thereof. These bags can contain solid laundry cleaning compositions or partial components and / or liquid cleaning compositions or partial components separated by a water-soluble film. The chamber for the liquid component can be different in composition from the chamber containing the solid (US2009 / 0011970 A1).
[0724] Water soluble film-The composition of the present invention can also be encapsulated in a water-soluble film. Preferably, the preferred film material is a polymer material. The film material can be obtained, for example, by casting, blow molding, extrusion or inflation extrusion of a polymer material, as known in the art. Suitable for use as a preferred polymer, copolymer or derivative thereof for bag material is selected from polyvinyl alcohol, polyvinyl pyrrolidone, polyalkylene oxide, acrylamide, acrylic acid, cellulose, cellulose ether, cellulose ester, cellulose amide, polyvinyl acetate, polycarboxylic acid and salt, polyamino acid or peptide, polyamide, polyacrylamide, maleic acid / acrylic acid copolymer, polysaccharide (including starch and gelatin), natural gum (such as xanthan gum and carragan (carragum)). More preferred polymers are selected from polyacrylates and water-soluble acrylic copolymers, methylcellulose, sodium carboxymethylcellulose, dextrin, ethylcellulose, hydroxyethylcellulose, hydroxypropyl methylcellulose, maltodextrin, polymethacrylate, and most preferably selected from polyvinyl alcohol, polyvinyl alcohol copolymers and hydroxypropyl methylcellulose (HPMC), and combinations thereof. Preferably, the level of polymer in bag material (e.g., PVA polymer) is at least 60wt%. The polymer may have any weight average molecular weight, preferably from about 1.000 to 1.000.000, from about 10.000 to 300.000, from about 20.000 to 150.000. Mixtures of polymers may also be used as bag materials.
[0725] Naturally, different membrane materials and / or membranes of different thicknesses can be used to make the chambers of the invention. A benefit in choosing different membranes is that the resulting chambers can exhibit different solubility or release characteristics.
[0726] Preferred film materials are PVA films known under the Monosol trade references M8630, M8900, H8779, and those described in US 6166117 and US 6787512, and PVA films having corresponding solubility and deformation characteristics.
[0727] The film material herein can also include one or more additive ingredients. For example, it may be beneficial to add a plasticizer, such as glycerol, ethylene glycol, diethylene glycol, propylene glycol, sorbitol and mixtures thereof. Other additives include functional detergent additives to be delivered to the washing water, such as organic polymer dispersants, etc.
[0728] Method for making the composition
[0729] The compositions of the present invention may be formulated into any suitable form and prepared by any method chosen by the formulator, non-limiting examples of which are described in the applicant's examples and in US4990280, US20030087791A1, US20030087790A1, US20050003983A1, US20040048764A1, US4762636, US6291412, US20050227891A1, EP1070115A2, US5879584, US5691297, US5574005, US5569645, US5565422, US5516448, US5489392, US5486303, all of which are incorporated herein by reference. Compositions of the invention or compositions prepared according to the invention include cleaning and / or treatment compositions, including but not limited to compositions for treating fabrics, hard surfaces and any other surfaces in the field of fabric and home care, including: air care (including air fresheners and odor delivery systems), car care, dishwashing, fabric conditioning (including softening and / or freshening), laundry descaling, laundry and rinse additives and / or care, hard surface cleaning and / or treatment (including floor and toilet bowl cleaners), all-purpose or "heavy duty" detergents in granular or powder form, especially cleaning detergents; all-purpose detergents in liquid, gel or paste form, especially the so-called heavy duty liquid types; liquid delicate fabric detergents; manual dishwashing detergents or light duty dishwashing detergents, especially those of the high foaming type; machine dishwashing detergents, including different tablet, granular, liquid and rinse aid types for use in homes and institutions: car or carpet shampoos, bathroom cleaners (including toilet bowl cleaners); and cleaning adjuvants, such as bleach additives and "stain sticks" or pre-treatment types, compositions loaded with substrates (e.g., tablets with added desiccant). Preferred are compositions and methods for cleaning and / or treating textiles and / or hard surfaces (most preferably textiles). The composition is preferably a composition used in a pre-treatment step or in the main wash step (most preferably for textile wash steps) of a wash process.
[0730] As used herein, the term "fabric and / or hard surface cleaning and / or treatment composition" is a subset of cleaning and treatment compositions, which, unless otherwise indicated, includes general-purpose or "heavy-duty" detergents in granular or powder form, especially cleaning detergents; general-purpose detergents in liquid, gel or paste form, especially the so-called heavy-duty liquid types; liquid fine fabric detergents; manual dishwashing detergents or light-duty dishwashing detergents, especially those of the high-sudsing type; machine dishwashing detergents, including different tablet, granular, liquid and rinse aid types for use in households and institutions; liquid cleaning and disinfecting agents, car or carpet shampoos, bathroom cleaners (including toilet bowl cleaners); fabric conditioning compositions (including softening and / or refreshing), which may be in liquid, solid and / or dryer tablet form; and cleaning adjuvants, such as bleach additives and "stain sticks" or pre-treatment types, substrate-loaded compositions (e.g., dryer-added tablets). All applicable such compositions may be in standard, concentrated or even highly concentrated form, even to the extent that such compositions may be non-aqueous in some respects.
[0731] How to use
[0732] The present invention is included in the method for cleaning any surface (including processing textiles or hard surfaces or other surfaces) in the field of fabric and / or household care. It is considered that cleaning as described can be in small scale (such as family housework (familyhouse hold)) together with large scale (such as in such as industrial and professional settings). In one aspect of the present invention, the method is included in the step of contacting the surface to be treated in the pre-treatment step or main washing step of the washing process (most preferably for use in the textile washing step or alternatively for use in dishwashing (including manual and automatic / mechanical dishwashing)). In one embodiment of the present invention, lipase variant and other components are sequentially added to the method for cleaning and / or processing surface. Alternatively, lipase variant and other components are added simultaneously.
[0733] As used herein, washing includes, but is not limited to, scrubbing and mechanical agitation. Washing can be performed with a foam composition (as described in WO 08 / 101958), and / or by applying alternating pressure (pressure / vacuum) as an additional method or alternative to scrubbing and mechanical agitation. Drying such surfaces or fabrics can be accomplished by any of the common means employed in a household or industrial environment. The cleaning composition of the present invention is ideally suited for use in laundry and dishwashing applications. Therefore, the present invention includes a method for cleaning objects (including, but not limited to, fabrics, tableware, knives, and kitchenware). The method includes a step of contacting an object to be cleaned with the cleaning composition, the cleaning composition comprising at least one embodiment of the applicant's cleaning composition, cleaning additive, or a mixture thereof. The fabric may include most any fabric that can be washed under conventional consumer or institutional use conditions. The solution may have a pH from 8 to 10.5. The composition may be used in a concentration from 500ppm to 15.000ppm in a solution. The water temperature range is typically from 5°C to 90°C. The ratio of water to fabric is typically from 1:1 to 30:1.
[0734] In one aspect, the present invention relates to a method of producing a composition using a polypeptide having at least 60% identity to SEQ ID NO: 2. In one aspect, the present invention relates to use of the composition for cleaning an object.
[0735] In one aspect, the present invention relates to a method for producing the composition, the method comprising adding a polypeptide having at least 60% identity to SEQ ID NO: 2, and a surfactant. In one aspect, the present invention relates to a method for cleaning a surface, the method comprising contacting lipid stains present on the surface to be cleaned with the cleaning composition. In one aspect, the present invention relates to a method for hydrolyzing lipids in dirt and / or stains present on a surface, the method comprising contacting dirt and / or stains with a cleaning composition. In one aspect, the present invention relates to the use of the composition in the hydrolysis of carboxylic acid esters. In one aspect, the present invention relates to the use of the composition in the hydrolysis, synthesis or interesterification of esters. In one aspect, the present invention relates to the use of the composition for the manufacture of a stable formulation.
[0736] plant
[0737] The present invention also relates to plants, such as transgenic plants, plant parts or plant cells, which include polynucleotides of the present invention to express and produce the variant in a recoverable amount. The variant can be recovered from the plant or plant part. Alternatively, the plant or plant part comprising the variant can be used as is to improve the quality of food or feed, for example, to improve nutritional value, palatability and rheological properties, or to destroy anti-nutritional factors.
[0738] Transgenic plants can be dicots (dicots) or monocots (monocots). Examples of monocots are grasses, such as Kentucky bluegrass (bluegrass, Poa); forage grasses, such as Festuca, Lolium; temperate grasses, such as bentgrass (Agrostis); and cereals, such as wheat, oats, rye, barley, rice, sorghum, and maize (corn).
[0739] Examples of dicots are tobacco, legumes (e.g., lupins, potatoes, sugar beets, peas, beans, and soybeans), and crucifers (family Brassicaceae) (e.g., cauliflower, rapeseed, and the closely related model organism Arabidopsis thaliana).
[0740] The example of plant part is stem, callus, leaf, root, fruit, seed and tuber and the independent tissue that comprises these parts, for example epidermis, mesophyll, parenchyma, vascular tissue, meristem.Specific plant cell compartment, such as chloroplast, apoplast (apoplast), mitochondria, vacuole, peroxisome and cytoplasm are also considered to plant part.In addition, any plant cell, no matter which kind of tissue origin, is all considered to plant part.Similarly, plant part, such as separation to contribute to the specific tissue and cell of utilization of the present invention are also considered to plant part, for example embryo, endosperm, aleurone and seed coat.
[0741] Also included within the scope of the present invention are the progeny of such plants, plant parts and plant cells.
[0742] Transgenic plants or plant cells expressing variants can be constructed according to methods known in the art. In short, the plant or plant cell is constructed by the following method: one or more expression constructs encoding variants are incorporated into the plant host genome or chloroplast genome, and the resulting modified plants or plant cells are propagated as transgenic plants or plant cells.
[0743] The expression construct is preferably a nucleic acid construct comprising a polynucleotide encoding a variant, operably linked to appropriate regulatory sequences required for expression of the polynucleotide in the selected plant or plant part. Furthermore, the expression construct may contain a selectable marker for identifying plant cells that have integrated the expression construct, and the DNA sequences necessary for introducing the construct into the plant in question (the latter depending on the method of introducing the DNA used).
[0744] For example, the choice of regulatory sequences such as promoter and terminator sequences and optional signal or transit sequences is determined based on when, where, and how the variant is desired to be expressed. For example, expression of the gene encoding the variant can be constitutive or inducible, or can be developmental, stage or tissue specific, and the gene product can be targeted to a specific tissue or plant part, such as seeds or leaves. Regulatory sequences are described, for example, by Tague et al., 1988, Plant Physiology 86:506.
[0745] For constitutive expression, the 35S-CaMV, maize ubiquitin 1, or rice actin 1 promoter can be used (Franck et al., 1980, Cell 21:285-294; Christensen et al., 1992, Plant Mol. Biol. 18:675-689; Zhang et al., 1991, Plant Cell 3:1155-1165). Organ-specific promoters can be, for example, promoters from storage tissues (e.g., seeds, potato tubers, and fruits) (Edwards and Coruzzi, 1990, Ann. Rev. Genet. [Annual Bulletin of Genetics] 24:275-303) or from metabolic sink tissues (e.g., meristems) (Ito et al., 1994, Plant Mol. Biol. [Plant Molecular Biology] 24:863-878), seed-specific promoters from rice (e.g., glutelin, prolamin, globulin, or albumin promoters) (Wu et al., 1998, Plant Cell Physiol. [Plant and Cell Physiology] 39:885-889), the Vicia faba promoter from legumin B4 and an unknown seed protein gene from Vicia faba (Conrad et al., 1998, J. Plant Physiol. [J]. Plant Cell ... [Journal of Plant Physiology] 152:708-711), a promoter from a seed oleosomal protein (Chen et al., 1998, Plant Cell Physiol. [Plant and Cell Physiology] 39:935-941), a storage protein napA promoter from Brassica napus, or any other seed-specific promoter known in the art, for example, as described in WO 91 / 14772. In addition, the promoter can be a leaf-specific promoter, such as the rbcs promoter from rice or tomato (Kyozuka et al., 1993, Plant Physiol. 102:991-1000), the Chlorella virus adenine methyltransferase gene promoter (Mitra and Higgins, 1994, Plant Mol. Biol. 26:85-93), the aldP gene promoter from rice (Kagaya et al., 1995, Mol. Gen. Genet. 248:668-674), or a wound-inducible promoter such as the potato pin2 promoter (Xu et al., 1993, Plant Mol. Biol. 22:573-588).Likewise, the promoter can be induced by abiotic treatments such as changes in temperature, drought or salinity, or by exogenous application of substances that activate the promoter (e.g., ethanol; estrogens; plant hormones such as ethylene, abscisic acid and gibberellic acid; and heavy metals).
[0746] Promoter enhancer elements can also be used to achieve higher expression of variants in plants. For example, the promoter enhancer element can be an intron placed between the promoter and the polynucleotide encoding the variant. For example, Xu et al., 1993, supra, disclosed the use of the first intron of the rice actin 1 gene to enhance expression.
[0747] The selectable marker gene and any other parts of the expression construct can be selected from those available in the art.
[0748] The nucleic acid construct can be incorporated into the plant genome according to conventional techniques known in the art, including Agrobacterium-mediated transformation, virus-mediated transformation, microinjection, particle bombardment, biolistic transformation, and electroporation (Gasser et al., 1990, Science 244:1293; Potrykus, 1990, Bio / Technology 8:535; Shimamoto et al., 1989, Nature 338:274).
[0749] Agrobacterium tumefaciens-mediated gene transfer is currently the method used to generate transgenic dicots (for review, see Hooykas and Schilperoort, 1992, Plant Mol. Biol. 19:15-38) and for transformation of monocots, although other transformation methods may be used for these plants. One method used to generate transgenic monocots is particle bombardment (with microscopic gold or tungsten particles coated with transforming DNA) of embryonic callus or developing embryos (Christou, 1992, Plant J. 2:275-281; Shimamoto, 1994, Curr. Opin. Biotechnol. 5:158-162; Vasil et al., 1992, Bio / Technology 10:667-674). An alternative method for transforming monocots is based on natural plastid transformation, as described by Omirulleh et al., 1993, Plant Mol. Biol. 21: 415-428. Additional transformation methods include those described in US 6395966 and US 7151204 (both of which are incorporated herein by reference in their entirety).
[0750] After transformation, transformants that have incorporated the expression construct are selected and regenerated into whole plants according to methods well known in the art. Transformation procedures are often designed for selective elimination of the selection gene during regeneration or in subsequent generations by, for example, co-transformation with two independent T-DNA constructs or site-specific excision of the selection gene using a specific recombinase.
[0751] Except directly transforming concrete plant genotype with construct of the present invention, transgenic plant can also be produced by making the plant with construct hybridize with the second plant lacking this construct.For example, the construct of coding variant can be introduced into specific plant variety by hybridization, without always directly transforming the plant of this given variety.Therefore, the present invention not only encompasses the plant directly regenerated from the cell transformed according to the present invention, but also encompasses the offspring of this type of plant.As used herein, offspring can refer to the offspring of any generation of the parent plant prepared according to the present invention.This type of offspring can include the DNA construct prepared according to the present invention.Hybridization causes by cross-pollination with donor plant system according to the initial system, transgenic is introduced into plant system.The limiting examples of this type of step are described in US 7151204.
[0752] Plants can be generated by backcross transformation methods. For example, plants include plants of genotypes, lines, inbreds, or hybrids known as backcross transformations.
[0753] Genetic markers can be used to assist one or more transgenics of the present invention to be infiltrated from one genetic background to another. The selection assisted by markers provides an advantage relative to conventional breeding, being that it can be used to avoid the error caused by phenotypic variation. In addition, genetic markers can provide data on the relative degree of improved germplasm in the individual offspring of specific hybridization. For example, when having a desired proterties and having a plant with a desired genetic background of non-agronomy in addition and hybridizing with improved parent, genetic markers can be used to select not only to have an interested proterties, but also to have an offspring with a relatively large proportion of desired germplasm. In this way, the number of generations required for infiltrating one or more proterties into a specific genetic background is minimized.
[0754] The present invention also relates to methods of producing a variant of the present invention, comprising: (a) cultivating a transgenic plant or plant cell comprising a polynucleotide encoding the variant under conditions conducive for production of the variant; and (b) recovering the variant.
[0755] Microcapsule composition comprising the lipase variant of the present invention
[0756] In this respect, the present invention relates to a microcapsule composition, wherein the membrane of the microcapsule is produced by cross-linking multibranched polyamines having a molecular weight above 1 kDa, wherein the microcapsule comprises the lipase variant of the present invention.
[0757] The membrane formed by cross-linking the multibranched polyamines enables the enzyme to be separated from the (anionic) surfactants in the detergent, which are known to be detrimental to the stability of the enzyme.
[0758] When using encapsulated enzymes in detergents, a crucial parameter is the ability to release the enzyme immediately when the detergent is diluted in water, such as in laundry or dishwashing applications. The microcapsules of the present invention have excellent properties in this regard and are able to release the entire encapsulated enzyme within one minute.
[0759] These microcapsules do not require the presence of a core polymer to release the enzyme upon dilution in water. Furthermore, the present invention does not require the enzyme to be in precipitated form in the core of the microcapsule in order to control premature release, as described in WO 97 / 24177.
[0760] Lipase variants of the present invention and optionally other enzymes are encapsulated in microcapsules with semipermeable membranes, and in these capsules (before being added to liquid detergents) there is a water activity higher than that in liquid detergents, when being added to detergents (water is just overflowing), these capsules will experience (partially) collapse, therefore leaving more concentrated and more sticky enzyme-containing interior in these capsules. The collapse of the film can also lead to a reduction in permeability. This can be further used by adding stabilizers / polymers, especially those that can not be permeable by the film. The collapse and the resulting viscosity increase will reduce / hinder hostile components (for example, surfactants or chelating agents) from diffusing into these capsules, and therefore increase the storage stability of enzyme in the liquid detergent. The components in the liquid detergent that are sensitive to the enzyme (for example, components that serve as the enzyme substrate) are also protected from being degraded by the enzyme. In the washing process, the liquid detergent is diluted with water, therefore increasing the water activity. Water will diffuse into these capsules (osmosis) now. The capsules will swell and the membrane will become permeable to the enzymes whereby they can leave the capsules, or simply burst and release the enzymes in this way. This concept is very effective in stabilizing the enzymes against hostile components in liquid detergents and vice versa also protecting enzyme-sensitive components in the liquid detergent from the effects of the enzymes.
[0761] Examples of detergent components that are sensitive to enzymes and can be degraded by enzymes include (relevant enzymes in parentheses): xanthan gum (xanthanase), polymers with ester bonds (lipase), hydrogenated castor oil (lipase), perfume (lipase), methyl ester sulfonate surfactant (lipase), cellulose and cellulose derivatives (e.g., CMC) (cellulase), and dextrins and cyclodextrins (amylase).
[0762] Sensitive detergent ingredients can also be encapsulated and thereby stabilized in the microcapsules of the present invention. Sensitive detergent ingredients are prone to degradation during storage. Such detergent ingredients include bleaching compounds, bleach activators, perfumes, polymers, builders, surfactants, etc.
[0763] In general, the microcapsules of the present invention can be used to separate incompatible components / compounds in detergents.
[0764] Adding these microcapsules to detergents can be used to influence the visual appearance of the detergent product, such as an opaque effect (small microcapsules) or the effect of clearly visible particles (large microcapsules). The microcapsules can also be colored.
[0765] These microcapsules can be used to reduce enzyme dust levels during handling and processing of enzyme products.
[0766] Unless otherwise indicated, all percentages throughout this application are indicated as percentages by weight (% w / w).
[0767] Microcapsules
[0768] Typically, the microcapsules are produced by forming water droplets into a water-immiscible continuum - i.e. typically by preparing a water-in-oil emulsion - and then forming the film by interfacial polymerization via the addition of a crosslinking agent. After final solidification, the capsules can be harvested and further washed and formulated by methods known in the art. The capsule formulation is then added to the detergent.
[0769] The payload, the main membrane ingredients to be encapsulated and eventually additional components are found in the aqueous phase. The components that stabilize the tendency of the water droplets to coalesce (emulsifiers, emulsion stabilizers, surfactants, etc.) are found in the continuum and the crosslinker is also added through the continuum.
[0770] The emulsion can be prepared by any method known in the art, for example, by mechanical agitation, dripping methods, membrane emulsification, microfluidics, ultrasonic treatment, etc. In some cases, simple mixing of these phases will automatically lead to an emulsion, often referred to as self-emulsification. It is advantageous to use a method that results in a narrow particle size distribution.
[0771] The crosslinker(s) are then typically added to the emulsion, either directly or more typically by preparing a solution of the crosslinker in a solvent in which the continuous phase is soluble. The emulsion and crosslinker or solution thereof may be mixed by methods conventionally used in the art, for example, by simple mixing or by carefully controlling the flow of the emulsion and crosslinker solution through an inline mixer.
[0772] In some cases, it is necessary to cure the capsules to complete the film formation. Curing is often a simple stirring of the capsules for a period of time to allow the interfacial polymerization reaction to complete. In other cases, the film formation can be terminated by adding a reaction quencher.
[0773] The capsules may be post-modified, for example by reacting components onto the membrane to hinder or reduce flocculation of the particles in detergents as described in WO 99 / 01534.
[0774] The produced capsules can be isolated or concentrated by methods known in the art, for example, by filtering, centrifuging, distilling or decanting the capsule dispersion.
[0775] The resulting capsules can be further formulated, for example, by adding surfactants to impart desired properties to the product for storage, transport and later handling, as well as addition to detergents. Other microcapsule formulations include rheology modifiers, biocides (e.g., Proxel), acids / bases for pH adjustment (which will also be adjusted within the microcapsules), and water for adjusting water activity.
[0776] The capsule forming method may include the following steps:
[0777] - Preparation of initial water phase and oil phase,
[0778] - forming a water-in-oil emulsion,
[0779] - Film formation by interfacial polymerization,
[0780] - optional post-modification,
[0781] - optional separation and / or formulation,
[0782] -Add to detergent.
[0783] The process may be a batch process or a continuous or semi-continuous process.
[0784] Microcapsule according to the present invention is a small aqueous sphere with a uniform film around it. The material inside the microcapsule is called core, internal phase or filler, and the film is sometimes called shell, coating or wall. These microcapsules of the present invention have a diameter between 0.5 μm and 2 millimeters. Preferably, the average diameter of these microcapsules is in the range of 1 μm to 1000 μm, more preferably in the range of 5 μm to 500 μm, even more preferably in the range of 10 μm to 500 μm, even more preferably in the range of 50 μm to 500 μm, and most preferably in the range of 50 μm to 200 μm. Alternatively, the diameter of these microcapsules is in the range of 0.5 μm to 30 μm; or in the range of 1 μm to 25 μm. The diameter of this microcapsule is measured in the oil phase after polymerization is completed. The diameter of this capsule can change according to the water activity of the surrounding chemical environment.
[0785] The microencapsulation of enzyme (as used in the present invention) can be carried out by interfacial polymerization, wherein two kinds of reactants in the polymerization reaction meet at the interface and react rapidly.The basis of this method is the reaction of polyamines and acid derivatives, usually acid halides, serving as a kind of cross-linking agent.The polyamines are preferably substantially water-soluble (when in free alkali form).Under the correct conditions, flexible film forms rapidly at the interface.A mode of carrying out the polymerization is to use an aqueous solution of the enzyme and polyamines, which is emulsified with a non-aqueous solvent (and an emulsifier), and a solution comprising the acid derivative is added.Alkaline agents may be present in the enzyme solution to neutralize the acid formed in the reaction process.Polymer (polyamide) film is formed immediately at the interface of these emulsions.The polymer film of the microcapsule typically has cationic properties, and therefore is combined / complexed with compounds with anionic properties.
[0786] The diameter of the microcapsules is determined by the size of the droplets, which is controlled by, for example, the stirring rate.
[0787] Emulsion
[0788] An emulsion is a temporary or permanent dispersion of one liquid phase in a second liquid phase. The second liquid phase is often referred to as a continuous phase. Surfactants are often used to aid in the formation and stabilization of emulsions. Not all surfactants stabilize emulsions in the same way. The type and amount of surfactants need to be selected for optimal emulsion effectiveness, especially for the preparation and physical stability of the emulsion, as well as stability during dilution or further processing. Physical stability refers to maintaining the emulsion in the form of a dispersion. Processes such as coagulation, polymerization, adsorption to container walls, sedimentation, and creaming are various forms of physical instability and should be avoided. Examples of suitable surfactants are described in WO 97 / 24177, pages 19-21; and in WO 99 / 01534.
[0789] Emulsions can be further classified as simple emulsions, in which the dispersed liquid phase is a simple homogeneous liquid, or a more complex emulsion, in which the dispersed liquid phase is a heterogeneous combination of liquid or solid phases, such as double emulsions or composite emulsions. For example, a water-in-oil double emulsion or composite emulsion can be formed, in which the aqueous phase itself further contains an emulsified oil phase; this type of emulsion can be designated as an oil-in-water-in-oil (o / w / o) emulsion. Alternatively, a water-in-oil emulsion can be formed, in which the aqueous phase contains a dispersed solid phase, commonly referred to as a suspension-emulsion. Other more complex emulsions can be described. Because of the inherent difficulties in describing such systems, the term emulsion is used to describe both simple and more complex emulsions, without necessarily limiting the form of the emulsion or the type and number of phases present.
[0790] Polyamine
[0791] The rigidity / flexibility and permeability of the membrane are mainly influenced by the choice of polyamine. The polyamine according to the present invention is a multi-branched polyamine. Each branch (preferably ending in a primary amino group) acts as a tethering point in the membrane network, resulting in the advantageous properties of the present invention. The multi-branched polyamine according to the present invention is a polyamine having more than two branch points and more than two reactive amino groups (capable of reacting with a crosslinker, i.e., primary and secondary amino groups). When preparing the emulsion, the multi-branched polyamine is used as a starting material - it is not formed in situ from other starting materials. In order to obtain the attractive properties of the present invention, the multi-branched structure of the polyamine must be present as a starting material.
[0792] There is a close relationship between the number of branch points and the number of primary amines, since a primary amine will always be located at the end of a branch: a linear amine can only contain two primary amines. Each branch point for the hypothetical introduction of such a linear diamine will allow one or more primary amines to be introduced at the end of the branch or branches introduced. In this article, we understand the primary amino group as a part of the branch, i.e. the end point of the branch. For example, we consider tri(2-aminoethyl)amine or 1,2,3-propanetriamine to be molecules with one branch point. For the present invention, the polyamine has at least four primary amines. Multiple branch points can be introduced from aliphatic hydrocarbon chains (as in the examples described above) or from unsaturated carbon bonds (as in, for example, 3,3'-diaminobenzidine), or from tertiary amino groups (as in N,N,N',N'-tetra-(2-aminoethyl)ethylenediamine).
[0793] In addition to the number of branch points, we have found that the compactness of the reactive amino groups is very important. For example, the material N,N,N',N'-tetra-(12-aminododecyl)ethylenediamine is not suitable. Neither peptides nor proteins (such as an enzyme) are suitable for film formation. Therefore, the multi-branched polyamine is not a peptide or a protein.
[0794] In one embodiment, the reactive amino groups constitute at least 15% of the molecular weight of the multi-branched polyamine, such as more than 20%, or more than 25%. Preferably, the molecular weight of the multi-branched polyamine is at least 1 kDa. More preferably, the molecular weight of the multi-branched polyamine is at least 1.3 kDa.
[0795] In a preferred embodiment, the multi-branched polyamine is polyethyleneimine (PEI) and its modified forms, which have more than two branching points and more than two reactive amino groups; wherein the reactive amino groups account for at least 15% of the molecular weight of PEI, such as greater than 20%, or greater than 25%. Preferably, the molecular weight of the PEI is at least 1 kDa.
[0796] Combinations of different multibranched polyamines can be used to prepare the microcapsules according to the invention.
[0797] The advantageous properties of the microcapsules of the present invention (e.g., enzyme storage stability, reduced enzyme leaching, reduced flux of detergent ingredients) can be improved by adding one or more small amines having a molecular weight of less than 1 kDa. The small amine is preferably substantially water-soluble (when in free base form) and can be a substance such as ethylenediamine, hexamethylenediamine, hexamethylenediamine, diethylenetetramine, ethylenetetramine, phenylenediamine, piperazine, tetramethylenepentamine or, preferably, diethylenetriamine (DETA). When preparing the microcapsules of the present invention, these small amines can be added in an amount of up to 50%, preferably up to 40%, up to 30%, up to 20%, up to 10%, up to 5% by weight of the total content of small amines and multi-branched polyamines.
[0798] Crosslinking agent
[0799] A cross-linking agent as used in the present invention is a molecule having at least two groups / sites capable of reacting with amines to form covalent bonds.
[0800] The crosslinking agent is preferably oil-soluble and may be in the form of an anhydride or an acid halide, preferably an acid chloride. For example, it may be adipoyl chloride, sebacoyl chloride, dodecanoyl chloride, phthaloyl chloride, terephthaloyl chloride, isophthaloyl chloride, or trimesoyl chloride, but preferably, the crosslinking agent is terephthaloyl chloride or trimesoyl chloride.
[0801] One or more enzymes
[0802] In one embodiment, the composition or microcapsule composition of the present invention may further comprise an enzyme selected from the group consisting of proteases, amylases, lipases, cellulases, mannanases, pectinases, DNases, laccases, peroxidases, haloperoxidases, perhydrolases, and combinations thereof.
[0803] The one or more enzymes in the composition or encapsulated in the microcapsule of the present invention may include one or more enzymes suitable for inclusion in laundry or dishwashing detergents (detergent enzymes), such as proteases (e.g., subtilisin or metalloproteases), lipases, cutinases, amylases, carbohydrases, cellulases, pectinases, mannanases, arabinanases, galactanases, xanthanases, xylanases, DNA enzymes, perhydrolases, oxidoreductases (e.g., laccases, peroxidases, peroxygenases and / or haloperoxidases). Preferred detergent enzymes are proteases (e.g., subtilisin or metalloproteases), lipases, amylases, lyases, cellulases, pectinases, mannanases, DNA enzymes, perhydrolases, and oxidoreductases (e.g., laccases, peroxidases, peroxyhydroxy fatty acid hydroxylating epoxidases and / or haloperoxidases); or combinations thereof. More preferred detergent enzymes are proteases (eg, subtilisin or metalloproteases), lipases, amylases, cellulases, pectinases, and mannanases; or combinations thereof.
[0804] The composition or microcapsule composition of the present invention may comprise more than 0.1% (w / w) active enzyme protein, in particular the lipase variant of the present invention; preferably more than 0.25%, more preferably more than 0.5%, more preferably more than 1%, more preferably more than 2.5%, preferably more than 5%, more preferably more than 7.5%, more preferably more than 10%, more preferably more than 12.5%, more preferably more than 15%, even more preferably more than 20% and most preferably more than 25% (w / w) active enzyme protein.
[0805] Protease: The protease for use in the present invention is a serine protease, such as subtilisin, metalloprotease and / or trypsin-like protease. Preferably, these proteases are subtilisin or metalloprotease; more preferably, these proteases are subtilisin.
[0806] Serine proteases are enzymes that catalyze the hydrolysis of peptide bonds and have an essential serine residue at the active site (White, Handler and Smith, 1973 "Principles of Biochemistry," Fifth Edition, McGraw-Hill Book Company, NY, pp. 271-272). Subtilisin includes, and preferably consists of, subgroups I-S1 and I-S2, as defined by Siezen et al., Protein Engng. 4 (1991) 719-737; and Siezen et al., Protein Science 6 (1997) 501-523. Since the structure of the active site of serine proteases is highly conserved, the subtilisin according to the present invention may be functionally equivalent to the subtilases of the specified subgroups proposed by Siezen et al. (supra).
[0807] Subtilisin can be animal, plant or microbial origin, including chemical or genetically modified mutants (protein engineered variants), preferably alkaline microbial subtilisin. The example of subtilisin is those derived from Bacillus, such as subtilisin Novo, subtilisin Carlsberg, subtilisin BPN', subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO89 / 06279) and protease PD138 (WO 93 / 18140). Example description is in WO 98 / 020115, WO 01 / 44452, WO01 / 58275, WO 01 / 58276, WO 03 / 006602 and WO 04 / 099401. The example of trypsin-like protease is trypsin (for example, porcine or bovine origin) and the Fusarium protease described in WO 89 / 06270 and WO 94 / 25583. Other examples are the variants described in WO 92 / 19729, WO 88 / 08028, WO 98 / 20115, WO 98 / 20116, WO 98 / 34946, WO 2000 / 037599, WO 2011 / 036263, especially the variants with substitutions in one or more of the following positions: 27, 36, 57, 76, 87, 97, 101, 104, 120, 123, 167, 170, 194, 206, 218, 222, 224, 235 and 274.
[0808] The metalloprotease may be of animal, plant or microbial origin, including chemically or genetically modified mutants (protein engineered variants), preferably an alkaline microbial metalloprotease. Examples are described in WO 2007 / 044993, WO 2012 / 110562 and WO 2008 / 134343.
[0809] Examples of commercially available subtilisins include Kannase TM 、Everlase TM 、Relase TM , Esperase TM , Alcalase TM 、Durazym TM 、Savinase TM 、Ovozyme TM 、Liquanase TM 、CoronaseTM、Polarzyme TM , Pyrase TM ,Pancreatic Trypsin NOVO(PTN),Bio-Feed TM Pro and Clear-Lens TM Pro; Blaze (all available from Novozymes A / S, Bagsvaerd, Denmark). Other commercially available proteases include Neutrase TM 、Ronozyme TM Pro、Maxatase TM Maxacal TM Maxapem TM Opticlean TM 、Properase TM 、Purafast TM 、Purafect TM 、Purafect Ox TM 、Purafact Prime TM 、ExcellaseTM、FN2 TM 、FN3 TM and FN4 TM (Available from Genencor International, Gist Brocades, BASF, or DSM). Other examples are Primase TM and Duralase TM Blap R, Blap S and Blap X available from Henkel are also examples.
[0810] Lyase: The lyase may be a pectin lyase derived from Bacillus, in particular Bacillus licheniformis or B. agaradhaerens, or a variant derived from any of these sources, e.g. as described in US 6124127, WO 99 / 027083, WO 99 / 027084, WO 02 / 006442, WO 02 / 092741, WO 03 / 095638, commercially available pectin lyases are XPect; Pectawash and Pectaway (Novozymes).
[0811] Mannanase: The mannanase may be an alkaline mannanase of Family 5 or 26. It may be a wild type from Bacillus or Humicola, in particular Bacillus viscidus, Bacillus licheniformis, Bacillus alkaliphilus, Bacillus clausii or Humicola insolens. Suitable mannanases are described in WO 99 / 064619. A commercially available mannanase is Mannaway (Novozymes).
[0812] Cellulase: Suitable cellulases include those of bacterial or fungal origin. Chemically modified mutants or protein engineered mutants are included. Suitable cellulases include cellulases from Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, such as the fungal cellulases produced by Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307, US 5,648,263, US 5,691,178, US 5,776,757 and WO 89 / 09259.
[0813] Particularly suitable cellulases are alkaline or neutral cellulases having color care benefits. Examples of such cellulases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96 / 11262, WO 96 / 29397, WO 98 / 08940. Other examples are cellulase variants such as those described in WO 94 / 07998, EP 0 531 315, US 5,457,046, US 5,686,593, US 5,763,254, WO 95 / 24471, WO 98 / 12307 and PCT / DK 98 / 00299.
[0814] Commercially available cellulases include Celluzyme TM and Carezyme TM (Novozymes), Clazinase TMand Puradax HA TM (Genencor International) and KAC-500(B) TM (Kao Co., Ltd.).
[0815] Besides the lipase variant of the invention, the composition or microcapsule composition may comprise other lipases.
[0816] Other lipases and cutinases: Suitable lipases and cutinases include those of bacterial or fungal origin. Chemically modified mutants or protein engineered mutants are included. Examples include lipases from Thermomyces, for example from T. lanuginosus (formerly named Humicola lanuginosus) as described in EP 258 068 and EP 305 216; cutinases from Humicola, for example Humicola insolens described in WO 96 / 13580; Pseudomonas lipases, for example from Pseudomonas alcaligenes or Pseudomonas pseudoalcaligenes (EP 218 272), Pseudomonas cepacia (EP 331376), Pseudomonas stutzeri (GB 1,372,034), Pseudomonas fluorescens, Pseudomonas sp. strain SD 705 (WO 95 / 06720 and WO 95 / 06720). 96 / 27002), Pseudomonas wisconsinensis (WO 96 / 12012); Bacillus lipase, for example from Bacillus subtilis (Dartois et al., 1993, Biochemica et Biophysica Acta [Biochemistry and Biophysics Acta], 1131:253-360), Bacillus stearothermophilus (JP 64 / 744992) or Bacillus pumilus (WO 91 / 16422).
[0817] Other examples are those lipase variants described, for example, in WO 92 / 05249, WO 94 / 01541, EP 407 225, EP 260 105, WO 95 / 35381, WO 96 / 00292, WO 95 / 30744, WO 94 / 25578, WO 95 / 14783, WO 95 / 22615, WO 97 / 04079, WO 97 / 07202, WO 00 / 060063, WO 2007 / 087508 and WO 2009 / 109500.
[0818] Preferred commercially available lipases include LipolaseTM , Lipolase Ultra TM and Lipex TM ; Lipex Evity100L, Lecitase TM 、Lipolex TM ;Lipoclean TM , Lipoprime TM (Novozymes). Other commercially available lipases include Lumafast (Genencor International); Lipomax (Gister-Blaucades / Genencor International) and Bacillus lipase from Solvay.
[0819] Amylases: Suitable amylases include those of bacterial or fungal origin. Chemically modified mutants or protein engineered mutants are included. Amylases include, for example, alpha-amylases obtained from Bacillus, such as a special strain of Bacillus licheniformis (described in more detail in GB 1,296,839).
[0820] Examples of suitable amylases include amylases having SEQ ID NO: 2 in WO 95 / 10603 or variants thereof having 90% sequence identity to SEQ ID NO: 3. Preferred variants are described in WO 94 / 02597, WO 94 / 18314, WO97 / 43424 and in SEQ ID NO: 4 of WO 99 / 019467, such as variants having substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 178, 179, 181, 188, 190, 197, 201, 202, 207, 208, 209, 211, 243, 264, 304, 305, 391, 408 and 444.
[0821] Various suitable amylases include those having SEQ ID NO: 6 in WO 02 / 010355 or variants thereof having 90% sequence identity to SEQ ID NO: 6. Preferred variants of SEQ ID NO: 6 are those having deletions in positions 181 and 182 and a substitution in position 193.
[0822] Other suitable amylases are hybrid alpha-amylases comprising residues 1-33 of an alpha-amylase derived from Bacillus amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006 / 066594 and residues 36-483 of a Bacillus licheniformis alpha-amylase shown in SEQ ID NO: 4 of WO 2006 / 066594, or variants thereof having 90% sequence identity. Preferred variants of this hybrid alpha-amylase are those having a substitution, deletion or insertion in one or more of the following positions: G48, T49, G107, H156, A181, N190, M197, 1201, A209 and Q264. Most preferred variants of the hybrid alpha-amylase comprising residues 1-33 of the alpha-amylase derived from Bacillus amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006 / 066594 and residues 36-483 of SEQ ID NO: 4 are those having the following substitutions:
[0823] M197T;
[0824] H156Y+A181T+N190F+A209V+Q264S; or
[0825] G48A+T49I+G107A+H156Y+A181T+N190F+I201F+A209V+Q264S.
[0826] Another suitable amylase is an amylase having SEQ ID NO: 6 in WO 99 / 019467 or a variant thereof having 90% sequence identity to SEQ ID NO: 6. Preferred variants of SEQ ID NO: 6 are those having substitutions, deletions or insertions in one or more of the following positions: R181, G182, H183, G184, N195, I206, E212, E216 and K269. Particularly preferred amylases are those having deletions in positions R181 and G182, or positions H183 and G184.
[0827] Additional amylases that may be used are those having SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 2 or SEQ ID NO: 7 of WO 96 / 023873 or variants thereof having 90% sequence identity thereto. Preferred variants of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 7 are those having substitutions, deletions or insertions in one or more of the following positions: 140, 181, 182, 183, 184, 195, 206, 212, 243, 260, 269, 304 and 476. More preferred variants are those having deletions at positions 181 and 182 or positions 183 and 184. Most preferred amylase variants of SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 7 are those having deletions in positions 183 and 184 and substitutions in one or more of positions 140, 195, 206, 243, 260, 304 and 476.
[0828] Other amylases that can be used are those having SEQ ID NO: 2 of WO 08 / 153815, SEQ ID NO: 10 in WO 01 / 66712, or variants thereof having 90% sequence identity to SEQ ID NO: 2 of WO 08 / 153815 or 90% sequence identity to SEQ ID NO: 10 in WO 01 / 66712. Preferred variants of SEQ ID NO: 10 in WO 01 / 66712 are those having substitutions, deletions or insertions in one or more of the following positions: 176, 177, 178, 179, 190, 201, 207, 211 and 264.
[0829] Additional suitable amylases are those having SEQ ID NO: 2 of WO 09 / 061380 or variants thereof having 90% sequence identity to SEQ ID NO: 2. Preferred variants of SEQ ID NO: 2 are those having C-terminal truncations and / or substitutions, deletions or insertions in one or more of the following positions: Q87, Q98, S125, N128, T131, T165, K178, R180, S181, T182, G183, M201, F202, N225, S243, N272, N282, Y305, R309, D319, Q320, Q359, K444, and G475. More preferred variants of SEQ ID NO: 2 are those with substitutions at one or more of the following positions: Q87E, R, Q98R, S125A, N128C, T131I, T165I, K178L, T182G, M201L, F202Y, N225E, R, N272E, R, S243Q, A, E, D, Y305R, R309A, Q320R, Q359E, K444E and G475K, and / or those with deletions at positions R180 and / or S181 or T182 and / or G183. The most preferred amylase variants of SEQ ID NO: 2 are those with the following substitutions:
[0830] N128C+K178L+T182G+Y305R+G475K;
[0831] N128C+K178L+T182G+F202Y+Y305R+D319T+G475K;
[0832] S125A+N128C+K178L+T182G+Y305R+G475K; or
[0833] S125A+N128C+T131I+T165I+K178L+T182G+Y305R+G475K, wherein these variants are C-terminally truncated and optionally further comprise a substitution at position 243 and / or a deletion at position 180 and / or position 181.
[0834] Other suitable amylases are alpha-amylases having SEQ ID NO: 12 in WO 01 / 66712 or variants having at least 90% sequence identity to SEQ ID NO: 12. Preferred amylase variants are those having substitutions, deletions or insertions in one or more of the following positions in SEQ ID NO: 12 in WO 01 / 66712: R28, R118, N174; R181, G182, D183, G184, G186, W189, N195, M202, Y298, N299, K302, S303, N306, R310, N314; R320, H324, E345, Y396, R400, W439, R444, N445, K446, Q449, R458, N471, N484. Particularly preferred amylases include variants having deletions of D183 and G184 and having substitutions R118K, N195F, R320K and R458K, and variants additionally having substitutions in one or more positions selected from the group consisting of: M9, G149, G182, G186, M202, T257, Y295, N299, M323, E345 and A339, most preferably variants additionally having substitutions in all of these positions.
[0835] Other examples are amylase variants as described in WO 2011 / 098531, WO 2013 / 001078 and WO 2013 / 001087.
[0836] Commercially available amylases are Stainzyme; Stainzyme Plus; Duramyl TM Termamyl TM , TermamylUltra; Natalase, Fungamyl TM and BAN TM (Novozymes), Rapidase TM and PurastarTM / Effectenz TM , Powerase and Preferenz S100 (from Genencor International / DuPont).
[0837] Deoxyribonuclease (DNA enzyme): Suitable deoxyribonuclease (DNA enzyme) is any enzyme that catalyzes the hydrolytic cleavage of the phosphodiester bonds in the DNA backbone to degrade the DNA. According to the present invention, DNA enzymes obtainable from bacteria are preferred; in particular, DNA enzymes obtainable from Bacillus are preferred; in particular, DNA enzymes obtainable from Bacillus subtilis or Bacillus licheniformis are preferred. Examples of such DNA enzymes are described in patent applications WO 2011 / 098579 or PCT / EP2013 / 075922.
[0838] Perhydrolase: Suitable perhydrolases are capable of catalyzing a perhydrolysis reaction resulting in the production of a peracid from a carboxylate (acyl) substrate in the presence of a peroxide source (e.g., hydrogen peroxide). While many enzymes carry out this reaction at low levels, perhydrolases exhibit high perhydrolysis:hydrolysis ratios (generally greater than 1). Suitable perhydrolases may be of plant, bacterial, or fungal origin. Chemically modified mutants or protein engineered mutants are included.
[0839] Examples of useful perhydrolases include naturally occurring mycobacterium perhydrolases or variants thereof. One exemplary enzyme is derived from Mycobacterium smegmatis. This enzyme, its enzymatic properties, its structure and variants thereof are described in WO 2005 / 056782, WO 2008 / 063400, US 2008 / 145353 and US 2007167344.
[0840] Oxidase / Peroxidase: Suitable oxidases and peroxidases (or oxidoreductases) include various sugar oxidases, laccases, peroxidases, and haloperoxidases.
[0841] Suitable peroxidases include those included in the enzyme classification EC 1.11.1.7 as stated by the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (IUBMB), or any fragments derived therefrom that exhibit peroxidase activity.
[0842] Suitable peroxidases include those of plant, bacterial or fungal origin. Include chemically modified mutants or protein engineered mutants. Examples of useful peroxidases include from Coprinus comatus, for example, from C. cinerea (EP 179,486), and variants thereof, such as those described in WO 93 / 24618, WO 95 / 10602 and WO 98 / 15257.
[0843] Peroxidases for use in the present invention also include haloperoxidases, such as chloroperoxidases, bromoperoxidases, and compounds exhibiting chloroperoxidase or bromoperoxidase activity. Haloperoxidases are classified according to their specificity for halide ions. Chloroperoxidases (EC 1.11.1.10) catalyze the formation of hypochlorite from chloride ions.
[0844] In one embodiment, the haloperoxidase is a chloroperoxidase. Preferably, the haloperoxidase is a vanadium haloperoxidase, i.e. a vanadate-containing haloperoxidase. In a preferred method of the invention, a vanadate-containing haloperoxidase is combined with a chloride ion source.
[0845] Haloperoxidases have been isolated from many different fungi, particularly from the dematiaceous hyphomycete group of fungi, such as Caldariomyces (e.g., C. fumago), Alternaria, Curvularia (e.g., C. verruculosa and C. inaequalis), Entomophthora, Schizomyces, and Botrytis.
[0846] Haloperoxidases have also been isolated from bacteria, such as Pseudomonas (eg, P. pyrrocinia) and Streptomyces (eg, S. aureofaciens).
[0847] In a preferred embodiment, the haloperoxidase may be derived from Curvularia, in particular Curvularia verruculosa or Curvularia inaequalis, such as Curvularia inaequalis CBS102.42 described in WO 95 / 27046; or Curvularia verruculosa CBS147.63 or Curvularia inaequalis CBS444.70 described in WO 97 / 04102; or derived from Drechslera hartlebii as described in WO 01 / 79459, Dendryphiella salina as described in WO 01 / 79458, Phaeotrichoconis crotalarie as described in WO 01 / 79461 or Geniculosporium species as described in WO 01 / 79460.
[0848] The oxidase according to the present invention particularly includes any laccase encompassed by enzyme classification EC 1.10.3.2 or fragments derived therefrom exhibiting laccase activity, or compounds exhibiting similar activity, such as catechol oxidase (EC 1.10.3.1), o-aminophenol oxidase (EC 1.10.3.4) or bilirubin oxidase (EC 1.3.3.5).
[0849] Preferred laccases are enzymes of microbial origin. The enzymes may be derived from plants, bacteria or fungi (including filamentous fungi and yeast).
[0850] Suitable examples from fungi include laccases that may be derived from strains of Aspergillus, Neurospora (e.g., Neurospora crassa), Podospora, Botrytis, Collybia, Fomes, Lentinula, Pleurotus, Trametes (e.g., Trametes villosa and Trametes versicolor), Rhizoctonia (e.g., R. solani), Coprinus (e.g., C. cinerea, C. comatus, C. friesii, and C. plicatilis ), Psathyrella (e.g., P. condelleana), Pleurotus (e.g., P. papilionaceus), Myceliophthora (e.g., Myceliophthora thermophila), Schytalidium (e.g., S. thermophilum), Polyporus (e.g., P. pinsitus), Psoralea (e.g., P. radiata) (WO 92 / 01046), or Coriolus (e.g., C. hirsutus) (JP 2238885).
[0851] Suitable examples from bacteria include laccases derivable from strains of the genus Bacillus.
[0852] Preferred are laccases derived from Coprinus or Myceliophthora; in particular a laccase derived from Coprinus cinerea, as disclosed in WO 97 / 08325; or from Myceliophthora thermophila, as disclosed in WO 95 / 33836.
[0853] Examples of other oxidases include, but are not limited to, amino acid oxidases, glucose oxidases, lactate oxidases, galactose oxidases, polyol oxidases (e.g., WO 2008 / 051491), and aldose oxidases. Oxidase and its corresponding substrate can be used as a hydrogen peroxide generating enzyme system, thereby serving as a source of hydrogen peroxide. Several enzymes, such as peroxidases, haloperoxidases, and perhydrolases require a source of hydrogen peroxide. Other examples of such combinations of oxidases and substrates are readily recognized by one of ordinary skill in the art by studying EC 1.1.3._, EC 1.2.3._, EC 1.4.3._, and EC 1.5.3._ or similar categories (under the International Association of Biochemistry).
[0854] Enzyme stabilizers and / or rheology modifiers
[0855] These compositions or microcapsules may also contain enzyme stabilizers as known in the art, for example, polyols, polymers, reversible enzyme inhibitors, divalent cations, enzyme substrates, antioxidants, etc. Water-soluble stabilizers are preferred.
[0856] The addition of slowly dissolving stabilizers can be used to create a local environment inside the capsule that is more friendly to the encapsulated enzyme / compound, thereby improving stability during storage.
[0857] Examples of reversible protease inhibitors are boronic acid, peptide aldehydes and their derivatives and macromolecular protein-based inhibitors (like BASI / RASI inhibitors, see WO 2009 / 095425). Examples of metalloproteinase inhibitors are described in WO 2008 / 134343. Protease inhibitors are described in more detail below under the heading "Protease inhibitors".
[0858] The stabilizing polymers can be based on, for example, polyvinyl pyrrolidone, polyvinyl acetate, polyvinyl alcohol and copolymers thereof. The stabilizing polyols can be smaller molecules like glycerol, sorbitol, propylene glycol, etc., but also larger molecules like polyethylene glycol, polysaccharides, etc.
[0859] Among the stabilized divalent cations, Ca2+, Mg2+ and Zn2+ are known in the art. Therefore, in one embodiment, the composition of the present invention comprises a source of Ca2+, Mg2+ or Zn2+ ions. Preferably, the source of Ca2+, Mg2+ or Zn2+ ions is a poorly soluble (slowly dissolving) salt of Ca2+, Mg2+ or Zn2+. Poorly soluble means that the solubility in pure water at 20°C is less than 5g / l, 2g / l, 1g / l, 0.5g / l, 0.2g / l, 0.1g / l or 0.05g / l. The preferred salt of Ca2+, Mg2+ or Zn2+ is calcium carbonate, magnesium carbonate, zinc carbonate, calcium sulfate, calcium sulfite, magnesium sulfite, zinc sulfite, calcium phosphate, calcium hydrogen phosphate, magnesium phosphate, zinc phosphate, calcium citrate, magnesium citrate, zinc citrate, calcium oxalate, magnesium oxalate, zinc oxalate, calcium tartrate, magnesium tartrate, or zinc tartrate.
[0860] Slowly dissolving acids or bases can also be used to create a local pH inside the microcapsule that is more friendly to the encapsulated enzyme / compound.
[0861] In most cases, these enzymes are stabilized by adding their substrate (e.g., protein for protease and starch for amylase). Antioxidants or reductants can be used to reduce the oxidation of enzymes, such as thiosulfate, ascorbate, etc. The net dosage of these stabilizers required for each gram of detergent is much lower than adding these stabilizers to the continuous detergent phase, because they are concentrated in the endocereum phase, and will not diffuse out during storage in many cases, or only slowly diffuse out depending on the structure and molecular weight of the stabilizer. In particular, high molecular weight stabilizers (e.g., higher than 1kDa, or higher than 2kDa and more preferably higher than 5kDa) will provide improved net efficiency. Therefore, high molecular weight inhibitors, polymers, polyols, cations, enzyme substrates and antioxidants are preferred.
[0862] The enzyme can be protected by adding a "sacrificial" protein. The component that destabilizes the enzyme reacts with the added sacrificial agent or sacrificial protein by reacting to the amino acid groups (e.g., amino groups) on the protein. Preferred are sacrificial proteins that have a large enough molecular weight to stay inside these capsules.
[0863] A somewhat different way to improve enzyme stability is to add rheology-modified components, which increase the viscosity of the inner capsule phase. The increased internal viscosity will slow down the diffusion of enzyme destabilizers into these capsules (and / or slow down the diffusion of enzyme stabilizers out of the capsule) and therefore extend the life of the enzyme. Examples of such viscosity modifiers are polymers, such as polyethylene glycol (PEG), polyethylene oxide (PEO), hydrophilic polyurethanes, polyvinyl pyrrolidone (PVP) and PVP vinyl acetate copolymers, starch, hyaluronic acid, water-soluble cellulose derivatives (like carboxymethyl cellulose), water-soluble gums (like gum arabic, locust bean gum, guar gum or xanthoceras, etc.) and combinations or copolymers thereof. Most preferably, nonionic high molecular weight polymers have a molecular weight higher than 1kDa, or higher than 2kDa, more preferably higher than 5kDa. Preferred nonionic polymers are because they are more compatible with the reactive membrane polymers than ionic polymers in most cases.
[0864] High viscosity can be achieved in the following ways: use high viscosity aqueous phase to produce these capsules, or more complicatedly, produce capsules when viscosity increase occurs for the first time after producing this emulsion / these capsules. This "triggered" viscosity increase is preferred because it may be difficult to prepare an emulsion with a high viscosity aqueous phase. When added to the detergent by an inner capsule phase with a water activity higher than that of the detergent added thereto, the triggered viscosity increase can be completed in situ, so water will diffuse out of these capsules (but not rheology modifiers) to increase the viscosity of the inner phase after being added to the detergent. This can also be used using the diffusion of salt or other low molecular weight components, for example, by having a component that increases viscosity when salt concentration is reduced by being added to the detergent (for example, a polymer, which precipitates when the initial salt content is high, but is soluble when the salt concentration is reduced due to the diffusion of salt when added to the detergent). Another way to trigger viscosity is to use a component whose viscosity depends on pH. For some interfacial polymerization methods (e.g., amine-acid halide reaction), the pH of the internal phase will change during the encapsulation process, and in the case of amine-acid halide, the pH will decrease during the interfacial polymerization process. This can be used to trigger an increase in viscosity. Many rheology modifiers (like polyacrylates) exhibit viscosity maxima at special pH or pH ranges. Examples of rheology modifiers are Carbopol 934 from Lubrizol and Texipol 63-258 from Scott-Bader, where the viscosity increases significantly when the pH is reduced from 11 to 8 or when the pH is increased from 4 to 8. Another polymer type with different viscosities at low pH and at high pH is partially hydrolyzed polyacrylamide. Another possibility is to use a temperature-dependent rheology modifier, thereby achieving emulsification / encapsulation at one temperature, and then changing the temperature to increase viscosity. Light-induced or ultrasound-induced viscosity can also be used. Yet another approach is to use a shear thinning rheology modifier so that when the emulsion is formed the viscosity is low under high shear and high when the shear is reduced.
[0865] Another stabilization technique is to ensure that the enzyme is precipitated in the capsules during storage, for example by adding a precipitant like a salt or polyethylene glycol (PEG). The same "triggered stabilization" as described above can be used, for example by adding PEG, which upon addition to the detergent is concentrated by diffusion through water to the extent that the enzyme will precipitate. In this way, the enzyme can be in solution during processing of the capsules, but precipitate when added to the detergent.
[0866] In the preparation of these microcapsules, the enzymes can also be used in precipitated or crystalline form.
[0867] In a specifically contemplated embodiment, the microcapsule composition of the present invention is a composition described in WO 2014 / 177709 (hereby incorporated by reference) comprising a lipase variant of the present invention.
[0868] In another embodiment, the present invention relates to microcapsule compositions comprising the lipase variants of the present invention trapped in compartments formed by a membrane produced by crosslinking (a) a multi-branched polyamine having a molecular weight greater than 800 Da and (b) an aliphatic amine or aromatic amine having a molecular weight less than 300 Da; wherein the weight ratio of (a) / (b) is in the range of 0.1 to 1000.
[0869] As described above, the microcapsules may further comprise an enzyme selected from the group consisting of proteases, metalloproteinases, subtilisins, amylases, lipases, cutinases, cellulases, mannanases, pectinases, xanthanases, DNases, laccases, peroxidases, haloperoxidases, perhydrolases, and combinations thereof. Other enzymes described above are also contemplated.
[0870] In one embodiment, the reactive amino groups of the multi-branched polyamine constitute at least 15% of the molecular weight. In one embodiment, the diameter of the compartment is at least 50 microns. In a preferred embodiment, the compartment comprises at least 1% of active enzyme, particularly lipase variant of the present invention, accounting for the total compartment weight. Also as mentioned above, these microcapsules may further comprise an alcohol, such as a polyol.
[0871] In a preferred embodiment, (a) is polyethyleneimine.
[0872] In one embodiment, (b) is an ethyleneamine or an alkanolamine. In a preferred embodiment, (b) is selected from the group consisting of ethylenediamine, diethylenetriamine, triethylenetetramine, di(3-aminopropyl)amine, monoethanolamine, diethanolamine, triethanolamine, hexamethylenediamine, phenylenediamine, piperazine, and tetraethylenepentamine. In a more preferred embodiment, (b) is selected from the group consisting of diethylenetriamine, triethylenetetramine, di(3-aminopropyl)amine, monoethanolamine, and diethanolamine.
[0873] According to the present invention, the compartment of the microcapsule comprises a source of Mg2+, Ca2+ or Zn2+ ions, such as a sparingly soluble salt of Mg2+, Ca2+ or Zn2+.
[0874] In a preferred embodiment, the membrane is produced by using an acid chloride as crosslinking agent, such as isophthaloyl chloride, terephthaloyl chloride or trimesoyl chloride.
[0875] In a preferred embodiment, the membrane is produced by interfacial polymerization.
[0876] In a specifically contemplated embodiment, the microcapsule composition of the present invention is a composition comprising a lipase variant of the present invention as described in WO 2015 / 1144784 (hereby incorporated by reference).
[0877] Liquid products
[0878] In a final aspect, the present invention relates to liquid products comprising the microcapsule composition of the present invention. In a preferred embodiment, the liquid product comprises water or at least a substantial amount of water.
[0879] The following paragraphs describe embodiments of the present invention. :
[0880] 1. A variant of a parent lipase, the variant having lipase activity, having at least 60% but less than 100% sequence identity to SEQ ID NO: 2, and comprising one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, V60E,K, K98I, N101D, R118F, G163S, Y220F, T231R, N233R, T244E, and P256T.
[0881] 2. The variant as described in paragraph 1, wherein the variant comprises substitutions at positions corresponding to T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, V60E,K, K98I, N101D, R118F, G163S, Y220F, T244E, and P256T.
[0882] 3. A variant as described in paragraph 1 or 2, which comprises a substitution corresponding to any one of the following group of substitutions:
[0883]
[0884] 4. A variant as described in any of paragraphs 1-3, wherein the variant comprises substitutions corresponding to E56R+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, D57N, V60E,K, K98I, N101D, R118F, G163S, Y220F, T244E and P256T.
[0885] 5. A variant as described in any of paragraphs 1-4, wherein the variant comprises substitutions at positions corresponding to R118F+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, V60E,K, K98I, N101D, G163S, Y220F, T244E, and P256T.
[0886] 6. A variant as described in any of paragraphs 1-5, wherein the variant comprises substitutions at positions corresponding to E56R+R118F+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, D57N, V60E,K, K98I, N101D, G163S, Y220F, T244E, and P256T.
[0887] 7. A variant as described in any of paragraphs 1-6, wherein the variant comprises substitutions at positions corresponding to E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
[0888] 8. A variant as described in any of paragraphs 1-7, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
[0889] 9. A variant as described in any of paragraphs 1-8, wherein the variant comprises substitutions at positions corresponding to G23S+F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to D27N, A40I, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
[0890] 10. A variant as described in any of paragraphs 1-9, wherein the variant comprises substitutions at positions corresponding to D27N+F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, A40I, D57N, V60E,K, K98I, N101D, G163S, Y220F and T244E.
[0891] 11. A variant as described in any of paragraphs 1-10, wherein the variant comprises substitutions at positions corresponding to A40I+F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
[0892] 12. A variant as described in any of paragraphs 1-11, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
[0893] 13. A variant as described in any of paragraphs 1-12, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+K98I+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, N101D, G163S, Y220F, and T244E.
[0894] 14. A variant as described in any of paragraphs 1-13, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+K98I+R118F+G163S+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, N101D, Y220F, and T244E.
[0895] 15. A variant as described in any of paragraphs 1-14, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+K98I+R118F+G163S+T231R+N233R+T244E+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, N101D, and Y220F.
[0896] 16. A variant as described in any of paragraphs 1-15, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+V60E,K+K98I+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, N101D, G163S, Y220F, and T244E.
[0897] 17. A variant as described in any of paragraphs 1-16, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+N101D+K98I+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, N101D, G163S, Y220F, and T244E.
[0898] 18. A variant as described in any of paragraphs 1-17, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+V60E,K+K98I+N101D+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, G163S, Y220F, and T244E.
[0899] 19. A variant as described in any of paragraphs 1-18, wherein the variant comprises a substitution at a position corresponding to one of the following group of substitutions:
[0900] E56R+R118F+T231R+N233R;
[0901] R118F+T231R+N233R+P256T;
[0902] A40I+R118F+T231R+N233R;
[0903] F51I+E56R+R118F+T231R+N233R;
[0904] F51L+E56R+R118F+T231R+N233R;
[0905] E56R+D57N+R118F+T231R+N233R;
[0906] E56R+V60K+R118F+T231R+N233R;
[0907] G23S+E56R+R118F+T231R+N233R;
[0908] D27N+E56R+R118F+T231R+N233R;
[0909] F51I+E56R+R118F+T231R+N233R;
[0910] E56R+R118F+T231R+N233R+P256T;
[0911] G23S+D27N+E56R+R118F+T231R+N233R;
[0912] G23S+F51I+E56R+R118F+T231R+N233R;
[0913] G23S+E56R+R118F+T231R+N233R+P256T;
[0914] D27N+F51I+E56R+R118F+T231R+N233R;
[0915] D27N+E56R+R118F+T231R+N233R+P256T;
[0916] F51I+E56R+R118F+T231R+N233R+P256T;
[0917] G23S+D27N+F51I+E56R+R118F+T231R+N233R;
[0918] G23S+D27N+E56R+R118F+T231R+N233R+P256T;
[0919] G23S+D27N+F51I+E56R+V60K+R118F+T231R+N233R+P256T;
[0920] G23S+D27N+F51I+E56R+V60E+R118F+T231R+N233R+P256T; <h2 style=";text-align:left;direction:ltr">
[0921] <h2 style=";text-align:left;direction:ltr"> G23S+F51I+E56R+R118F+T231R+N233R+P256T;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0922] <h2 style=";text-align:left;direction:ltr"> D27N+F51I+E56R+R118F+T231R+N233R+P256T;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0923] <h2 style=";text-align:left;direction:ltr"> G23S+D27N+F51I+E56R+R118F+T231R+N233R+P256T;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0924] <h2 style=";text-align:left;direction:ltr"> A40I+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0925] <h2 style=";text-align:left;direction:ltr"> F51L+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0926] <h2 style=";text-align:left;direction:ltr"> D57N+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0927] <h2 style=";text-align:left;direction:ltr"> K98I+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0928] <h2 style=";text-align:left;direction:ltr"> G163S+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0929] <h2 style=";text-align:left;direction:ltr"> A40I+F51L+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0930] <h2 style=";text-align:left;direction:ltr"> A40I+D57N+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0931] <h2 style=";text-align:left;direction:ltr"> A40I+K98I+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0932] <h2 style=";text-align:left;direction:ltr"> A40I+G163S+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0933] <h2 style=";text-align:left;direction:ltr"> A40I+E56R+R118F+T231R+N233R+P256T;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0934] <h2 style=";text-align:left;direction:ltr"> F51L+D57N+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0935] <h2 style=";text-align:left;direction:ltr"> F51L+K98I+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0936] <h2 style=";text-align:left;direction:ltr"> F51L+G163S+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0937] <h2 style=";text-align:left;direction:ltr"> F51L+E56R+R118F+T231R+N233R+P256T;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0938] <h2 style=";text-align:left;direction:ltr"> D57N+K98I+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0939] <h2 style=";text-align:left;direction:ltr"> D57N+G163S+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0940] <h2 style=";text-align:left;direction:ltr"> D57N+E56R+R118F+T231R+N233R+P256T;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0941] <h2 style=";text-align:left;direction:ltr"> K98I+G163S+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0942] <h2 style=";text-align:left;direction:ltr"> K98I+E56R+R118F+T231R+N233R+P256T;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0943] <h2 style=";text-align:left;direction:ltr"> G163S+E56R+R118F+T231R+N233R+P256T;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0944] <h2 style=";text-align:left;direction:ltr"> A40I+F51L+D57N+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0945] <h2 style=";text-align:left;direction:ltr"> A40I+F51L+K98I+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0946] <h2 style=";text-align:left;direction:ltr"> A40I+F51L+G163S+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0947] <h2 style=";text-align:left;direction:ltr"> A40I+F51L+E56R+R118F+T231R+N233R+P256T;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0948] <h2 style=";text-align:left;direction:ltr"> A40I+D57N+K98I+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0949] <h2 style=";text-align:left;direction:ltr"> A40I+D57N+G163S+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0950] <h2 style=";text-align:left;direction:ltr"> A40I+D57N+E56R+R118F+T231R+N233R+P256T;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0951] <h2 style=";text-align:left;direction:ltr"> A40I+K98I+G163S+E56R+R118F+T231R+N233R;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0952] <h2 style=";text-align:left;direction:ltr"> A40I+K98I+E56R+R118F+T231R+N233R+P256T;<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0953] A40I+G163S+E56R+R118F+T231R+N233R+P256T;
[0954] F51L+D57N+K98I+E56R+R118F+T231R+N233R;
[0955] F51L+D57N+G163S+E56R+R118F+T231R+N233R;
[0956] F51L+D57N+E56R+R118F+T231R+N233R+P256T;
[0957] F51L+K98I+G163S+E56R+R118F+T231R+N233R;
[0958] F51L+K98I+E56R+R118F+T231R+N233R+P256T;
[0959] F51L+G163S+E56R+R118F+T231R+N233R+P256T;
[0960] D57N+K98I+G163S+E56R+R118F+T231R+N233R;
[0961] D57N+K98I+E56R+R118F+T231R+N233R+P256T;
[0962] D57N+G163S+E56R+R118F+T231R+N233R+P256T;
[0963] K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0964] A40I+F51L+D57N+K98I+E56R+R118F+T231R+N233R;
[0965] A40I+F51L+D57N+G163S+E56R+R118F+T231R+N233R;
[0966] A40I+F51L+D57N+E56R+R118F+T231R+N233R+P256T;
[0967] A40I+F51L+K98I+G163S+E56R+R118F+T231R+N233R;
[0968] A40I+F51L+K98I+E56R+R118F+T231R+N233R+P256T;
[0969] A40I+F51L+G163S+E56R+R118F+T231R+N233R+P256T;
[0970] A40I+D57N+K98I+G163S+E56R+R118F+T231R+N233R;
[0971] A40I+D57N+K98I+E56R+R118F+T231R+N233R+P256T;
[0972] A40I+D57N+G163S+E56R+R118F+T231R+N233R+P256T;
[0973] A40I+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0974] F51L+D57N+K98I+G163S+E56R+R118F+T231R+N233R;
[0975] F51L+D57N+K98I+E56R+R118F+T231R+N233R+P256T;
[0976] F51L+D57N+G163S+E56R+R118F+T231R+N233R+P256T;
[0977] F51L+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0978] D57N+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0979] A40I+F51L+D57N+K98I+G163S+E56R+R118F+T231R+N233R;
[0980] A40I+F51L+D57N+K98I+E56R+R118F+T231R+N233R+P256T;
[0981] A40I+F51L+D57N+G163S+E56R+R118F+T231R+N233R+P256T;
[0982] A40I+F51L+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0983] A40I+D57N+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0984] F51L+D57N+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0985] A40I+F51L+D57N+K98I+G163S+E56R+R118F+T231R+N233R+P256T;
[0986] A40I+F51L+E56R+D57N+K98I+R118F+G163S+T231R+N233R+P256T;
[0987] A40I+E56R+R118F+T231R+N233R;
[0988] E56R+R118F+T231R+N233R+T244E;
[0989] G23S+D27N+E56R+R118F+T231R+N233R;
[0990] G23S+A40I+E56R+R118F+T231R+N233R;
[0991] G23S+F51I+E56R+R118F+T231R+N233R;
[0992] G23S+E56R+R118F+T231R+N233R+T244E;
[0993] G23S+E56R+R118F+T231R+N233R+P256T;
[0994] D27N+A40I+E56R+R118F+T231R+N233R;
[0995] D27N+F51I+E56R+R118F+T231R+N233R;
[0996] D27N+E56R+R118F+T231R+N233R+T244E;
[0997] D27N+E56R+R118F+T231R+N233R+P256T;
[0998] A40I+F51I+E56R+R118F+T231R+N233R;
[0999] A40I+E56R+R118F+T231R+N233R+T244E;
[1000] A40I+E56R+R118F+T231R+N233R+P256T;
[1001] F51I+E56R+R118F+T231R+N233R+T244E;
[1002] F51I+E56R+R118F+T231R+N233R+P256T;
[1003] E56R+R118F+T231R+N233R+T244E+P256T;
[1004] G23S+D27N+A40I+E56R+R118F+T231R+N233R;
[1005] G23S+D27N+A40I+E56R+V60K+R118F+T231R+N233R;
[1006] G23S+D27N+A40I+E56R+V60E+R118F+T231R+N233R;
[1007] G23S+D27N+F51I+E56R+R118F+T231R+N233R;
[1008] G23S+D27N+E56R+R118F+T231R+N233R+T244E;
[1009] G23S+D27N+E56R+R118F+T231R+N233R+P256T;
[1010] G23S+A40I+F51I+E56R+R118F+T231R+N233R;
[1011] G23S+A40I+E56R+R118F+T231R+N233R+T244E;
[1012] G23S+A40I+E56R+R118F+T231R+N233R+P256T;
[1013] G23S+F51I+E56R+R118F+T231R+N233R+T244E;
[1014] G23S+F51I+E56R+R118F+T231R+N233R+P256T;
[1015] G23S+E56R+R118F+T231R+N233R+T244E+P256T;
[1016] G23S+E56R+V60K+R118F+T231R+N233R+T244E+P256T;
[1017] G23S+E56R+V60E+R118F+T231R+N233R+T244E+P256T;
[1018] D27N+A40I+F51I+E56R+R118F+T231R+N233R;
[1019] D27N+A40I+E56R+R118F+T231R+N233R+T244E;
[1020] D27N+A40I+E56R+R118F+T231R+N233R+P256T;
[1021] D27N+F51I+E56R+R118F+T231R+N233R+T244E;
[1022] D27N+F51I+E56R+R118F+T231R+N233R+P256T;
[1023] D27N+E56R+R118F+T231R+N233R+T244E+P256T;
[1024] A40I+F51I+E56R+R118F+T231R+N233R+T244E;
[1025] A40I+F51I+E56R+R118F+T231R+N233R+P256T;
[1026] A40I+E56R+R118F+T231R+N233R+T244E+P256T;
[1027] F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[1028] F51I+E56R+V60K+R118F+T231R+N233R+T244E+P256T;
[1029] F51I+E56R+V60E+R118F+T231R+N233R+T244E+P256T;
[1030] G23S+D27N+A40I+F51I+E56R+R118F+T231R+N233R;
[1031] G23S+D27N+A40I+F51I+E56R+V60K+R118F+T231R+N233R;
[1032] G23S+D27N+A40I+F51I+E56R+V60E+R118F+T231R+N233R;
[1033] G23S+D27N+A40I+E56R+R118F+T231R+N233R+T244E;
[1034] G23S+D27N+A40I+E56R+V60K+R118F+T231R+N233R+T244E;
[1035] G23S+D27N+A40I+E56R+V60E+R118F+T231R+N233R+T244E;
[1036] G23S+D27N+A40I+E56R+R118F+T231R+N233R+P256T;
[1037] G23S+D27N+F51I+E56R+R118F+T231R+N233R+T244E;
[1038] G23S+D27N+F51I+E56R+R118F+T231R+N233R+P256T;
[1039] G23S+D27N+E56R+R118F+T231R+N233R+T244E+P256T;
[1040] G23S+A40I+F51I+E56R+R118F+T231R+N233R+T244E;
[1041] G23S+A40I+F51I+E56R+R118F+T231R+N233R+P256T;
[1042] G23S+A40I+E56R+R118F+T231R+N233R+T244E+P256T;
[1043] G23S+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[1044] D27N+A40I+F51I+E56R+R118F+T231R+N233R+T244E;
[1045] D27N+A40I+F51I+E56R+R118F+T231R+N233R+P256T;
[1046] D27N+A40I+E56R+R118F+T231R+N233R+T244E+P256T;
[1047] D27N+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[1048] A40I+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[1049] A40I+F51I+E56R+V60K+R118F+T231R+N233R+T244E+P256T;
[1050] A40I+F51I+E56R+V60E+R118F+T231R+N233R+T244E+P256T;
[1051] G23S+D27N+A40I+F51I+E56R+R118F+T231R+N233R+T244E;
[1052] G23S+D27N+A40I+F51I+E56R+V60K+R118F+T231R+N233R+T244E;G23S+D27N+A40I+F51I+E56R+R118F+T231R+N233R+P256T;
[1053] G23S+D27N+A40I+F51I+E56R+V60K+R118F+T231R+N233R+P256T;G23S+D27N+A40I+F51I+E56R+V60E+R118F+T231R+N233R+P256T;
[1054] G23S+D27N+A40I+E56R+R118F+T231R+N233R+T244E+P256T;
[1055] G23S+D27N+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[1056] G23S+A40I+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[1057] D27N+A40I+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[1058] D27N+A40I+F51I+E56R+V60K+R118F+T231R+N233R+T244E+P256T;D27N+A40I+F51I+E56R+V60E+R118F+T231R+N233R+T244E+P256T;G23S+D27N+A40I+F51I+E56R+R118F+T231R+N233R+T244E+P256T;
[1059] G23S+D27N+A40I+F51I+E56R+K98I+N101D+R118F+T231R+N233R+T244E+P256T;
[1060] G23S+D27N+A40I+F51I+E56R+V60K+R118F+T231R+N233R+T244E+P256T;
[1061] G23S+D27N+A40I+F51I+E56R+V60E+R118F+T231R+N233R+T244E+P256T;
[1062] F51I+E56R+R118F+T231R+N233R;
[1063] E56R+R118F+T231R+N233R+T244E;
[1064] D27N+F51I+E56R+R118F+T231R+N233R;
[1065] D27N+E56R+R118F+T231R+N233R+T244E;
[1066] F51I+E56R+R118F+T231R+N233R+T244E;
[1067] D27N+F51I+E56R+R118F+T231R+N233R+T244E;
[1068] G23S+E56R+R118F+T231R+N233R;
[1069] D27N+E56R+R118F+T231R+...
Claims
1. A variant of a parent lipase, the variant having lipase activity, having at least 60% but less than 100% sequence identity to SEQ ID NO: 2, and comprising one or more (e.g., several) substitutions at positions corresponding to A40I, G23S, D27N, F51I,L, E56R, D57N, V60E,K, K98I, N101D, G163S, Y220F, T231R, N233R, T244E and P256T.
2. The variant of claim 1, wherein the variant comprises a substitution at a position corresponding to T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, V60E,K, K98I, N101D, R118F, G163S, Y220F, T244E, and P256T.
3. The variant of claim 1 or 2, comprising a substitution corresponding to any one of the following group of substitutions:
4. The variant of any one of claims 1 to 3, wherein the variant comprises substitutions corresponding to E56R+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, D57N, V60E,K, K98I, N101D, R118F, G163S, Y220F, T244E, and P256T.
5. The variant of any one of claims 1 to 4, wherein the variant comprises substitutions at positions corresponding to R118F+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, E56R, D57N, V60E,K, K98I, N101D, G163S, Y220F, T244E, and P256T.
6. The variant of any one of claims 1-5, wherein the variant comprises substitutions at positions corresponding to E56R+R118F+T231R+N233R and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, D57N, V60E,K, K98I, N101D, G163S, Y220F, T244E, and P256T.
7. The variant of any one of claims 1-6, wherein the variant comprises substitutions at positions corresponding to E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, F51I,L, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
8. The variant of any one of claims 1-7, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
9. The variant of any one of claims 1-8, wherein the variant comprises substitutions at positions corresponding to G23S+F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to D27N, A40I, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
10. The variant of any one of claims 1-9, wherein the variant comprises substitutions at positions corresponding to D27N+F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, A40I, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
11. The variant of any one of claims 1-10, wherein the variant comprises substitutions at positions corresponding to A40I+F51I,L+E56R+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, D57N, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
12. The variant of any one of claims 1-11, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, K98I, N101D, G163S, Y220F, and T244E.
13. The variant of any one of claims 1-12, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+K98I+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, N101D, G163S, Y220F, and T244E.
14. The variant of any one of claims 1-13, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+K98I+R118F+G163S+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, N101D, Y220F, and T244E.
15. The variant of any one of claims 1-14, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+K98I+R118F+G163S+T231R+N233R+T244E+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, N101D, and Y220F.
16. The variant of any one of claims 1-15, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+V60E,K+K98I+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, N101D, G163S, Y220F, and T244E.
17. The variant of any one of claims 1-16, wherein the variant comprises substitutions at positions corresponding to F51I,L+E56R+D57N+N101D+K98I+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, V60E,K, N101D, G163S, Y220F, and T244E.
18. The variant of any one of claims 1 to 17, wherein the variant comprises a residue corresponding to Substitutions at positions F51I,L+E56R+D57N+V60E,K+K98I+N101D+R118F+T231R+N233R+P256T and one or more (e.g., several) substitutions at positions corresponding to G23S, D27N, A40I, G163S, Y220F, and T244E.
19. The variant of any one of claims 1-18, which is a variant of a parent lipase selected from the group consisting of: a) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% identity, at least 96%, at least 97%, at least 98%, or at least 99%, or 100% sequence identity to SEQ ID NO: 2; b) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions, medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions with (i) the polypeptide coding sequence of SEQ ID NO: 1 or (ii) the full-length complementary sequence of (i); c) a polypeptide encoded by a polynucleotide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to SEQ ID NO: 1; and d) A fragment of the polypeptide of SEQ ID NO:
2.
20. The variant of any one of claims 1-19, wherein the variant has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% identity, at least 96%, at least 97%, at least 98%, or at least 99% but less than 100% sequence identity to SEQ ID NO:
2.
21. A composition comprising a variant as claimed in any one of claims 1 to 20.
22. The composition of claim 21, further comprising a surfactant.
23. Use of a variant according to any one of claims 1 to 20 for hydrolysing a lipase substrate.
24. A method for cleaning a surface, the method comprising contacting the surface with a variant as claimed in any one of claims 1 to 20.
25. A method for hydrolyzing a lipase substrate, the method comprising treating the lipase substrate with the lipase variant of any one of claims 1-20.
26. A polynucleotide encoding a variant according to any one of claims 1 to 20.
27. A nucleic acid construct comprising the polynucleotide of claim 26, wherein the polynucleotide is operably linked to one or more control sequences that direct the production of the lipase variant in a recombinant host cell.
28. An expression vector comprising the polynucleotide according to claim 26 or the nucleic acid construct according to claim 27.
29. A host cell comprising the nucleic acid construct according to claim 27 or the expression vector according to claim 28.
30. A method for producing a lipase variant, the method comprising: a) culturing the host cell according to claim 29 under conditions suitable for expressing the variant; as well as b) recovering the variant.
31. A microcapsule composition, wherein the membrane of the microcapsule is produced by cross-linking multi-branched polyamines having a molecular weight higher than 1 kDa, wherein the microcapsule comprises the lipase variant according to any one of claims 1-20.
32. A liquid product comprising the microcapsule composition of claim 31.
